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ABSTRACT
Background:  Although  high  concentrations  of  carbon  monoxide  (CO)  are 
unquestionably toxic,  emerging evidence reveals that CO at low concentrations 
plays  a  significant  role  in  vasorelaxation,  blockade  of  apoptotic  pathways, 
suppression of inflammation and protection against ischaemia-reperfusion  (l-R) 
injury.  Our group  has  recently  identified  a  series  of compounds  (CO-releasing 
molecules  or  CO-RMs)  which  exert  important  pharmacological  activities  by 
carrying and delivering CO to biological systems.
Aims:  The  present  study  was  designed  to  evaluate  the  influence  of  CO 
released from  CO-RMs  on  mitochondrial  respiration  and  its  consequences  on 
renal  haemodynamic,  biochemical,  and  physiological  parameters  as well  as to 
examine the possible beneficial effects of CO-RMs against l-R injury.
Methods:  Parallel  experiments  were  conducted  using:  1)  the  isolated  renal 
cortical  rat  mitochondria  for  evaluation  of  oxygen  consumption,  hydrogen 
peroxide  production,  and  lipid  peroxidation.  2)  the  ex  vivo  isolated  perfused 
rabbit  kidney  (IPRK)  model  to  measure  the  physiological  and  biochemical 
parameters  and  mitochondrial  respiration  for  freshly  harvested  kidneys  and 
kidneys exposed to ischaemic injury,  and 3) an in  vitro model of renal  proximal 
tubular epithelial  (LLC-PKi) cells  to  assess  membrane  integrity  and  metabolic 
activity.
Results:  The  major  findings  of  this  study  indicate  that  CO  modulates 
mitochondrial  respiratory  activity  in  isolated  rat  mitochondria.  In  IPRK  model, 
CO  reduces  tubular  reabsorption  and  increases  urine  and  perfusion  flow  rate 
and  glomerular  filtration  rate  of  freshly  isolated  kidneys.  However,  in  IPRK 
model, kidneys flushed with a cold preservation solution supplemented with CO-
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RMs  and  stored  at 4  °C  for 24 or 48  hr displayed  at  reperfusion  a  significant 
protective  vasodilatory  effect,  improved  renal  function  and  mitochondrial 
respiration  compared  to  control  kidneys  flushed  with  cold  solution  alone. 
Additionally,  CO  released  from  CO-RMs  protects  against  preservation  injury 
using the in vitro model of LLC-PKi  cells.  In contrast, in a warm  l-R model using 
the IPRK circuit,  CO was only beneficial by increasing the perfusate flow rate at 
reperfusion.
Conclusion:  the  results  emphasize  that  CO  liberated  from  CO-RMs  has  a 
protective  vasodilatory  effect,  improves  renal  function  and  increases 
mitochondrial  respiration  after cold  ischaemia  and  reperfusion.  These findings 
suggest that CO-RMs could be used therapeutically in preservation solutions as 
an  efficacious  strategy  to  prevent  the  injury  sustained  by  organs  during  cold 
storage prior to transplantation.
3UC1 QUOTATION
QUOTATION
Whether a person shows themseCves to he a genius in science or in writing a 
song,  the onCy point is, whether the thought,  the discovery,  or the deed, is
hiving and can hive on
lofiann Woffgang Von Goethe 
1749-1832
German poet novelist and dramatist, author of "Faust"
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1  INTRODUCTION
1.1  Renal Anatomy
Knowledge of the structure of the kidney is important to the understanding of its 
function.  Normally  there  are  two  kidneys,  one  on  each  side  of  the  vertebral 
column  at  the  level  of  T12  to  L3,  behind  the  peritoneum  in  the  posterior 
abdominal wall.  The lateral  surface  is convex while the medial  one  is  concave 
and where the renal  hilum  is located,  through which  pass the  renal  pelvis,  the 
lymphatic system,  the nerves  and the  renal  blood vessels.  Fresh  human  adult 
kidney  is  ovoid  in  outline,  reddish-brown  in  colour,  measures  about  10  cm  in 
length,  5 cm  in width and 2.5 cm  in thickness,  and weighs about 150 g (Figure 
1-1). The kidney is surrounded by a strong fibrous capsule within  peri-renal fat. 
The urine formed by the kidney is initially drained  into the funnel-shaped renal 
pelvis,  which  is  the  dilated  part  of the  ureter that  carries  urine  to  the  urinary 
bladder by peristaltic movement.
The renal arteries usually arise at right angle from the aorta, where each artery 
divides  close  to  the  hilum  into five  segmental  arteries.  The  initial  branches  of 
these arteries are called lobar arteries,  and these divide into interlobar arteries 
which themselves divide into arcuate arteries at the junction of the medulla and 
the  cortex.  These  then  divide  into  interlobular  arteries,  giving  rise  to  afferent 
arterioles.  Several  veins drain the  kidney  and  unite to form the  renal  vein  that 
drain  into the  inferior vena cava  (Figure  1-2).  The  lymph vessels of the kidney 
follow the renal vein and drain into the lumber lymph nodes.  Innervations of the 
kidney  come  from  the  renal  plexus  and  consist  of  sympathetic  and 
parasympathetic fibres. The suprarenal  (adrenal) gland is located on the upper
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part of each kidney.  Each kidney is divided into a dark outer region, termed the 
cortex,  and a paler inner region,  termed the medulla, which  is further divided to 
form  the  renal  pyramids.  The  apex  of  each  conical  shaped  pyramid  extends 
towards  the  renal  pelvis  to  form  a  papilla,  the  urine  draining  from  the  papilla 
towards  the  calyces  which  are  cuplike  structures  joining  within  the  kidney  to 
form the renal  pelvis (Figure  1-1). The functional unit of the kidney is called the 
nephron  and  each  human  kidney  contains  about  one  million  nephrons,  each 
nephron  consisting  of  two  components,  which  are  the  glomerulus  and  the 
tubules (Figure 1-3).
Major calyx 
Minor calyx
Renal pelvis 
Renal column 
Renal papilla
Ureter
Figure 1-1: Longitudinal section of the kidney
The  kidney is  divided  into  outer cortex and  inner medulla,  which forms  renal  pyramids 
that  end  as  a  renal  papilla,  then  calyx,  and  lastly  renal  pelvis.  Adapted  from 
(www.phvsioweb.org/kidney.html)
Renal pyramids
Renal
capsule
Renal cortex
Renal medulla
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Each glomerulus is supplied with blood by afferent arterioles forming a network 
of  capillaries,  which  invaginate  the  blinded  end  of  the  associated  tubules, 
forming the glomerular or Bowman’s capsule. These capillaries rejoin and leave 
the glomerulus to form the efferent arteriole.
Renal artery 
Renal pelvis
Renal vein
Afferent arteriole
Cortex
Nephron
Interlobular 
artery & vein
Arcuate 
artery 
& vein
Medulla
Interlobar artery 
& vein
—   Ureter
Figure 1-2: Renal blood vessels
The  renal  artery  arises from  the  aorta,  where  each  artery  divides  into  five  segmental 
arteries,  the  initial  branch  of  these  arteries  called  lobar  arteries,  which  divide  into 
interlobar arteries  which  themselves  divide  into  arcuate  arteries  at the junction  of the 
medulla  and  the  cortex.  These  then  divide  into  interlobular  arteries,  giving  rise  to 
afferent arterioles.  Adapted from (www.phvsioweb.org/kidnev.htmn
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The Bowman’s capsule is the blind end of the nephron tubule, from which arise 
the proximal tubules, the descending and ascending parts of the loop of Henle, 
the distal  convulated tubule,  and the outer and  inner medullary collecting  duct, 
which opens at the tip of the renal papilla into the renal calyx and into the renal 
pelvis (Figure 1-3). The glomeruli, proximal and distal tubules are situated in the 
cortex,  whereas  the  loops  of  Henle  and  the  collecting  ducts  extend  down 
through  the  medulla.  In  humans  about  15  %  of  nephrons  are  long-looped, 
whose  glomeruli  are  in  the  inner  one-third  of  the  cortex  (juxtamedullary 
nephron) and have long loop of Henle, which pass deeply into the medulla.
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Figure 1-3: The structure of the nephron
Each nephron consists of the glomerulus and the tubules.  Each glomerulus is supplied 
with  blood  by afferent arterioles forming  a  network of capillaries,  which  invaginate the 
blinded  end  of  the  tubules  forming  the  glomerular  or  Bowman’s  capsule.  These 
capillaries  rejoin  and  leave  the  glomerulus  to  form  the  efferent  arteriole.  From  the 
capsule, arise the different parts of the tubules.
Adapted from (www.phvsioweb.org/kidnev.html)
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1.2  Renal Physiology
The  kidneys form the site of connection  between the circulating  blood  and the 
outside  of the  body,  leading  to  the formation  and  excretion  of  urine.  The  two 
main  functions  of the  nephron  are  glomerular filtration  and  adjustment  of the 
filtered fluid as it passes through the tubules.
1.2.1  Glomerular Filtration Rate
The filtration barrier of the glomeruli allows only free passage of solutes with  a 
diameter  of  less  than  4  nm,  thus  retaining  cells  and  proteins  within  the 
circulating  blood.  Under  physiological  conditions,  the  balance  between  the 
resistance in the afferent and efferent arterioles determines the regulation of the 
filtration rate.  Factors leading to afferent arteriolar dilatation or efferent arteriolar 
constriction  such  as  NO,  dopamine  and  prostaglandins  will  increase  the 
glomerular filtration rate (GFR) and vasa versa.  However,  if the renal function is 
impaired due for example to low renal perfusion pressure,  maintenance of GFR 
is  dependent on  intrinsic factors  such  as  prostaglandins for  afferent  arteriolar 
vasodilatation  and  angiotensin for efferent arteriolar vasoconstriction.  The  rate 
of  excretion  of  a  solute  (Es)  by  the  kidney  is  given  by  the  product  of  the 
concentration of the solute in the urine (Us) and the urine flow rate (V), which is 
defined as the urine volume over a known period: Es= Us x V (Ganong,  1999). 
The renal clearance of the solute or GFR is defined as the apparent volume of 
plasma  from  which  the  solute  is  completely  removed  per  unit  of time  during 
passage through the kidney.  It is equivalent to the ratio of the excretion rate to 
the  plasma  concentration  of that solute  (Ps):  GFR= (Us x V) / Ps;  the  unit of 
clearance is ml/min.  In man, the normal GFR is about 180 L/dayor 125 ml/min.
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The  substance  used  to  measure  GFR  should  be  freely  filtered,  neither 
reabsorbed nor secreted.  In addition, the substance should not be metabolized 
or stored,  not toxic and easy to measure in plasma and urine.  Inulin, which is a 
polymer of fructose  meets these  criteria  and  hence  was  used  in  humans  and 
animals  to  measure  GFR  (Olbrich  et  al.,  1950).  Creatinine  (Cr)  is  an 
endogenous  substance  derived  from  the  metabolic  breakdown  of  creatine,  a 
component of skeletal muscle (Baum et al.,  1975).  Like inulin,  it is freely filtered 
at the glomerulus without tubular reabsorption,  thus the creatinine clearance is 
equal  to  GFR.  Urea  is  also  one  of the  key  parameters  to  assess  the  kidney 
function, which is one of the main metabolic products of protein metabolism that 
is freely filtered at the glomerulus;  since it is subjected to approximately 50% of 
reabsorption, its clearance is around half the GFR (Baum et al.,  1975).
1.2.2  Tubular Function
The  main  function  of  the  tubular  cells  is  either  secretion  or  reabsorption  of 
solutes.  It does so either through an active transport that needs ATP,  through a 
secondary  active  transport,  or  by  passive  diffusion.  The  movement  of solutes 
occurs  through  ion  channels,  exchangers,  co-transporters,  and  pumps.  The 
amount of any solute that is filtered  is the product of the  GFR and the plasma 
level  of  that  solute,  but  tubular  cells  may  add  more  of  the  substance  to  the 
filtrate or may remove some or all of the substance from the filtrate. The amount 
of the solute excreted equals the concentration of the  solute in the urine times 
the urine volume per unit time (Ganong,  1999).
The  reabsorption  of  Na+   and  Cl' plays  a  major  role  in  body  electrolytes  and 
water metabolism. Na+  is actively transported out of all parts of the renal tubules 
except the portion of the loop of Henle.  This active transport pumps  Na+  by the
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Na+-K+   ATPase  from  the  tubular  cell  into  the  interstitium,  the  Na+-K+   ATPase 
catalyzes the hydrolysis of ATP to ADP and the produced energy will be used to 
transport three  Na+  out of the tubular cell,  taking  two  K+   into the  cell  for each 
ATP  hydrolyzed.  In normal  human  adults the percentage of Na+  reabsorbed  is 
about 99.4% (Ganong,  1999).
Glucose  is  reabsorbed  along  with  Na+   in  the  early  portion  of  the  proximal 
tubules by a secondary active transport; this means that glucose reabsorption is 
coupled  to  the  active  transport of  Na+.  First,  glucose  and  Na+   move  from  the 
tubular  lumen  into  the  tubular  cell  by  a  cotransporter  called  SGLT2. 
Subsequently,  Na+  is  pumped  out by the  Na+-K+  ATPase  as  described  before, 
and  lastly glucose is transported out of the cell to the  interstitium  by a  second 
cotransporter called GLUT2 (Figure 4-12,  page 175).  In a normal human,  all the 
filtered glucose is reabsorbed so that the percentage of glucose reabsorption is 
100% (Hansen et al.,  1997).
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1.3  Renal Pathology
Disorders of the  kidneys arise from  a wide  range  of pathological  causes  as  in 
other organ systems (e.g.  infections,  tumour,  and vascular disorder).  However, 
the kidney is unusual  in that it is much  more prone to immunological disorders 
than  most  other  organs.  Disorders  of the  kidney  can  be  conveniently  divided 
into  categories  according  to  which  structural  component  of  the  kidney  is 
primarily affected: glomerulus, tubules and interstitium, and blood vessels.
1.3.1  Renal Glomerular Disease
The  glomerulus  is  the  target  of  many  diseases  leading  to  temporary  or 
permanent  impairment  of  kidney  function.  The  term  glomerulonephritis  is 
traditionally  used  to  describe  a  group  of  diseases  in  which  the  primary 
pathology  is  structural  abnormality  of the  glomerulus;  despite  the  suffix  “itis”, 
most  of  these  diseases  are  not  characterized  by  inflammatory  changes. 
Glomerular  diseases  are  classified  according  to  the  histological  pattern  of 
damage  seen  on  renal  biopsies.  Patients  may  be  asymptomatic  or  mainly 
exhibit haematuria,  proteinuria,  renal failure,  nephrotic and  nephritic syndrome 
and  hypertension.  The  Nephrotic  syndrome  is  a  triad  of  proteinuria, 
hypoalbuminaemia,  and  oedema.  Minimal  change  glomerulonephritis  is  the 
commonest  cause  of  nephritic  syndrome  in  children;  other  common  causes 
include  membranous  glomerulonephritis  and  total  segmental 
glomerulosclerosis.  The  Nephritic syndrome  is  a  combination  of  haematuria 
and  proteinuria.  It  is  usually  associated  with  hypertension,  oedema,  oliguria 
(urine output < 400 ml per day) and a rising urea and creatinine levels.
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1.3.2  Renal Tubular and Interstitial Disease
The  main  causes  of these  diseases  are  infections,  ischaemia,  and  toxic  and 
metabolic disorders.
Pyelonephritis can be acute or chronic. The acute type is caused by bacterial 
infection,  and  characterized  microscopically  by  variable  numbers  of  small 
abscesses.  The  chronic type  is  considered  as  a  common  cause  of end-stage 
renal failure and characterized by interstitial chronic inflammation and scarring, 
which  destroys nephrons.  It is caused  by infection  secondary to obstruction  or 
reflux of urine.
Acute tubular necrosis is a common and  important cause of reversible acute 
renal  failure  in  which  metabolic  or toxic  disturbances  cause  necrosis  of  renal 
tubular  epithelial  cells.  The  common  cause  is  ischaemia  due  to  renal 
hypoperfusion,  but  less  commonly  it  can  be  caused  by  toxins  such  as  heavy 
metals, organic solvents, and drugs.
Interstitial nephritis is an important cause of acute and chronic renal failure.  It 
is  an  inflammatory  disease  of  the  renal  interstitium,  associated  with  tubular 
atrophy or damage.  Most commonly  it is  caused  by drugs  such  as  analgesics 
and antibiotics which lead to acute or chronic drug-induced  interstitial nephritis; 
less  commonly  it  is  caused  by  radiation  leading  to  radiation  nephritis.  Blood 
Vessels diseases include hypertension and vasculitis.
1.3.3  Renal Failure
Acute renai failure is a significant deterioration in renal function occurring over 
hours  or  days.  Clinically,  there  may  be  no  symptoms  or  signs,  but  oliguria  is 
common.  Biochemically, acute renal failure is detected by elevated plasma urea 
and  Cr  concentrations.  It  is  often  associated  with  multiple  organ  failure  and
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sepsis (Sheridan and  Bonventre,  2000).  Common causes of acute  renal failure 
include renal hypoperfusion and acute tubular necrosis.
Chronic  renal  failure  is  defined  as  the  irreversible,  substantial,  and  long­
standing loss of renal function, which can be classified according to the GFR as 
mild  (30-50 ml/min),  moderate (10-29 ml/min),  severe  (<  10  ml/min),  and  end- 
stage  (<  5  ml/min).  End-stage  renal  failure  is  the  degree  of  renal  failure  that 
without  renal  replacement  therapy  could  result  in  death.  Common  causes  of 
chronic renal failure include glomerulonephritis,  diabetes mellitus,  hypertension, 
and polycystic kidney disease.
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1.4  Renal Transplantation
1.4.1  Historical Highlights
Organ  transplantation  has  a  long  history  beginning  with  skin  auto  grafting  in 
India during the sixth  century  B.C  (Deschamps  et al.,  2005).  In  1906,  Mathieu 
Jaboulay  from  Lyon  carried  out  the  first  recorded  attempt  of  heterotopic 
transplantation  of the  kidney  using  goat  and  pig  kidneys  (Jaboulay,  1906).  In 
1936, the Russian surgeon Yu Yu Voronoy performed the first human-to-human 
kidney allograft from a cadaveric donor,  but the kidney never worked (Voronoy, 
1936).  The first wholly successful  human transplant took place  in  Boston from 
one  twin  to  another  in  1955  by  Joseph  Murray,  who  later  received  the  Nobel 
Prize  in  1990 for this achievement (Murray et al.,  1955).  In  1961,  azathioprine 
and  steroids  were  introduced  as  immunosuppressants  and  were  the  gold 
standard until the  introduction  in  1976 of cyclosporine,  which  greatly  improved 
the  outcomes  of cadaver kidney transplants  in  animals  and  humans  (Caine  et 
al.,  1978;  Green and Allison,  1978).  In  1962,  Caine and  colleagues  performed 
the first successful  cadaveric renal  allograft  in  a  human  who was  treated with 
azathioprine (Murray, 2005).  Nowadays,  tacrolimus and  mycophenolate  mofetil 
have  emerged  as  effective  and  well  tolerated  options  for  inducing  and 
maintaining immunosuppression (Ahsan et al.,  1997).
1.4.2  Donors
The  kidney is  one of the  most successfully transplanted  organs today.  It is  an 
effective,  cost-efficient therapy,  and the treatment of choice for end-stage renal 
disease. A successful kidney transplant offers enhanced quality and duration of 
life and  is  more effective than  chronic haemodialysis from  both a  medical  and
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economical  prospective  (Bonventre  and  Weinberg,  1992).  Overall,  renal 
transplantation improves survival  in all  age groups  and for all  underlying  renal 
pathologies  (Andrews,  2002).  The  most  common  aetiologies  of  renal  disease 
leading  to  kidney  transplantation  are  diabetes,  chronic  glomerulonephritis, 
polycystic kidney disease,  hypertension,  and interstitial nephritis.  In the  UK, the 
number  of  patients  registered  on  the  active  kidney  or  kidney  and  pancreas 
transplant list increased to 5,425 at 31  March 2005 (UKTSSA, 2005).  Currently, 
waiting  lists  for  kidney  transplantation  are  expanding  by  about  3%  per  year 
(Figure  1-4),  and  suitable  donors  for  organs  are  in  short  supply  (Andrews,
2002). Grafts for kidney transplantation can be obtained from:
I.  Living related donor kidneys.
II.  Living unrelated donor kidneys.
The above two donor kidneys are generally excluded from preservation or cold 
ischaemia.  Despite the fact that laparoscopic nephrectomy minimizes  morbidity 
in living renal donors (Andrews, 2002), living donor kidney transplants increased 
by  3%  to  475  in  2004-2005,  and  now  represent  27%  of  the  total  kidney 
transplant  programme  (UKTSSA,  2005).  The  main  objection  to  living  kidney 
donation is that it exposes the healthy donor to the  risks of major surgery and 
life with  a solitary kidney entirely for the benefit of the recipient (Nicholson and 
Bradley,  1999).
III.  Cadaveric heart beating donors,  most of transplanted kidneys are obtained 
from a brainstem dead but heart beating donors in which their circulation and 
ventilation  are  supported until the  organ  is  removed  (Kimber et al.,  2001).  In 
this case,  a considerable period of ischaemia resulting from cold preservation 
prior to transplantation is likely.
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IV.  Cadaveric  non-heart  beating  donors,  who  have  already  suffered  cardio­
respiratory arrest.  Here,  a significant period of warm  ischaemia  is  inevitable, 
so  rapid  organ  retrieval  is  needed  to  minimize  damage  secondary  to  warm 
ischaemia  (Kimber  et  al.,  2001).  For  instance,  the  median  (range)  warm 
ischaemic time for non-heart beating donors kidneys was 25 min (5 to 53 min) 
(Nicholson  et  al.,  2000).  In  2005,  the  number  of transplants from  non-heart 
beating donors increased by 20% to 143 (UKTSSA, 2005).
The critical role of cold preservation and ischaemia to chronic renal rejection is 
evident  by  the  fact  that  more  than  85%  of  grafts  from  living  related  and 
unrelated  donor  kidneys  survive  5  years  compared  to  approximately  50% 
survival for cadaveric donor kidneys (Cruthirds et al., 2003).  In contrast,  despite 
being  associated with  poor initial  graft function,  the  long-term  allograft  survival 
(five  years)  of  non-heart  beating  donors  kidneys  does  not  differ  significantly 
from that of heart beating donors and living transplants (Nicholson et al., 2000).
1.4.3  Post-Transplantation Complications
1.  Delayed  graft function  describes  acute transplant  kidney  dysfunction  in  the 
immediate  postoperative  phase  after  the  transplant  procedure  (Peeters  et 
al.,  2004).  It is  usually due to acute tubular necrosis,  which affects 20-30% 
of kidney transplants and reduces the short and  long-term allograft survival 
(Faure  et  al.,  2003).  Moreover,  there  are  increased  rates  of delayed  graft 
function  and  primary  non-function  in  non-heart  beating  kidneys,  but  long 
term function is good (Kimber et al., 2001).
2.  Chronic allograft nephropathy is the most prevalent cause of renal transplant 
failure in the first post-transplant decade,  but its pathogenesis has remained
39B _____________   INTRODUCTION
elusive.  Clinically,  it is characterized by a slow but variable loss of function, 
often in combination with proteinuria and hypertension (Paul,  1999).
3.  Nephrotoxicity of drugs used to prevent rejection  such  as cyclosporine and 
tacrolimus (Jain et al., 2000).
4.  Recurrence  of  native  kidney  disease  (e.g.  glomerulonephritis)  (Newstead, 
2003).
5.  Graft  rejection  (Peeters  et  al.,  2004),  which  could  be  hyperacute  (within 
hours),  accelerated acute (within the first week),  acute (within 3-6 months), 
or chronic (> 6 months).
6.  Cardiovascular disease is a major cause of both graft loss and patient death 
in  renal  transplant recipients (Fellstrom,  2001).  These  include hypertension 
(Kasiske  et  al.,  2004),  arterial  stenosis  (Ruggenenti  et  al.,  2001),  and 
venous thrombosis (Guirguis et al., 2000).
7.  Post-transplantation infections (Nampoory et al., 2003).  For example,  human 
cytomegalovirus infection is the single most frequent infectious complication 
in the early period after kidney transplantation (Sagedal et al., 2005).
8.  Post-transplantation diabetes mellitus (Salvadori et al., 2003).
9.  Post-transplantation bone disease (Brandenburg et al., 2004).
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Figure 1-4: Cadaveric kidney programme in the UK
A  summary  of  activity  cadaveric  kidney  programme  in  the  UK  represents  number  of 
donors, transplants and patients on the active transplant list between  1  April  1995 - 31 
March 2005. Adapted from UKTSSA Website: www.uktransplant.oro.uk.
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1.5  Renal Preservation
1.5.1  Historical Highlights
It  was  stated  in  1924  by  Avrmovici  that  “the  tolerance  of  the  canine  kidney 
against anoxic damage is temporary dependent and is improved considerably at 
lower  temperature”;   by  using  simple  ice  cooling  he  was  the  first  person  to 
successfully  protect  kidneys  against  ischaemia  during  kidney  transplantation 
(Marberger and Dreikorn,  1983).  In 1956, Bogardus and Schlosser showed that 
cooling  of  dog  kidneys  to  23-26  °C  resulted  in  marked  protection  against 
functional  damage  (Bogardus  and  Schlosser,  1956).  In  1963,  Caine  and  co­
workers reported that dog kidneys could be preserved for 8-12 hr by immersing 
them  in ice water (Caine et al.,  1963).  In  1967,  Belzer and colleagues reported 
the preservation of dog kidneys with continuous hypothermic perfusion for up to 
72  hr (Belzer et al.,  1967),  but 20 years  later the  same  group  published  on  a 
successful  five  and  seven  days  perfusion  preservation  of  the  canine  kidney 
(McAnulty  et al.,  1989;  McAnulty et  al.,  1991).  In  1969,  Collins  et al.  reported 
the successful  preservation for transplantation of the canine kidney by an initial 
perfusion, followed by cold storage for up to 30 hr (Collins et al.,  1969).
1.5.2  Methods of Renal Preservation
The  principles  of organ  preservation  are flushing,  cooling,  and  pharmacologic 
intervention, which aim to deliver a viable and functioning graft to a recipient by 
minimizing  cellular  swelling  and  membrane  pump  activity,  and  hence 
maintaining  the  cellular  ATP  level.  The  two  methods  now  used  for  kidney 
preservation for transplantation are:
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1.  Continuous machine perfusion near 8 °C that provides a supply of metabolic 
substrates  and  removes  by-products,  recreating  the  normal  circulation 
(Belzer,  1977).
2.  Gravity  perfusion  with  cold  intracellular flush  solution  via  the  renal  artery, 
followed  by  storage  in  the  same  cold  solution  at  0-4  °C  to  decrease 
metabolism as much as possible (Roels et al.,  1998).
Figure  1-5  (Page  46)  shows  an  example  of  a  commercially  available  kidney 
perfusion machine.  Machine perfusion provides a higher quality graft and allows 
longer preservation periods of the kidney (Southard and Belzer,  1995).  It has an 
advantage over static cold storage in that it allows continual delivery of oxygen 
and  substrates  to  the  organ  for  synthesis  of  ATP  and  other  metabolites,  in 
addition,  it  allows  removal  of  end  products  of  metabolism  and  stimulates 
continuous  metabolism  (Southard  and  Belzer,  1995).  Machine  perfusion  has 
been successfully used to store kidney for up to 5-7 days (McAnulty et al.,  1989; 
McAnulty  et  al.,  1991).  However,  the  standard  practice  today  continues  to 
involve  flushing  and  storage  of  the  kidney  at  4  °C  for  the  minimum  time 
necessary  before  transplantation,  while  continuous  perfusion  preservation  is 
only  clinically  used  at  a few centres  (St  Peter et  al.,  2002).  Additionally,  cold 
storage  is  simpler  and  cheaper  than  continuous  machine  perfusion,  which 
requires  an  expensive,  cumbersome  device  that  necessitates  more  delicate 
transportation and additional personnel to run it (St Peter et al., 2002).
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1.5.3  Kidney Preservation Solutions
In this project,  the cold flushing and storage method was chosen as this is the 
most  frequently  used  method  in  clinical  renal  transplantation.  Therefore,  this 
introduction  deals  only  with  solutions  used  for  this  specific  method  and  with 
emphasis on kidney preservation (Table 1-1).
Collins  solution  is  one  of the first solutions for kidney  preservation  developed 
by  G.M.  Collins  in  Los Angeles  in  1969  (Collins  et al.,  1969),  and  then  it was 
modified  to  Eurocollins  solution  by  the  Euro-transplant  Organization  by 
removing  magnesium without negative  effects  on  preservation  results  (Klen  et 
al.,  1983).  One  of the  major disadvantages  of this  solution  is the  presence  of 
glucose  which  is  metabolised  even  at  hypothermia,  resulting  in  doubling  of 
intracellular  substrate  molecules  and  cell  swelling;  as  a  consequence,  the 
solution  has  almost  been  abandoned  because  of  the  glucose  disadvantage 
(Muhlbacher et al.,  1999).
The  hypertonic  citrate  solution  was  introduced  by  Ross  and  colleagues  in 
1976 (Ross et al.,  1976), it is a stable and effective solution, distinguished by its 
hypertonicity  and  a  high  concentration  of  citrate  and  sulphate  anions  and 
magnesium.  It also contains mannitol to prevent cells swelling. Additionally,  the 
high  level  of citrate sequesters the free  Ca2+  in the  extracellular fluid  before  it 
enters cells (Green,  1995).
Histidine-Tryptophan-Ketoglutarat solution (HTK) was introduced initially as a 
cardioplegic  solution  by  H.J.  Bretschneider  from  Gottingen,  Germany 
(Bretschneider,  1980). The basic philosophy is the introduction of a very potent 
buffer system, which is Histidine,  along with the two substrates. The first clinical 
use  of Bretschneider's  HTK-solution for in-situ-protection  of the  kidney in  mild
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hypothermia  was  reported  in  1988  (Blech  et  al.,  1988).  The  HTK  has  been 
tested in clinical trials and the results show the same safety and efficacy profile 
as UW (Muhlbacher et al.,  1999).
University  of  Wisconsin  solution  (UW)  was  developed  as  a  result  of  the 
continuous  research  effort  headed  by  F.O.  Belzer  (Southard,  2002).  The 
solution  was  targeted  at  maintaining  the  osmotic  concentration  by  the 
administration  of  metabolically  inert  substrates  like  lactobonate  and  raffinose 
and  not  by  glucose,  the  use  of  the  colloid  carrier  hydroxyethylstarch,  and 
addition  of oxygen  radical  scavengers,  glutathione,  allopurinol,  and  adenosine. 
This solution was proven to guarantee extreme long cold ischaemia tolerance of 
up  to  72  hr  in  kidneys,  and  was  found  superior  to  Eurocollins  because  it 
decreased  the  rate  of  delayed  graft function  from  33%  to  23%  (Ploeg  et  al., 
1988).  Therefore,  UW was  adopted  as  the  standard  preservation  solution  for 
livers,  kidneys, and pancreases despite the disadvantage of high viscosity, high 
price, and awkward handling (Muhlbacher et al.,  1999).
The  Celsior  solution  is  a  novel  preservation  solution,  created  by  Pasteur- 
Merieux (Menasche  et al.,  1994).  It  is  a  high  sodium,  low  potassium  solution, 
containing  lactobionate  and  mannitol for osmotic properties,  with  histidine  and 
reduced glutathione as oxygen radical  scavengers;  in addition,  it also contains 
glutamate  as  an  energy  substrate  (Menasche  et  al.,  1994).  Celsior  was  first 
used  clinically  as  a  novel  cardioplegic  solution  (Llosa  et  al.,  2000),  but  also 
showed  a  protective  effect  in  lung  (Xiong  et  al.,  1999),  liver  (Cavallari  et  al., 
2003), pancreas (Boggi et al., 2005), and intestinal transplantation (deRoover et 
al.,  2004).  Because of its low viscosity and anti-oxidant and anti-edematogenic 
properties,  it  has  also  been  used  for  kidney  preservation  and  transplantation,
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and  showed  an  equal  or  superior  efficacy  to  that  of  UW   in  experimental  and 
clinical  fields  (Baldan  et  al.,  1997;  Faenza  et  al.,  2001;  Mohara  et  al.,  1999). 
The  promising  results  of  Celsior  as  a  universal  cold  storage  solution  for  intra- 
thoracic organs as well  as  intra-abdominal  organs  support  its  use  in this  project 
as  a  novel  storage  solution  for  kidneys  perfused  in  the  isolated  rabbit  circuit. 
Beyond  all  aspects  of preservation  potencies  of all  these  solutions,  it  must  not 
be  forgotten  that  cold  ischaemia  itself  is  a  risk  factor  for  organ  function. 
Therefore, the time of cold ischaemia should be kept as short as possible.
mm
Figure 1-5: Standard kidney perfusion machine
Waters  RM3  Renal  Preservation  System  (Waters  Medical  Systems,  Minneapolis,  MN, 
USA).
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Content (mmol/L)  Collins EC UW HTK Citrate Celsior
— — 5 — — —
— — 1 — —
10 10 — — — —
— — — 0.015 — 0.25
— — — — 54 —
15 15 — 50 — 41.5
— 50g — — —
— ---- 16mg/L — — —
126 198 — — — —
— — — — 20
— — 3 — — 3
— — — 180 — 30
— — 40 — — —
115 115 125 10 80 15
— — — 1 — —
— — 100 — — 80
— — 30 33.8g/L 60
30 — 5 4 41 13
10 10 30 15 84 100
320 406 320 310 486 320
— — 200000 — — —
1  7.0-7.3 7.0-7.3 7.4 7.2 7.1 7.3
57.5 57.5 25 — — —
— — 30 — — —
30 5 — 41 —
— — 2 — —
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1.6  Renal Ischaemic Injury
1.6.1  Background
Renal  injury  can  be  caused  by  numerous  factors,  including  ischaemia, 
autoimmune  diseases  and  toxins.  Ischaemia  entails  abolition  of  blood  flow  to 
the  organ,  starvation  of  the  tissue  of  oxygen  and  nutrients  and  causes 
accumulation of metabolic waste products.  During the ischaemic period  (Figure 
1-7),  the  main  biochemical  changes  at  the  cellular  level  are  inhibition  of 
oxidative  metabolism,  depletion  of ATP,  a  decrease  in  antioxidant  activity,  an 
increase  in  anaerobic  metabolism,  and  inhibition  of the  Na+-K+   ATPase  pump 
(Brezis and Epstein,  1993). ATP is broken down rapidly to AMP  and  increases 
the  levels  of adenosine,  inosine,  and  hypoxanthine,  which,  in  the  absence  of 
oxygen,  cannot  be  further  metabolised  because  this  process  occurs  under 
aerobic  conditions.  In  addition,  anaerobic  glycolysis  leads  to  accumulation  of 
lactic  acid,  which  lowers  intracellular  pH,  and  to  lysosomal  instability  with 
activation of lytic enzymes (Perico et al.,  2004).  Ischaemia is the main problem 
in renal preservation and transplantation, and it is essential to avoid or minimize 
ischaemic damage.  Additionally,  ischaemic  injury to the  renal  allograft  prior to 
transplantation is a major cause of delayed graft function.  There are two types 
of ischaemia: warm ischaemia (Wl) and cold ischaemia.
1.6.2  Warm Ischaemia
The  most frequently  used  renal  model  of  ischaemia  consists  of a  temporary 
occlusion  of the renal artery in  normothermia and with the kidney in situ.  Wl  is 
tolerated without serious alteration of rabbit kidney function for no more than 30 
min;  after that there are gross changes in some tubules,  and at 60 min there is
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total  necrosis  of  all  segments  of  the  majority  of  tubules;  in  addition,  90%  of 
animals will survive 30 min of Wl while 75% will survive 60 min of Wl,  therefore 
much of this damage is reversible (Pegg,  1986).  In fact, after 60 min of Wl there 
is  permanent  histological  damage  of  the  rat  kidney  (Jablonski  et  al.,  1983). 
However,  it has been demonstrated that 18 hr of ex vivo warm  perfusion of rat 
kidneys  resulted  in  immediate  function  after  transplantation  (Brasile  et  al.,
2002).
1.6.3  Cold Ischaemia
It  is  well  known  that  cold  preservation  of  kidneys  minimises  the  ischaemic 
damage.  In general,  kidneys harvested from cadaveric donors are preserved to 
attenuate  the  ischaemic  injury  that  occurs  during  the  time  from  harvest  to 
transplantation.  It has  been  shown  that renal  oxygen  demand  can  be  reduced 
by  around  97%  by  simple  hypothermia  (Pegg,  1986)  and  that  oxygen 
consumption  drops  in  relation  to  renal  temperature  (Marberger  and  Dreikorn, 
1983). The main principle of cold preservation is to slow the metabolic reactions 
that  need  ATP,  and  lowering  the  kidney  temperature  by  cold  preservation 
rapidly  reduces  the  energy-dependent  metabolic  activity  of the  kidney.  It  has 
been shown that metabolism is slowed by a factor of 1.5-2 for each  10 °C drop 
in  temperature  (McLaren  and  Friend,  2003).  Despite  the  beneficial  effects  of 
cold  storage,  cold  l-R  injury  of transplanted  kidneys  is  associated  with  acute 
tubular  necrosis  leading  to  delayed  graft  function  and  reduced  short-term 
allograft survival (Ahlenstiel et al., 2003).  Delayed graft function may be due to 
ischaemic  and  immunologic  causes  that  may  act  synergistically  (Ahlenstiel  et 
al.,  2003).  As  the  transplant waiting  lists  are  increasing,  it  appears  crucial  to 
attenuate  cold  l-R  injury  in  order  to  prevent  delayed  graft  function  and
49UCL INTRODUCTION
consecutively  improve  the  outcome  of  kidney  transplantation.  Simple  cold 
storage after rapid flushing of the kidneys at 4 °C using preservation solutions is 
extremely effective and the strategy commonly used to reduce ischaemic injury 
during cold storage, certainly for a period of 24 hr (Marshall,  1980). A prominent 
feature  of  renal  cold  ischaemia  is  cell  swelling  as  the  Na+   pump  becomes 
arrested  due to cooling  and  lack of ATP.  Therefore,  the preservation  solutions 
specifically  developed  to  minimize  enzymatic  activity  and  energy  substrate 
depletion.  However,  despite  the  preservation  attempts,  prolonged  cold 
preservation of kidneys leads inevitably to injury from hypothermic ischaemia.
1.6.4  Renal Ischaemia-Reperfusion Injury
1.6.4.1  The Clinical Problem
Kidney  transplantation  requires  discontinuation  of  the  organ  blood  supply. 
Ischaemia-reperfusion (l-R) injury is a serious concern in organ transplantation. 
It is a leading cause of kidney damage and bears the potential to shorten graft 
and  patient survival.  It  is a  major cause  of dysfunction  in transplanted  organs, 
which  affects  early  and  late  post-transplant  kidney  allograft  function.  This  is 
evident  by  the  fact  that  transplants  from  living  donors  have  better  long-term 
survival  than  those  from  cadavers  (Andrews,  2002),  which  suggests  that  l-R 
injury could be implicated in the pathogenesis of chronic transplant dysfunction. 
Therefore,  the  central  focuses  of  kidney  transplantation  therapy  are  the 
reduction of ischaemic time and the prevention of rejection in order to decrease 
the  discrepancy  between  demand  and  supply  for  kidney  transplantation.  For 
instance,  the  number of patients  registered  on  the  active  transplant  list  in  the 
UK on the 31  March 2005 for a kidney or kidney and pancreas transplant has
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increased by 32% since  1996,  and the number of patients waiting for a kidney 
transplant represents 92 patients per million populations (UKTSSA, 2005).
1.6.4.2  Pathophysiology of Ischaemia-Reperfusion Injury
Reperfusion  allows  rewarming,  reoxygenation,  which  is  a  return  to  aerobic 
metabolism,  and production of ATP.  But the reoxygenation event itself, which is 
necessary  for  organ  recovery,  can  also  lead  to  injury  through  the  following 
cytoplasmic and mitochondrial mechanisms,  leading to graft dysfunction (Figure 
1-7).
Mitochondria and reactive oxygen species:  Mitochondria (see section  1.7.6) 
are  key  contributors  to  l-R  injury,  as  mitochondrial  respiration  and  oxidative 
phosphorylation  are  essential  for  keeping  the  ATP  demands  and  restoring 
cellular energy after ATP  depletion  caused  by  ischaemia.  For  instance,  it  has 
been  shown  that the  mitochondrial  respiratory  defect  is  an  early  event  in  cold 
preservation-reoxygenation  injury  of  endothelial  cells  in  vitro  (Steinlechner- 
Maran  et  al.,  1997).  One  of  the  mechanisms  proposed  for  l-R  injury  is  that 
ischaemia  will  lead  to  cellular  oedema  and  accumulation  of  end  products  of 
anaerobic  metabolism  such  as  protons,  lactate,  and  hypoxanthine.  On 
reperfusion or reoxygenation, these by-products contribute to the generation of 
oxygen free  radicals  and other reactive oxygen  species  (ROS) which  damage 
the  tissue  and  induce  acute  inflammatory  responses  (McLaren  and  Friend, 
2003).  The  mitochondria  are  the  major  generator  of  ROS  during  normal 
metabolism.  Remarkably,  complex  I  and  complex  III  of the  electron-transport 
chain are the major sites for ROS  production (Chen et al.,  2003).  ROS  include 
the  superoxide  anion  radicals  (O2'),  hydrogen  peroxide  (H2O2),  and  reactive 
hydroxyl radical (HO').  Of these,  H2O2 is the most stable and abundant,  since it
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is the by-product of superoxide scavenging by the superoxide dismutase (SOD) 
enzymes  (Degli,  2002).  In  addition  to  l-R  injury,  the  rate  of  ROS  production 
increased  in  a  number  of  pathological  conditions  including  hypoxia,  aging, 
apoptosis  and  chemical  inhibition  of  mitochondrial  respiration  (Chen  et  al.,
2003).  Complex  I  inhibition  by  rotenone  can  increase  ROS  generation  in 
submitochondrial  particles  (Chen  et  al.,  2003).  Furthermore,  the  oxidation  of 
either  complex  I  or  complex  II  substrates  in  the  presence  of  complex  III 
inhibition with  antimycin A will also increase ROS  (Chen et al.,  2003).  Much of 
the damage to cells results from the ROS-induced alteration of macromolecules 
such as polyunsaturated fatty acids in membrane lipids,  essential  proteins,  and 
DNA.  Additionally,  oxidative  stress  and  ROS  have  been  implicated  in  disease 
states,  such  as  Alzheimer’s  disease,  Parkinson’s  disease,  cancer,  and  aging 
(Balaban et al., 2005;  Hensley et al., 2000).
Lipid  peroxidation:  ROS  are  capable  of  reacting  with  proteins,  lipids  and 
nucleic  acids,  leading  to  lipid  peroxidation  of biological  membranes  and  MDA 
production.  Lipid  peroxidation  also  impairs  mitochondrial  and  cellular function, 
fundamentally  by  damaging  membranes  (Degli,  2002).  Due  to  its  membrane 
composition,  the  mitochondrion  is  especially  sensitive  to  lipid  peroxidation.  In 
fact,  the major phospholipids components of the  mitochondrial  membranes are 
rich in unsaturated fatty acids that are particularly susceptible to oxygen radical 
attack because of the presence of double bounds that can undergo peroxidation 
through  a  chain  of  oxidative  reactions  (Paradies  et  al.,  1999).  For  both 
hypothermic  storage  and  reperfusion-induced  injury,  ROS  play  an  important 
pathogenetic role, mainly by provoking and increased levels of lipid peroxidation 
products (Ahlenstiel et al., 2003; Jung et al.,  1990).
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Inflammation  is  a  major  component  of  l-R  injury  and  playing  a  considerable 
role in its pathophysiology (Bonventre and Zuk, 2004).  In fact, a deleterious role 
of  the  inflammatory  response  was  shown  in  renal  l-R  injury  (Daemen  et  al., 
1999).  There  is  an  increasing  body  of  evidence  to  suggest  that  ischaemia 
triggers the release of pro-inflammatory  mediators  along with the  up-regulated 
expression of adhesion proteins in kidney that activated the neutrophils and the 
complement system (De Greef et al.,  1998;  Sheridan and  Bonventre,  2000).  In 
agreement,  infiltrating cells were  implicated strongly in the  renal  l-R injury and 
increased  infiltration of neutrophils and  macrophages  into the  renal  tissue was 
seen (Saikumar and Venkatachalam, 2003).
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Figure  1-6:  The  role  of  reactive  oxygen  species  in  cell  growth,  survival  and 
apoptosis
Cell  growth,  survival,  and  damage  are  induced  by  reactive  oxygen  species  (ROS). 
Examples  of  ROS  are superoxide anion  radicals (0 2'),  hydrogen  peroxide  (H20 2),  and 
hydroxyl  radical  (HO).  The  main  source  of  ROS  in  vivo  is  mitochondrial  electron 
transport chain.  Under normal  conditions,  ROS are cleared from  the  cell  by the action 
of  superoxide  dismutase  (SOD),  catalase,  or  glutathione  (GSH)  peroxidase.  The 
diagram also showed the possible targets of ROS.
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Apoptosis  and  necrosis  play  a  key  role  in  l-R  injury.  Cell  death  by 
hypoxia/ischaemia may occur by apoptosis as well as necrosis in experimental 
models of renal  injury both in vivo and in  vitro (Saikumar and Venkatachalam,
2003).  Less  severe  injury  often  results  in  apoptosis  rather  than  necrosis 
(Lieberthal  et  al.,  1996).  Necrosis  can  occur  during  hypoxia/ischaemia  as  a 
result of widespread cellular degradation,  and during reoxygenation/reperfusion 
as  a  consequence  of  the  development  of  the  mitochondrial  permeability 
transition  pore  (Saikumar  and  Venkatachalam,  2003).  In  vitro  models  of 
hypoxia/reoxygenation  suggest  that  apoptotic  cell  death  may  occur  during 
reoxygenation  as  a  consequence  of  mitochondrial  release  of  cytochrome  c 
during  hypoxia  (Saikumar  and  Venkatachalam,  2003).  In  one  study  in  human 
cadaveric  donor  renal  allografts,  it  was  shown  that  apoptosis  of tubular  cells 
occurs predominantly as a result of reperfusion after prolonged  cold ischaemia 
(Burns et al.,  1998).  Since kidney cells are exposed to varied degrees of oxygen 
deprivation  and  have  different  metabolic  responses,  it  is  not  surprising  that 
there  is  heterogeneity  in  injury  pattern,  for  instance,  apoptosis  is  more 
commonly  found  in  distal  tubular  cells  in  allografts  of  patients  with  biopsy 
confirmed acute tubular necrosis (Oberbauer et al.,  1999).
Calcium  overload:  Intracellular  Ca2+  accumulation  is  thought  to  be  a  major 
component  of renal  l-R  injury  (Green  et  al.,  1989) and  Ca2+ channel  blockers 
have been  used  successfully to reduce  l-R injury  in  the  kidney (Anaise et al., 
1987;  Dosluoglu  et  al.,  1993).  During  ischaemia,  increased  extracellular  K+  
stimulates  Ca2+  ion  channels  leading  to  increased  cytosolic and  mitochondrial 
Ca2+  concentrations.  During  reperfusion  massive  Ca2+  influx  enters  ischaemic
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cells,  activates  phospholipases  and  proteases,  and  it  alters  the  cellular 
cytoskeleton and volume regulation (Hauet et al.,  1998).
Endothelial  dysfunction  and  vasospasm:  After  reperfusion,  the  ischaemic 
kidney  shows  different  degrees  of  cellular  and  functional  damage  that 
contributes to profound reduction in the glomerular filtration rate,  and increased 
afferent arteriolar resistance (Alejandro et al.,  1995a).  There is also element of 
increased  vascular  resistance  that  derives  also  from  severe  injury  of  the 
proximal  tubule  that  results  in  transtubular  back  leak  of filtrate  and  impaired 
proximal  Na+   reabsorption  (Alejandro  et  al.,  1995b).  Damaged  vascular 
endothelium  disrupts  the  balance  of  eicosanoid  metabolism,  causing 
vasoconstriction  because  of excess  thromboxane  and  decreased  prostacyclin 
(Finn  et  al.,  1987).  Endothelin,  which  is  an  efficient  vasoconstrictor  in  the 
kidney,  is  increased  in the  peritubular capillary  network  of kidneys  exposed  to 
ischaemia  (Wilhelm  et  al.,  1999).  Additionally,  patients  with  delayed  graft 
function have high endothelin-1  concentrations in serum (Schilling et al.,  1996). 
In  this  vasoconstriction  environment,  nitric  oxide  (NO)  helps  to  maintain 
vascular  relaxation  and  medullary  oxygenation  (Brezis  et  al.,  1991),  and  is 
important in overcoming post-ischaemic vasoconstriction.  NO,  synthesized from 
L-arginine  by  the  nitric  oxide  synthase  (NOS)  enzymes,  is  a  messenger 
molecule  mediating  diverse  biological  functions  (Moncada  et  al.,  1991),  and 
involved  in  a  complex  sequence  of  events  both  physiologically  and 
pathophysiologically during  ischaemia  and  reperfusion  (Weight and  Nicholson,
1998).  In addition, there is evidence to indicate that NO is an important mediator 
of hypoxia-induced  proximal  tubule and  ischaemic ARF  (Kribben  et al.,  1999). 
NOS  activity  is  increased  by  hypoxia  leading  to  increased  generation  of  NO,
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which  has  the  potential  to  disrupt the  active  cytoskeleton,  leading  to  proximal 
tubular  cell  detachment  and  tubular  obstruction  (Shoskes  et  al.,  1997).  NO 
reacts  with  superoxide  radicals  to  produce  peroxynitrite  (OONO),  a  potent 
oxidant  that  then  decays  to  generate  hydroxyl  radical.  Therefore,  although 
increased generation of NO by iNOS can attenuate renal damage by promoting 
vasodilatation,  most  studies  suggest  a  negative  role  of  NO  in  this  setting 
through activation of oxygen radical-induced injury (Ling et al.,  1999;  Noiri et al., 
1996; Walker et al., 2000).
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Figure 1-7: The mechanisms of ischaemia-reperfusion injury
The  major  causes  and  key  events  of  l-R  injury,  which  show the  main  metabolic  and 
ionic  changes  that  occur  during  ischaemia  and  how  these  changes  influence  the 
mitochondrial function upon reperfusion. When  renal cell or tissue becomes ischaemic, 
there  is  a  rapid  fall  in  cellular  ATP  levels,  with  a  shift  to  AMP  as  the  predominant 
nucleotide.  Catabolism  of  AMP  increases  levels  of  adenosine,  inosine,  and 
hypoxanthine.  In the presence of oxygen (upon reperfusion), xanthine oxidase (XO) will 
convert the accumulated products into xanthine, which  contributes to the generation of 
reactive  oxygen  species from  the  mitochondria.  This  schematic figure  also  represents 
leucocytes  recruitment  and  activation,  and  the  generation  of  inflammatory  and 
vasoactive  mediators  after  graft  reperfusion.  ET:  Endothelin,  TxA2:   Thromboxane  A2, 
PGI2:   Prostaglandin,  RBF:  Renal blood flow.
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1.6.4.3  Protection against Ischaemia-Reperfusion Injury
In  normal  conditions,  cells  contain  multiple  endogenous  defence  mechanisms 
against  free  radicals.  For  example,  the  enzymes  catalase  and  superoxide 
dismutase  (SOD)  promote  catabolism  of  hydrogen  peroxide  and  superoxide, 
respectively  (Das  and  Maulik,  1994).  Glutathione,  normally  present  at  high 
concentrations  in  tubular cells,  serves  as  a source  of reducing  equivalents for 
detoxification of hydrogen  peroxide via glutathione  peroxidase  (Bonventre  and 
Weinberg,  1992).  Additionally,  vitamin  E  represents  the  non-enzymatic 
components that act as cellular antioxidants (Franssen et al.,  1995).
Several approaches have been used to counter the above-mentioned damaging 
mechanisms  in  order  to  achieve  improvements  in  l-R  injury  and  prolong 
preservation  time  (Table  1-2).  Of  these,  preservation  solutions  have  been 
designed to  minimize  ischaemic injury during  cold  storage  (Muhlbacher et al.,
1999).  Particular agents are added to these solutions to decrease cell swelling, 
maintain  calcium  homoeostasis,  decrease  ROS  generation,  and  provide  high- 
energy  substrates.  For example,  additives  such  as  trimetazidine  (Hauet  et al.,
1998),  polyethylene  glycol  (Faure  et  al.,  2004),  or  bioflavonoids  (Ahlenstiel  et 
al.,  2003) could supplement standard solutions and  protects against  l-R injury. 
Taking  advantage  of  the  known  ability  of free  radical  scavengers  to  combat 
oxidative  stress,  most  of  the  antioxidants  have  been  proved  to  be  beneficial 
against  l-R  injury  (Das  and  Maulik,  1994);  (Shoskes,  1998).  Among  the 
antioxidants, a-tocopherol (Avunduk et al., 2003),  SOD (Caramelo et al.,  1996), 
glutathione  (Gnaiger et  al.,  2000),  and  haem  oxygenase-1  (HO-1)  expression 
(Takahashi  et  al.,  2004)  are  probably  the  most  popular  and  have  been 
extensively studied.
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The use of pharmacological agents promoting renal blood flow has been shown 
to provide protection against l-R injury and improve graft function (Anaise et al., 
1987).  Because  NO  plays  an  important  role  in  maintaining  renal  blood  flow 
(Brezis  et  al.,  1991),  the  application  of  NO  donors  has  been  shown  to  be 
protective  against renal  ischaemic injury (Matsumura et al.,  1998).  In  addition, 
the  induction  of  HO-1  and  the  consequent  increase  in  endogenous  CO 
production  as  well  as  exogenous  CO  play  important  roles  in  renal 
vasorelaxation  (Neto et al.,  2004;  Zou et al., 2000).  There is also experimental 
evidence  of the  benefit  of antagonizing  the vasoconstrictor  mediators  of post- 
ischaemic tissue injury.  For example, studies in rats have shown that endothelin 
receptor  antagonists  ameliorated  renal  l-R  injury  (Huang  et  al.,  2002).  It  has 
also  been  demonstrated  that the  calcium  channel  blocker  nifedipine  improves 
recovery  of  kidneys  preserved  in  a  high-Na+,  low-K+   cold  storage  solution 
(Ramella-Virieux et al.,  1997).
Anti-inflammatory interventions can afford significant protection against renal  I- 
R  injury  (Brady,  1993;  Ventura  et  al.,  2002).  These  include  antagonists  of 
platelet  activating  factor  receptor,  monoclonal  antibodies  to  TNF,  inhibitors  or 
antagonists  of  cytokines,  monoclonal  antibodies,  complement  inhibitors,  and 
immunosuppressants  (Perico  et  al.,  2004).  In  addition,  specific  inhibitors  of 
apoptosis,  such  as  the  p53  inhibitor pifithrin-alpa,  have  been  demonstrated  to 
have  protective  effects  in  a  renal  model  of  l-R  injury  (McLaren  and  Friend,
2003).  Furthermore,  administration  of  caspase  inhibitors  markedly  reduced 
renal  l-R injury (Daemen et al.,  2002). As  mitochondria play a major role in  l-R 
injury,  a dramatic protection against ischaemic injury has been found after ATP
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supply with either pre-treatment or post-treatment with ATP-MgChand also with 
adenosine (Marberger and Dreikorn,  1983).
Recently,  it  has  become  apparent that  exposure  of tissues  to  brief  periods  of 
ischaemia  protects  them  from  the  harmful  effects  of  subsequent,  prolonged 
ischaemia  (Kosieradzki  et  al.,  2003).  This  process,  termed  ischaemic 
preconditioning,  has  been  demonstrated  to  confer  protection  against 
subsequent  ischaemic  attack  in  the  kidney  (Fuller  et  al.,  2005;  Park  et  al.,
2001).  Nonetheless,  clinical  studies  using  ischaemic  preconditioning  in  kidney 
transplantation are lacking.
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Anti-inflammatory agents •  Cytokines inhibitors [165]
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Anti-apoptotic agents •  Caspase inhibitors [79]
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Mitochondrial protection •  Adenosine [180]
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1.7  Mitochondria
1.7.1  Brief History
The  phenomenon  of  cell  respiration  was  first  discovered  in  1924  by  Otto 
Warburg (Shafrir,  1993), while ATP was first identified in 1929 by Karl Lohmann 
(Hofmann,  1978)  and  its  link to  respiration  was  shown  by  Herman  Kaclkar  in 
1937 (Saraste,  1999).  Oxygen uptake by tissue homogenates, and the action of 
simple respiratory inhibitors were first studied systematically in the 1930s, when 
it was realized that electrons flowed from substrates to oxygen via a sequence 
of  redox  carriers  (2004b).  Binding  of  CO  to  mammalian  cytochromes  a3  was 
recognized in 1939, when Keilin and Hartree measured the reduced cytochrome 
a3 -CO  complex  in  the  porcine  heart  (Brown  and  Piantadosi,  1990).  In  1950s 
Sjostrand  and  Palade  independently published the first  high-resolution  images 
of  mitochondria  and  described  the  major  features  of  mitochondrial  structure 
(Nisoli  et  al.,  2004).  Peter Mitchell  proposed  in  1961  the  chemiosmotic theory 
that  explains  the  coupling  between  respiration  and  ATP  synthesis  (Prebble, 
1996).  In the same year,  Efraim  Racker purified the catalytic component of the 
mitochondrial  ATPase  (Schatz,  1996).  In  1997,  Paul  Boyer  and  John  Walker 
shared half of the Nobel Prize for the discovery that ATP synthase functions in a 
novel way (Saraste,  1999).  In 1986, it was documented by Young et al. that CO 
is oxidized to CO2 by mitochondria (Young and Caughey,  1986).
1.7.2  Mitochondrial Structure
Mitochondria  are  found  in  the  cytoplasm  of most  cells  (Figure  1-8).  They  are 
thought to have arisen about  1.5 billion years ago from a symbiotic association 
between a glycolytic proto-eukaryotic cell and an oxidative bacterium  (Wallace,
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1999).  They vary in size,  but typically have a diameter of about 1   pm,  and their 
shape can  be spherical or elongated.  They also vary in number,  depending on 
the cell type and cell  energy demands,  so that tissues which  are  metabolically 
active,  like  skeletal  and  cardiac  muscles,  liver,  and  brain  contain  the  largest 
number of mitochondria (Szewczyk and Wojtczak, 2002).
Despite the variation of number and morphology,  all mitochondria have two lipid 
bilayer  membranes:  the  unwrinkled  outer  membrane  which  is  permeable  to 
small  molecules  and  ions  up  to  14  kDa,  and  the  inner  membrane  which  has 
infoldings  called  cristae that provide a  very large  surface  area,  which  is freely 
permeable to just a few small molecules such as water,  O2,  CO2 and  NH3.  The 
inner membrane also contains the components of the respiratory chain and ATP 
synthase.  Enclosed by the inner membrane is the mitochondrial matrix, which is 
a  water-containing  compartment  that  contains  the  mitochondrial  DNA, 
ribosomes,  granules,  and  all  the  pathways  of fuel  oxidation  except  glycolysis. 
These include the  pyruvate dehydrogenase complex,  the enzymes of the citric 
acid cycle,  and the pathways of fatty acid and amino acid oxidation (Szewczyk 
and Wojtczak, 2002; Wallace and Starkov, 2000).
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Figure 1-8:  Mitochondrial structure
The  mitochondria  consist  of  the  outer  membrane,  and  the  wrinkled  inner  membrane 
with  infoldings  called  cristae  and  the  matrix,  which  is  a water-containing  compartment 
that contains the mitochondrial  DNA,  ribosomes, granules,  and all the pathways of fuel 
oxidation.
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1.7.3  Mitochondrial Function
The  main function and the central  role of mitochondria  is  production  of energy 
inside the cell  in the process of oxidative phosphorylation that supplies ATP for 
organs  (Duchen,  2004).  Mitochondria  are  the  main  source  of  energy  that 
sustains  cellular metabolism  and  integrity.  In  general,  there  are two  pathways 
for  energy  production:  the first  is  glycolysis,  which  involves  the  breakdown  of 
glucose  and ATP  synthesis  in  a  reaction  that  takes  place  in  the  cytosol.  The 
second  is  oxidative  phosphorylation  through  the  mitochondria.  The  chemical 
energy released  by mitochondrial oxidations is used to generate ATP,  which is 
the major energy-carrying molecule of the cell.  In major mammalian tissues,  it is 
estimated that 80 to 90 % of ATP  is generated by the  mitochondria (Szewczyk 
and Wojtczak,  2002).  In the kidney about 95% of ATP  is supplied by oxidative 
phosphorylation  (Soltoff,  1986).  Organs also differ in their utilization  of energy; 
for example, 80 % of O2 consumption in the kidney is due to ion pumping, while 
repetitive tension  development  is the  main  cause  of O2 utilization  in  the  heart 
(Soltoff,  1986).
Mitochondria also play a role in programmed cell death or apoptosis (Green and 
Reed,  1998).  One  of  the  mechanisms  involved  appears  to  be  loss  of 
mitochondrial  trans-membrane  potential;  in  addition,  the  participation  of  pro- 
and  anti-apoptotic  Bcl-2  proteins  and  cytochrome  c  release,  which  results  in 
caspase  activation  and  apoptosis,  also  lead  to  mitochondrial  dysfunction 
(Bernardi  et  al.,  2001;  Borutaite  and  Brown,  2003;  Green  and  Reed,  1998). 
Lastly,  mitochondria  are  the  main  site  of  generation  in  the  cell  of  reactive 
oxygen  species  (ROS)  that  include  superoxide  anion  radicals  (02*),  hydrogen 
peroxide (H202), and reactive hydroxyl radical (HO') (Chen et al., 2003).  Certain
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conditions  such  as  l-R  injury,  inhibition  of the  respiratory  chain,  inflammation, 
aging,  and  ultraviolet  or  ionizing  irradiation  can  increase  ROS  generation 
(Szewczyk  and  Wojtczak,  2002).  As  a  consequence,  acute  ROS  exposure 
inactivates  complex  I,  II,  and  III  (see  below),  resulting  in  the  shutdown  of 
mitochondrial energy production, while chronic ROS exposure causes oxidative 
damage  to  mitochondrial  and  cellular  proteins,  lipids,  and  nucleic  acids 
(Wallace,  1999).
Mitochondrial  dysfunction  and the very high  mutation  rate  of the  mitochondrial 
DNA  lead  to  a  number  of  neurodegenerative  and  muscular  disorders  or 
mitochondrial  diseases.  Today,  about  200  different  diseases  involving  the 
mitochondrial  DNA  are  known  such  as  Leber  hereditary  optic  neuropathy, 
chronic  progressive  external  opthalmoplagia,  Leigh  syndrome,  and  dystonia 
(Schmiedel et al., 2003; Wallace,  1999).
1.7.4  The Mitochondrial Respiratory Chain
As  shown  in  Figure  1-9,  the  inner  mitochondrial  membrane  contains  the 
respiratory  chain  complexes,  which  are  proteins  with  varying  numbers  of 
subunits,  in which the first four complexes  (l-IV)  participate  in electron transfer 
and the generation of the so-called electrochemical proton gradient across the 
inner  mitochondrial  membrane.  The  primary  form  of  energy  stored  in  this 
gradient  is  used  by  the  last  complex  (V)  to  produce  ATP;  this  chemiosmotic 
model  was  first  proposed  in  1961  by  a  British  biochemist,  Peter  Mitchell 
(Prebble,  1996). The respiratory chain reaction starts by oxidation of the various 
substrates  that  are  dissolved  in  the  mitochondrial  matrix  via  the  activity  of 
dehydrogenases;  a  good  example  of  this  is  complex  II  (succinate 
dehydrogenase)  which  transfers  electrons from  succinate  to flavoproteins  and
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then through the Fe-S centre to ubiquinone (called coenzyme Q). The released 
energy  from  dehydrogenases  will  be  used  to  reduce  NAD+   to  NADH  or  the 
ubiquinone  to  ubiquinol,  NADH  is  then  oxidized  by  complex  I  (NADH: 
ubiquinone  reductase,  the  largest  enzyme  of  the  respiratory  chain)  and  the 
released  energy  is  used  to  reduce  ubiquinone to  generate  an  electrochemical 
proton  gradient.  The  reduced  ubiquinol  is  then  oxidized  by  complex  III 
(ubiquinol:  cytochrome  c  reductase,  bci-complex).  Complex  III  also  generates 
electrochemical  proton  gradient  that  is  used  to  reduce  cytochrome  c,  which 
functions  as  an  electron  carrier  between  complex  III  and  complex  IV 
(cytochrome  c oxidase).  Complex  IV  directly  reduces  0 2 to  water to  generate 
electrochemical  proton  gradient  that  is  used  by  complex V  (ATP  synthase)  to 
produce ATP from ADP and Pj  (2004b; Wallace and  Starkov,  2000). The ATP, 
generated in mitochondria,  is then exchanged for cytosolic ADP by the adenine 
nucleotide translocator (ANT).
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Figure 1-9: Schematic diagram of the mitochondrial respiratory chain
The oxidative phosphorylation process occurs within the mitochondrial inner membrane 
through  the  four enzyme  complexes  of the  electron  transport chain  (I,  II,  III  and  IV), 
complex V,  and the ANT.  Under physiologic conditions,  electrons (® )  are collected  by 
complex I and II, transferred to complex III via coenzyme Q ( C ^ )  ) and complex IV via 
cytochrome  c  (  )  and  finally  to  0 2 to give water.  The  released  energy from  the
electron  transport is  used  to  pump  protons  across  the  mitochondrial  inner membrane. 
The  electrochemical  gradient  generated  by  this  process  is  dissipated  by  transport  of 
protons  through  complex V,  and  the  energy  released  is  used  to form  ATP  from  ADP 
and  inorganic phosphate.  The generated ATP is then  exchanged for cytosolic ADP by 
the adenine nucleotide translocator (ANT).
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1.7.5  Isolated Mitochondria
The  addition  of  ADP  to  isolated  mitochondria  that  are  suspended  in  a 
respiratory buffer with an oxidizable substrate  is taken  as equivalent of energy 
consumption  in  the  intact  cell.  As  a  result,  three  processes  occur:  substrate 
oxidation,  O2 consumption,  and ATP  synthesis.  In  1955,  Chance  and Williams 
showed  that  isolated  mitochondria  utilized  O2  and  substrate  until  all  the 
available  ADP  and  Pj  were  converted  to  ATP  in  a  condition  that  they  called 
state  3.  Then,  despite  the  availability  of  0 2  and  substrate,  isolated 
mitochondrial  O2  consumption  ceased  in  a  condition  that was  called  state 4, 
and  the  ratio  of  O2  utilization  between  state  3  and  state  4  was  called  the 
respiratory  control  index  (RCI,  Figure  2-1)  (Chance  and  Williams,  1956). 
State  3  is  the  active  respiring  state,  while  state  4  is  the  slower  and  inactive 
state.  RCI  indicates  the  tightness  of  the  coupling  between  respiration  and 
phosphorylation;  normally RCI ranges from 3 to 10,  depending on the substrate 
used and the quality of the mitochondrial preparation.
Because  the  electrochemical  energy  of  substrate  oxidation  drives  the  ATP 
synthesis  in  mitochondria,  it is  known that inhibitors of electron transport to O2 
can  block ATP  synthesis.  More  interesting  is that the opposite  is  also true,  so 
that  inhibition  of  ATP  synthesis  blocks  electron  transfer.  These  inhibitions 
explain the coupling between oxidation (electron transport) and phosphorylation 
(ATP  synthesis).  Certain  conditions  including  mechanical  or  osmotic 
mitochondrial  destruction  can  uncouple  oxidation  from  phosphorylation.  In 
addition,  uncoupling  agents  such  as  dinitrophenol,  chlorocarbonyl  cyanide  p- 
trifluromethoxy-phenylhydrazone  (FCCP)  and  m-chlorocarbonyl  cyanide 
phenylhydrazone  (CCCP)  allow  respiration  to  proceed  without  any  ATP
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synthesis.  Mitochondrial  inhibitors can be classified into two groups:  oxidation or 
respiration inhibitors,  and phosphorylation  inhibitors (Table  1-3).
1   -   1
Type of interference Agent Mode of action
Inhibitors of electron transfer Rotenone Blocker of complex 1
Myxothiazol Inhibit complex  1   & complex 
III
TTFA Blocker of complex II
Antimycin A Blocker of complex III
Zinc ions Blocker of complex III
Cyanide
Azide
Sulfide
Non-competitive inhibitors 
of complex  IV
CO
NO
competitive inhibitors of 
complex  IV with  0 2
Poly cations competitive inhibitors of 
complex IV & cytochrome c
Inhibitors of ATP svnthase Oligomycin
Venturicidin
Blocks phosphorylation by 
the  F0/F1  ATPase.
Uncouplers DNP
FCCP
CCCP
Flydrophobic proton carrier
Valinomycin K inophore
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1.7.6  Mitochondrial Role in Organ Preservation and l-R Injury
The aim of hypothermia  in organ preservation  is to diminish the rate of energy 
utilization  in order to reduce the rate of energy production or ATP synthesis as 
measured  by  O2  consumption.  If  cells  of  transplanted  organs  are  to  remain 
normal or not to be irreversibly damaged during storage, the integrity of energy 
coupling  must  be  preserved.  Mitochondria  alteration  is  an  early  event  in 
ischaemia-induced  damage,  and  its  prevention  improves  tissue  survival  upon 
reperfusion (Janssens et al.,  1999).  The earliest changes seen in mitochondria 
after  ischaemia  are  due  to  insufficient  O2  supply to  tissue,  which  results  in  a 
decrease of O2 supply for oxidative phosphorylation,  leading to ATP  depletion, 
and a shift to anaerobic metabolism by the glycolysis pathway (Weinberg et al.,
2000).  It has been shown that ATP levels drop rapidly after ischaemia in rabbit 
kidneys, reaching 20% of normal in only 15 min (Pegg et al.,  1981).  Cellular and 
tissue  functions  can  be  fully  recovered  upon  reperfusion  if  the  duration  of 
ischaemia  is  relatively  short,  nonetheless,  longer  periods  of  ischaemia  cause 
irreversible tissue  injury  (Hartung  et al.,  1985).  While  reperfusion  is  necessary 
for  the  viability  of  the  organ,  ischaemia-induced  damage  is  exacerbated  by 
reoxygenation  during  reperfusion.  The transition from  reversible  to  irreversible 
ischaemia  is  partly  dependent  on  the  functional  state  of  mitochondria,  and 
restoration  of oxidative  metabolism  determines functional  recovery.  In  general, 
mitochondrial  dysfunction  in  ischaemic condition  can  be  attributed  to  inhibition 
of adenine nucleotide translocase, to reduced activity of complex I  and  III,  to a 
rise in cytosolic calcium,  to alteration of the membrane fluidity,  and to oxidative 
stress (Bouaziz et al., 2002).
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1.8  Carbon Monoxide
1.8.1  Historical Highlights
"Coal fumes  lead to heavy head  and  death" was the first mention of the  lethal 
effects of coal fumes by Aristotle,  Greece,  the third century B.C., while the first 
clinical description of coal gas poisoning was in 1775 by Harmant,  France [2],  In 
1842,  carbon  monoxide (CO) was  identified as the toxic substance in coal  gas 
by  LeBlanc,  France  [1].  In  1857,  the  French  physiologist  Claude  Bernard 
showed that CO produces hypoxia by reversible combination with haemoglobin 
(Claude Bernard,  1865);  his research became the background for assigning CO 
to  the  category  of  poisons  and  toxins.  In  1895  the  British  John  Haldane 
explained  the  toxic  effects  of  CO  to  be  hypoxia-related  due  to  binding  to 
haemoglobin and demonstrated that rats survive CO poisoning when  placed  in 
oxygen  at  2  atmospheres  pressure  (Haldane,  1895).  In  the  1920s,  Warburg 
found  that  CO  could  inhibit  respiration  in  yeast  (Piantadosi,  2002).  In  1927, 
Nicloux  discovered  a  baseline  carboxyhemoglobin  (HbCO)  level  in  dogs 
(Otterbein and Choi, 2000).  In 1944 during World War II,  Roughton and Darling 
reported  that  HbCO  shifted  the  oxyhemoglobin  dissociation  curve  to  the  left, 
while about 10 years earlier Fenn and Cobb reported that living tissues burned 
CO  by oxidizing it to CO2 (Piantadosi,  2002).  In  1951,  Sjostrand demonstrated 
that CO  is endogenously produced  in normal  man and that CO originates from 
alpha  methane  carbon  atoms  of  haem  (Sjostrand,  1951).  This  finding  was 
confirmed  later  by  Coburn,  who  recognized  that  the  amount  of  CO  in  tissue 
increase substantially during hypoxia due to transfer of CO from blood to tissue 
and binding of CO to haem proteins (Coburn,  1973;  Piantadosi,  2002).  In  1968
73IJCL INTRODUCTION
and  1969,  Tenhunen  and  colleagues  discovered  that  haem  oxygenase  (HO) 
was  the  enzyme  responsible  for  haem  catabolism,  and  in  the  mid  80’s  two 
isoforms of HO were discovered and cloned (Dulak and Jozkowicz,  2003). The 
production  of  CO  by  xenophobic  metabolism  was  discovered  in  1972,  when 
Stewart reported  increases in  HbCO  level following the  use of a paint stripper, 
whose  basic  ingredient  is  ethylene  chloride  (Stewart,  1975).  In  1986,  it  was 
documented that CO is oxidized to C02 by mitochondria (Young and Caughey, 
1986).  In the last decade, evidence has mounted to show that HO enzymes and 
their by-products are important players in biological life; despite the fact that CO 
is a dangerous exogenous poison at high concentration,  it is also emerging that 
it is an essential endogenous physiological regulator (Marks et al.,  1991).
1.8.2  Carbon Monoxide Sources
CO  is an odourless,  colourless,  tasteless,  non-irritant,  diatomic,  and chemically 
inert  gas  and  from  the  time  of  its  discovery  in  the  eighteenth  century,  it was 
known  as  one  of  the  most  lethal  gases  (Table  1-4).  CO  sources  can  be 
classified into exogenous and endogenous sources.
1.8.2.1  Exogenous Sources of CO
CO  comes  naturally  from  volcanic  gases,  photo-dissociation  of  CO  in  upper 
atmosphere,  coalmines,  and forest fires  [1],  Man-made  sources  of CO  include 
incomplete  fuel  combustion  used  in  transport  and  in  industrial  processes, 
burning  of solid waste  and  smoking  of cigarettes  (Mennear,  1993).  Therefore, 
tobacco  smokers  expose  themselves  to  CO  in  proportion  to  the  number  of 
cigarette  they  smoke  per  day  (Ryter  and  Otterbein,  2004).  The  CO  level  in
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cigarette smoke reaches up to 20 mg  per cigarette (Ryter et al.,  2002) or 100- 
200 ppm (Ryter et al., 2004).
1.8.2.2  Endogenous Sources of CO
Cells  and  tissues  can  produce  CO  as  a  product  of  haem  metabolism  (Morse 
and  Choi,  2002).  In  healthy  males,  the  average  rate  of  endogenous  CO 
production is about 0.4 ml hr'1  (10-12 pmol/24 hr/mol haem) which accounts for 
the  normal  percentage  of  0.3-0.7%  of  HbCO%  (Stewart,  1975).  Haem 
degradation  is responsible for more than 85% of endogenous CO as explained 
below; the remaining percentage of CO can be produced by non-haem sources 
including cytochrome P-450 dependent oxidation of certain xenobiotics and lipid 
substrates or as a by-product of iron-dependent peroxidation  processes  (Ryter 
and Otterbein, 2004).  Under normal conditions,  about 80% of CO in the body is 
stored  via  binding  to  Hb  to form  HbCO,  the  rest  of the  CO  is  bound  to  other 
haem-proteins such as  myoglobin or cytochrome c oxidase (Piantadosi,  2002). 
The administration of certain drugs can also accelerate the catabolism of haem 
and  increase  the  endogenous  CO  production,  good  examples  of  these  are 
phenobarbital  and  diphenylhydantoin  which  increase  the  total  amount  of 
endogenous  CO  by  50  %;  interestingly,  during  the  progesterone  phase  of the 
menstrual  cycle  in  female  the  endogenous  CO  production  is  twice  than  that 
detected during the oestrogen phase (Stewart,  1975).
1.8.2.3  The Haem Oxygenase System
CO  is a product of haem oxygenase enzymes,  the first and rate-limiting step in 
haem  degradation (Figure  1-10).  Each  haem  is degraded  into  1   mole of CO,  1  
mole  of biliverdin-IXa  and  1   mole  of ferrous  iron.  Three  isoforms  of HO  have
75been  characterized to  date:  the  constitutive forms  (HO-2)  and  (HO-3)  and  the 
inducible  form  (HO-1)  (Maines,  1997).  HO-1  is  also  known  as  heat  shock 
protein 32 and  it is sensitive to up-regulation in all tissue by a variety of stimuli 
that  cause  oxidative  stress  and  pathological  conditions  such  as  heat  shock, 
radiation,  haem,  NO,  cytokines,  ischaemia  and  hypoxia  (Maines,  1997; 
Motterlini  et al.,  1996).  HO-2 is expressed at high  levels  in  neuronal,  vascular, 
testicular  and  hepatic  tissues  (Ryter  et  al.,  2004),  and  is  involved  in  the 
regulation  of  neural  system  functions;  the  only  known  inducers  of  HO-2  are 
adrenal  glucocorticoids  (Otterbein  and  Choi,  2000).  HO-3  is  a  newly  identified 
isoform  and  has  been  found  only  in  rats  (Dulak  and  Jozkowicz,  2003).  All 
isoforms  of  HO  are  inhibited  by  certain  synthetic  and  naturally  occurring 
metalloporphyrins such as zinc protoporphrin-IX (Durante, 2002).
The  two  other  products  of  haem  degradation  have  been  reported  to  be 
biologically active.  Iron is sequestrated by ferritin which protects against oxidant 
damage  (Balia  et  al.,  1992).  The  water  soluble  biliverdin  is  converted  by 
NAD(P)H:biliverdin  reductase  to  the  lipophilic  bilirubin,  which  is  a  powerful 
endogenous  physiological  antioxidant  and  protects  the  mammalian  tissue 
against oxidative stress by scavenging ROS and reducing cell death (Baranano 
et al., 2002;  Clark et al.,  2000a;  Stocker et al.,  1987).  For example,  it has been 
reported  that  HO-1-derived  bilirubin  provides  cardiac  protection  against 
reperfusion  injury  in  an  isolated  rat  heart  model  (Clark  et  al.,  2000b). 
Furthermore,  it  has  been  shown  that  pre-treatment  with  low  doses  of  bilirubin 
can  improve  renal  function  after  l-R  injury  in  the  isolated  perfused  rat  kidney 
model  (Adin et al.,  2004).  Haem catabolism  is a colour-coded reaction that can
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be  observed  clinically  after  a  haematoma  or  bruising  (Figure  1-10)  (Otterbein, 
2002).
Figure 1-10: The Haem oxygenase reaction
The  HO  system  mediates  a  number  of  cytoprotective  effects,  because  of  its  end 
products,  biliverdin,  CO  and ferrous  iron  (^ fc )-  Biliverdin  is  converted  to  bilirubin  by 
biliverdin  reductase.  This  HO reaction can observed  clinically after a  bruising.  After  12 
hr,  oxygenated  haem has been  liberated  and gives purple-red colour,  after 2 days,  the 
bruise has gone anaerobic and deoxygenated haem  gives dark blue colour,  but over a 
number of days the  colour will  gradually change to green  (the colour of biliverdin)  and 
finally to yellow (the colour of bilirubin).  The production  of CO can also produce a pink 
colour on the skin as it binds to haemoglobin.
Contrc 
of cellul Protection 
against l-R 
injury
Physiological regulator
Suppression of 
inflammation
Vasorelaxation
Biliverdin
■Antioxidant effect 
■Cytoprotective effect
►  (ferritin)
Biliverdin
Reductase
•Antioxidant activity 
•Cytoprotective effect 
•Protection against l-R injury
!►   Bilirubin
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1.8.3  Carbon Monoxide as a Deadly Gas
CO  is historically  identified as a poison.  In fact,  in  vivo concentration  of CO  of 
4000 p.p.m.  or above are almost immediately lethal (Otterbein and Choi, 2000), 
and for this reason, this product of HO has been labelled as a silent,  senseless, 
and invisible killer.  Each year around 50 people in the United Kingdom die from 
CO poisoning (Walker and Hay,  1999), which usually occurs in poorly ventilated 
or enclosed areas in which CO is released from heating systems and fires,  and 
also explaining why most cases of CO poisoning occur in winter.  CO poisoning 
is also used as a suicidal  method by inhaling of car exhaust fumes  in a closed 
garage.  The well-known  mechanism  of  CO  toxicity  is that  after  inhalation,  the 
gas diffuses across the alveolar membrane  of the  lung  and  binds  reversibly to 
haemoglobin  (Hb)  in the blood.  Since the affinity of Hb to CO is about 200-250 
times the affinity for O2,  CO will compete with O2 for the binding to the four iron 
haems  of  Hb  and  HbCO  will  be  formed.  This  causes  a  shift  of  the 
oxyhaemoglobin  dissociation  curve  to  the  left,  changing  its  normal  sigmoid 
shape to  hyperbolic and  decreasing the  oxygen-carrying  capacity of the  blood 
producing hypoxia.  Our body compensates for the hypoxic stress by increasing 
the  cardiac  output  and  blood  flow  rate  to  the  vital  organs,  and  the  life- 
threatening  hypoxia  will  result  in  brain  damage  and  cardiovascular  collapse 
(Gorman  et al.,  2003).  In fact,  Hb  is  not the only  haem  protein that  binds  CO, 
but  other  haem  proteins will  also  reversibly bind  the  gas  including  myoglobin, 
cytochrome  oxidase,  cytochrome  P450,  and  hydroperoxidases.  The  toxicity 
elicited by CO  is dependent on both duration of exposure and concentration of 
HbCO%.  The clinical  manifestation of CO toxicity ranges from no symptoms at 
levels of HbCO below 10% to nausea, vomiting, headache,  shortness of breath,
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convulsion  and coma at levels  between  16-60% to  lethal  effects  if not treated  at 
levels  67-70%   of  HbCO  reading  (Gorman  et  al.,  2003;  Stewart,  1975).  CO 
poisoning  has  been  demonstrated  to  produce  a  significant  neuropathological 
damage and a learning deficit in rats (Piantadosi  et al.,  1997).
Synonyms Carbonic Oxide,  Carbon Oxide,  Exhaust Gas
Molecular Formula CO
Colour Colourless Gas
Odour Odourless Gas
Taste Tasteless Gas
Molecular weight 28.01
Melting Point - 205 °C
Boiling Point -191.5 °C
Flammability Flammable gas,  burn in air with a bright blue flame
Solubility
H20  = 3.3 ml  100 m l’’  at 0 °C. 2.14 ml  100 ml  at 25 
°C,  soluble in acetic acid,  benzene,  ethyl  acetate & 
chloroform
Specific Gravity Gas=  1.250 g L 1   at 0 °C,  liquid=0.793 g  L'1   at 0 °C
Conversion Factor 1  ppm=  1,25mg  m  at 25 °C
Vapour Pressure Greater than  1   atm at 20 °C
Vapour Density 0.968 (air=1)
Antidote Pure Oxygen (100%)
Biological half life 2-5 h
J  Reviewed from references (Ryter and  Otterbein, 2004;  Von  Burg,  1999)
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1.8.4  Carbon Monoxide as a Novel Therapeutic
The  traditional  view  about  CO  as  a  deadly  gas  started  to  change  in  the  last 
decade,  and  it  is only  believed function  as  a  lethal  poison  has  been  challenged 
by  new  discoveries  that  sustain  a  role  for  CO  in  the  control  of  physiological 
mechanisms (Figure  1-10). Therefore,  it is envisaged that a careful use of CO at 
low  concentrations  (10-500  p.p.m.)  could  be  developed  into  a  novel  therapy 
(Dulak  and  Jozkowicz,  2003).  The  mechanisms  responsible  for  the  protective 
effects  by  CO  may  involve  multiple  pathways  including  activation  of  soluble 
guanylate cyclase  (sGC),  potassium  channels,  mitogen-activated  protein  kinase 
(MAPK),  or mitochondria (Table  1-5).
:
CO Targets Physiological Function Reference
■   Vasorelaxation [274,  327]
Soluble
■   Anti-inflammatory [213]
Guanylate
■   Anti-apoptotic [175]
Cyclase
■   Anti-proliferative [199]
■   Neurotransmission [318]
(sGC)
■   Inhibits platelet aggregation [54]
■   Protection against  l-R injury [213]
K+  channels ■   Vasorelaxation [150,174,327,328]
■   Anti-inflammatory [13]
MAPK
■   Anti-apoptotic [49,  342]
■   Anti-proliferative [239, 293]
■   Protection against  l-R injury [106]
Inflammatory ■   Anti-inflammatory [236, 238]
Mediators ■   Protection against l-R injury [87,  106, 214, 215,219]
Mitochondria ■   Anti-proliferative [306]
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1.8.4.1  Physiological Regulator
It  was  originally  suggested  that  endogenous  CO  could  function  as  a 
physiological  regulator and  might be  involved  in  neuronal  signalling  (Verma  et 
al.,  1993).  CO has also been shown to play a major vasoregulatory function by 
inducing vasorelaxation  through a  mechanism that  may  involve  both the cyclic 
guanine  monophosphate  (cGMP)  pathway  and  calcium-activated  potassium 
channels (Coceani, 2000;  Kozma et al.,  1999; Zhang et al., 2001a; Zhang et al., 
2001b). Our group in particular, has reported that HO-1  induction in aortic tissue 
is correlated with an  increased endogenous production  of CO that suppresses 
vascular contractility by activation of soluble guanylate cyclase  (sGC)  (Sammut 
et  al.,  1998a).  Inhaled  CO  gas  causes  bronchodilation  in  vivo  via  cGMP, 
potentially reflecting a role of CO in the regulation of airway tone (Cardell et al.,
1998).  In  addition,  CO  gas  stimulates  insulin  release  and  propagates  Ca2+ 
signals between pancreatic (3-cells (Lundquist et al., 2003).
1.8.4.2  Anti-inflammatory Properties
Recent  progress  in  CO  research  indicates  that  CO  exerts  a  novel  anti­
inflammatory  effect  depending  on  the  p38  mitogen  activated  protein  kinase 
(MAPK)  pathway (Otterbein et al.,  2000).  These anti-inflammatory effects were 
observed both in vivo and in vitro where CO  selectively inhibits the expression 
of the  pro-inflammatory cytokines tumour necrosis factor-a,  interleukin-1 (3  and 
macrophage  inflammatory  protein-1 (3,  and  increase  the  lipopolysaccharide- 
induced  expression  of the  anti-inflammatory  cytokine  interleukin-10  (Otterbein, 
2002).  In  addition,  exogenous  CO  also  attenuates  aeroallergen-induced 
inflammation  in  mice  (Chapman  et  al.,  2001).  Accordingly,  it  has  been 
demonstrated in asthmatic and in critically ill patients that CO levels increase in
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breath  in  correlation  with  the  severity  of  inflammation  (Monma  et  al.,  1999), 
while  elevated  levels  of  exhaled  CO  in  patients  with  diabetes  have  been 
reported  and  correlated with  the  glucose concentration  in  blood  (Paredi  et al.,
1999).
1.8.4.3  Anti-apoptotic and Anti-proliferative Properties
One  potential  mechanism  whereby  CO  affords  cytoprotective  role  against 
cellular and  tissue  injury  is  through  its  anti-apoptotic  properties.  For  instance, 
endogenous CO acts as an anti-apoptotic agent by suppressing endothelial cell 
apoptosis via activation of p38 MAPK (Brouard  et al.,  2000).  In  support,  it has 
been  shown  that  exogenous  CO  can  attenuate  anoxia-reoxygenation-induced 
lung  endothelial  cell  apoptosis  via  modulation  of  p38  MAPK  and  caspase  3 
(Zhang  et  al.,  2003).  Interestingly,  another  study  showed  that  exogenous  CO 
blocks apoptosis of cultured vascular smooth muscle cells in a mechanism that 
involves  the  activation  of sGC,  while  the  p38  MAPK appears  to  have  no  role 
(Liu et al.,  2003).  The anti-apoptotic function of CO  is also accompanied  by its 
anti-proliferative action,  originally described in hypoxic vascular smooth  muscle 
cells  (Morita  et  al.,  1997).  Similarly,  CO  gas  markedly  inhibits  human  airway 
smooth  muscle  cell  proliferation  via  the  extracellular  signal-regulated  kinase 
(ERK)  1/ERK2  MAPK (Song  et  al.,  2002).  In  addition,  it  has  been  shown  that 
CO  gas  inhibits  platelet aggregation  by activation  of guanylate  cyclase  (Brune 
and Ullrich,  1987).
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1.8.4.4  Role of CO in Organ Preservation, Transplantation, and l-R Injury
With the increasing evidence supporting a role for CO in vasorelaxation and its 
cytoprotective  effects  spanning  from  inhibition  of  cellular  proliferation,  to 
blockade  of  apoptotic  pathways  and  suppression  of  inflammation,  the 
hypothesis that CO may provide protection in inflammatory diseases,  l-R injury, 
organ  transplant  models  and  organ  preservation  has  been  investigated. 
Indeed, exogenous CO at low concentration appears to have a protective role in 
organ transplantation,  graft rejection,  and in various models of l-R injury.  Listed 
below are the  organs  in which  CO  has demonstrated  a  beneficial  effect during 
transplantation and other pathologies (Table 1-6).
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Organ Effect of Carbon Monoxide Ref
fa Protects hearts from transplant-associated l-R injury 
fa Suppresses mouse-to-rat cardiac transplants rejection 
fa Prevents atherosclerosis post-aorta transplantation 
&  Suppresses stenosis after carotid balloon injury 
Successful transplantation from CO poisoning victim 
&  Protection against cardiac l-R injury
V)
[279]
[239]
239]
[260]
[106]
Cytoprotection in a rat model of lung transplantation 
j^| Protection against lung l-R injury
Protection against hyperoxic lung injury
[294]
[342]
[235]
*
^Cytoprotection against cold l-R injury in rat liver model 
^Protects liver from transplant-associated cold  l-R injury 
^Limits hemorrhagic shock-induced liver dysfunction 
^Protection against liver failure
[13]
[151]
[241]
[345]
f
f  Protects  kidneys  from  transplant-associated  cold  l-R 
injury
#  Prevents development of chronic allograft nephropathy
[215,219]
[184]
w
Protects  intestine  from  transplant-associated  cold  l-R 
injury
[213,214]
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1.8.5  Interactions between CO and NO
NO  and  CO  are  two  endogenously  produced  gases  that  are  synthesized  in 
enzymatic  reactions  that  involve  constitutive  and  inducible  isozymes.  NO  is 
synthesized  from  the  amino  acid  L-arginine  by  a  family  of  NO  synthases 
including the inducible isoform (iNOS) and the constitutively expressed isoforms 
neuronal (nNOS) and endothelial (eNOS) NO synthase (Moncada et al.,  1991). 
Like NO,  CO has biological functions and should not be considered as a waste 
product,  both  gases  share  many  common  properties  such  as  neuronal 
transmission,  vasorelaxation,  and  inhibition  of  platelet  aggregation  (Hartsfield,
2002).  While  CO  binds to haem  proteins  in the  reduced ferrous  state,  NO  can 
bind to both ferrous  and ferric-iron  proteins.  For example,  the  haem-containing 
enzyme sGC can be activated by NO and  CO to produce cGMP;  however,  CO 
is  a  weak  activator  and  30  to  100  times  less  powerful  than  NO  (Dulak  and 
Jozkowicz,  2003).  Interestingly,  the  molecule  3-(5’-hydroxymethyl-2’-furyl)-1- 
benzylindazole (YC-1) that sensitizes guanylate cyclase to activation by CO has 
been  described  and  in  its  presence  CO  augments  cGMP  production  to  levels 
similar to those obtained with NO (Dulak and Jozkowicz, 2003).  Both gases also 
affect  mitochondrial  cytochromes  functions,  causing  their  inhibition  and 
stimulating the formation  of ROS  and  lipid peroxidation (Brown,  1995;  Nisoli  et 
al., 2003).  One important difference between the two gases is that NO is a free 
radical,  while  CO  is  a  stable  gas  and  therefore  does  not  undergo  the  various 
oxidative  and  reductive  reactions  characteristic  of  NO  (Hartsfield,  2002). 
Interestingly,  it  has  also  been  shown  that  CO  may  modulate  the  NO-cGMP 
signalling system (Ingi et al.,  1996).
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1.8.6  Carbon Monoxide-Releasing Molecules
1.8.6.1  Background
Based on the  increasing  experimental  evidence supporting  a biological  role for 
CO  and  highlighting  its  cytoprotective  effects,  the  need  to  develop  a  specific 
way of CO  administration  and  delivery to  organs  and  cells  has  emerged.  The 
first and traditional way employed to investigate the effects of CO has been by 
inhalation  of  CO  gas.  Once  CO  diffuses  through  the  lung  membrane  to  the 
blood  it will  quickly bind to  Hb forming  HbCO  and  little  CO will  be  available  to 
reach  the  tissue;  this  means  that  very  high  concentrations  of  CO  should  be 
used  in  order  to  achieve  therapeutic  levels  in  tissues.  Moreover,  prolonged 
inhalation of CO  may lead to problems related to the systemic effects imposed 
by this gas on oxygen transport and delivery (Piantadosi,  2002),  hence making 
this approach of limited use in a therapeutic context,  in addition to the difficulty 
of storing  and  delivering  CO  gas  in  a  controlled-directed  manner.  The  second 
method used to study the physiological properties of CO is to induce HO-1  with 
compounds such as haemin and polyphenols;  in this instance,  bilirubin and iron 
production  will  be  increased  alongside  CO  and  it  will  prove  more  difficult  to 
discriminate  among  the  various  cellular effects  elicited  by  each  HO-1  derived 
product.
Lastly,  progress  in  the  field  of  CO  research  has  introduced  a  new  way  to 
administer CO by using safe compounds that can  carry and release  CO under 
physiological conditions.  In this respect and as a novel approach to deliver CO, 
our  group  has  recently  identified  a  class  of  compounds,  termed  carbon 
monoxide-releasing  molecules  (CO-RMs),  which  are  able  to  transport  and 
release CO both in vivo and in vitro in a safe and controllable fashion (Motterlini
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et  al.,  2002a;  Motterlini  et  al.,  2003).  These  carriers  of  CO  can  potentially 
enhance  the  specificity  of  CO  delivery  and  facilitate  its  use  as  a  therapeutic 
agent in the coming future (Motterlini et al., 2005).
1.8.6.2  Types of Carbon Monoxide-Releasing Molecules
Metal carbonyls were discovered 100 years ago and are used in the purification 
of  metals,  they  are  currently  used  clinically  in  the  treatment  of  cancer  and 
inflammation  (Fricker  et  al.,  1997).  In  2001,  our  group  has  discovered  that 
transition  metal  carbonyls  are  able to  carry,  transport and  release  CO  both  in 
vivo  and  in  vitro  in  a  controllable  fashion  under  physiological  conditions 
(Motterlini  et al.,  2002a).  They contain  metals  surrounded  by carbonyl  groups, 
and  their  interesting  property  to  release  CO  was  identified  spectro- 
photometrically  by  measuring  the  conversion  of  deoxymyoglobin  to 
carbonmonoxy  myoglobin  (MbCO)  and  by  using  nuclear  magnetic  resonance 
analysis  (Clark  et  al.,  2003;  Motterlini  et  al.,  2002a;  Motterlini  et  al.,  2004). 
Various CO-RMs,  as these chemical substances have been termed,  have been 
characterized and their biological activities evaluated.
The first two  CO-RMs  identified  are  dimanganese  decacarbonyl  ([Mn2(CO)io], 
CORM-1) and tricarbonyldichlororuthenium (II) dimer ([Ru(CO)3Cl2]2, CORM-2). 
CORM-1  and  CORM-2 are soluble in organic solvents (e.g.  dimethyl  sulfoxide, 
DMSO)  and  appear to  be  safe to  cells  in  a  concentration  range  of 40  to  210 
pmol  L'1   (Motterlini  et  al.,  2002a).  One  interesting  feature  of  CORM-1  is  the 
sensitivity to light, so with photo excitation of CORM-1, the metal-carbonyl bond 
can lead to CO release in aqueous solutions (Motterlini et al., 2002a).
In 2003, the first water soluble CO-RM was described by our group (Motterlini et 
al.,  2003).  Tricarbonylchloro(glycinato)ruthenium  (II)  ([Ru(CO)3CI(glycinate)],
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CORM-3)  is a newly synthesized form of metal  carbonyl that is able to liberate 
CO  under  physiological  conditions  and  it  has  been  made  water  soluble  by 
coordinating  a  biologically  compatible  ligand  (glycin)  onto  the  metal  centre 
(Motterlini  et  al.,  2003).  By  studying  the  kinetics  of  CO  release  based  on  the 
spectrophotometric conversion of myoglobin into MbCO,  it has been determined 
that one mole of CO is released per mole of CORM-3.  Interestingly,  the rate of 
CO  release from  CORM-3 varies  according to the type  of solution  used for its 
preparation;  for example,  CORM-3  is relatively stable  in distilled water,  while it 
rabidly  decomposes  in  human  plasma  suggesting  that  the  complexity  of  the 
buffer influences the release of CO (Motterlini et al., 2003).
Sodium  boranocarbonate  (Na2[H3BC02],  CORM-A1),  is  a  newly  identified  (in
2004)  water soluble  CO  releaser that,  unlike CORM-1,  CORM-2  and  CORM-3, 
does  not  contain  a  transition  metal  and  liberates  CO  at  a  much  slower  rate 
under physiological conditions (Motterlini et al.,  2004).  For instance,  the rate of 
MbCO formation,  and consequently the rate of CO release,  in phosphate buffer 
solution  is  much faster  in the case of CORM-3  (iVz «1  min,  at  37  °C  and  pH= 
7.4)  compared to  CORM-A1  (i'A ~ 21  min  at 37  °C  and  pH= 7.4)  (Motterlini  et 
al.,  2005).  It  is  important  to  mention  that  both  CORM-3  and  CORM-A1  are 
relatively safe and do not significantly affect cell viability on smooth muscle cells 
in vitro at concentrations up to 500 pM (Motterlini et al., 2005).
In  order to  prove  that the  effects  elicited  by  CO-RMs  are  due  to  CO,  inactive 
CO-RMs  (iCO-RMs)  has  been  used  as a  negative  control  to  demonstrate that 
CO  is  directly  responsible  for the  biological  properties  mediated  by  CO-RMs. 
The inactive form is chemically identical to CO-RM but does not release CO; for 
example,  CORM-3  left for 24  hr in  physiological  solution  like  phosphate  buffer
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saline  (PBS) will  become  inactive  by  liberating  all  the  CO  (Clark et  al.,  2003). 
CO-RMs  may  have  promising  therapeutic applications  and  the future of these 
compounds lie in their ability to work as novel CO donors in a manner similar to 
NO  donors,  i.e.,  by  facilitating  the  pharmacological  delivery  of  CO  for  the 
amelioration of a number of pathological conditions.
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1.8.6.3  Biological Activities of CO-RMs
1.8.6.3.1  Role of CO-RMs in Vasorelaxation
CORM-1  added to an  isolated  perfused  heart showed  a  marked  attenuation  in 
the  increase  of  coronary  pressure  when  challenged  with  an  inhibitor  of  NO 
synthase  (L-NAME)  (Motterlini  et  al.,  2002a).  Interestingly,  CORM-1  produced 
concentration-dependent  internal  anal  sphincter  relaxation  via  guanylate 
cyclase activation (Rattan et al.,  2004).  Furthermore,  CORM-1  was  reported to 
cause  a  concentration-dependent  vasodilatation  in  isolated  cerebral  arterioles 
(Fiumana  et  al.,  2003),  a  mechanism  that  involves  activation  of  guanylate 
cyclase  (Koneru  and  Leffler,  2004).  The  vasodilatory  action  of  CO  in  the 
cerebrovasculature is endothelium dependent and includes a permissive role of 
NO,  suggesting that NO facilitates the vasodilatory action of CO  (Barkoudah et 
al.,  2004).  The  same  authors  have  also  demonstrated  that  CORM-1  activates 
Ca2+-activated K+  channels in porcine cerebral arteriole smooth muscle cells (Xi 
et  al.,  2004).  The  administration  of  CORM-1  into  the  renal  artery  produced 
significant  renal  vasodilatation,  increased  glomerular  filtration  and  urinary 
excretion  of Na+   and water,  and  increased  urinary cGMP  excretion  (Arregui  et 
al., 2004).
CORM-2 has been reported to cause profound vasodilatation,  partly dependent 
on cGMP, when added to precontracted aortic rings (Motterlini et al., 2002a). An 
intravenous  administration  of  CORM-2  to  rats  strongly  attenuated  L-NAME- 
induced  hypertension,  an  effect  that  was  mimicked  by  activation  of  the  HO­
I/CO  pathway  following  stimulation  with  haemin  (Motterlini  et  al.,  2002a; 
Motterlini  et  al.,  2003).  Furthermore,  CORM-3  and  CORM-A1  produced  a 
concentration-dependent  relaxation  in  pre-contracted  aortic  vessels  in  a
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process  that  is  mediated  by  K+   channels  and  guanylate  cyclase  activation 
(Foresti et al., 2004b; Motterlini et al., 2004).
1.8.6.3.2 Role of CO-RMs in Proliferation and Apoptosis
Interestingly,  CORM-2  was  proven  to  inhibit  proliferation  and  attenuate  the 
release of the vasoconstrictor endothelin-1  in serum-induced human pulmonary 
artery  smooth  muscle  cells  (Stanford  et  al.,  2003;  Stanford  et  al.,  2004).  A 
similar anti-proliferative action by CORM-2 was observed in Jurkat T cells (Pae 
et  al.,  2004)  and  in  vascular  smooth  muscle  cells  stimulated  with  platelet- 
derived  growth  factor  (Choi  et  al.,  2004).  Additional  studies  revealed  both 
mitochondrial  respiratory  chain  and free  radical  generation  are targets for the 
anti-proliferative  effect  of  CORM-2  (Taille  et  al.,  2005).  A therapeutic  role  for 
CO-RMs  in  cardiac  diseases  could  also  be  predicted  as  CORM-2  inhibits 
cardiac myocyte hypertrophy induced by endothelin-1  or angiotensin-ll (Tongers 
et  al.,  2004).  Interestingly,  HO-1-deficient  endothelial  cells  showed  increased 
angiogenesis  following  CORM-2  starting  at  50  pM  (Li  et  al.,  2005),  whereas, 
CORM-3  showed  a  significant  increase  starting  at  a  concentration  of  25  pM, 
suggesting  a  different  CO-releasing  kinetic for the  two  drugs  (Li  et al.,  2005). 
Recent evidence revealed interesting anti-proliferative and anti-apoptotic effects 
by  CORM-3  in  porcine  aortic  endothelial  cells  and  primate  peripheral  blood 
mononuclear cells (Vadori et al., 2005).
1.8.6.3.3 Role of CO-RMs in Inflammation
CORM-2  appears  to  completely  suppress  the  inflammatory  response  by 
inhibiting  the  translocation  of  NF-kB  into  the  nucleus,  indicating  a  direct 
contributory  effect  of  CO  (Lee  et  al.,  2003).  Interestingly,  a  decrease  in  the
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expression  of  iNOS  and  nitrite  production  stimulated  by  LPS  in  RAW  264.7 
macrophages  (Oh  et al.,  2004) or smooth  muscle cells exposed  to  interleukin- 
1(3  is  also elicited  by CORM-2  in  a  concentration-dependent  manner (Yang  et 
al.,  2004).  Interestingly,  CORM-2  elicited  relaxation  responses  in  guinea-pig 
perfused  trachea  (Fedan  et  al.,  2004),  and  decreased  the  immunological 
response, suggesting that CO could be used pharmacologically in the treatment 
of  allergic  disease  (Vannacci  et  al.,  2004).  Furthermore,  CO  released  from 
CORM-2 has been shown to modulate the murine cutaneous immune system in 
vivo,  possibly  via  the  activation  of  sGC  (Allanson  and  Reeve,  2005).  More 
recently,  our  group  have  provided  evidence for  an  anti-inflammatory  action  of 
both CORM-2 and CORM-3, which inhibits the increase in TNF-a and NO levels 
in endotoxin-stimulated macrophages (Sawle et al.,  2005).  In agreement,  it has 
been  observed  that  treatment  of  pigs  with  CORM-3  prevents  the  release  of 
TNF-a  in  isolated  peripheral  blood  mononuclear  cells  stimulated  with  LPS 
(Seveso  et  al.,  2005).  Furthermore,  our  group  has  recently  reported  that 
infusion of CORM-3 in rat model of septic shock considerably reduced the fall in 
blood  pressure  induced  by LPS,  and  it was  more effective than  inducing  HO-1 
by  haemin  or  treating  the  endotoxemic  animals  with  bilirubin  (Foresti  et  al., 
2005).
1.8.6.3.4  Role of CO-RMs in Ischaemia-Reperfusion Injury
Our  laboratory  has  demonstrated  that  CORM-3  protects  against  hypoxia- 
reoxygenation  and  oxidative  stress  in  cardiac  cells  (Clark  et  al.,  2003). 
Interestingly,  the  attenuation  of  l-R  injury  in  rat  hearts  by  CORM-3  involves 
activation of ATP-dependent K+  channels  present in  mitochondria (Clark et al., 
2003).  CORM-3 used in ex-vivo models protects against l-R injury and prevents
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cardiac  allograft  rejection  in  vivo  (Clark  et  al.,  2003).  Additionally,  CORM-3 
decreases the myocardial infarct size when given just before reperfusion in vivo 
(Guo  et  al.,  2004),  it  also  induces  delayed  protection  against  myocardial 
infarction  which  is  similar  to  that  afforded  by  the  late  phase  of  ischaemic 
preconditioning,  and that this salubrious effect is sustained for 72 h (Stein et al.,
2005).  Moreover,  administration of CORM-2 or CORM-3 significantly decreased 
the levels of plasma creatinine and  limited renal  damage  in a  mouse  model  of 
ischaemia-induced acute renal failure (Vera et al., 2005).
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1.9  Hypothesis and Aims 
The main hypothesis of the Thesis is:
Can  low concentrations of CO released from  CO-RMs protect against renal  l-R
injury and be used as a novel therapeutic strategy for kidney preservation.
The major aims of the Thesis are:
Chapter 3  To  assess  the  influence  of  CO  liberated  from  CO-RMs  on  renal 
mitochondrial  function  in  a  rat  model,  and  to  investigate  the 
mechanism by which CO affect isolated mitochondria function.
Chapter 4  To study the biochemical and physiological effects of CO  liberated 
from CO-RMs on kidney function during normothermic perfusion on 
freshly  isolated  rabbit  kidneys,  and  the  mechanism  by  which  CO 
affect renal function.
Chapter 5  To assess how cold preservation of kidneys in the presence of CO- 
RMs  could  affect  renal  biochemical  and  physiological  functions  at 
reperfusion using an ex-vivo isolated rabbit kidney preparation, and 
the mechanism behind it.
Chapter 6  To  investigate  whether  flushing  with  CO-RMs  prior  to  warm 
ischaemia  will  protect  against  l-R  injury  in  the  isolated  perfused 
rabbit kidney model.
Chapter 7  To  examine  whether  adding  of  CO-RMs  to  the  preservation 
solutions will attenuate the cold storage injury of renal tubular (LLC- 
PKi)  cells,  and  the  mechanism  by  which  CO  may  affect  renal 
tubular cells after cold preservation in the presence of CO-RMs.
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2  MATERIALS AND METHODS
2.1  Chemicals, Reagents and Solutions
The chemical  structures of CORM-2,  CORM-3 and  C0RM-A1  are  represented 
in Table  1-7.  CORM-3 (provided by Dr Brian Mann,  University of Sheffield,  UK) 
and  CORM-A1  (provided  by  Prof.  Roger  Alberto,  University  of  Zurich, 
Switzerland)  were  freshly  prepared  as  stock  solutions  by  dissolving  the 
compounds in distilled water and adding them directly to the solution used in the 
experiment.  Inactive  CORM-3  was  prepared  by  dissolving  it  in  PBS  and  by 
keeping  it  in  an  open  Eppendorf  tube  over-night  to  allow  for  complete 
decomposition of the compound. To ensure the total elimination of residual CO, 
the  solution  was  bubbled  with  nitrogen  gas  before  adding  it  to  the  solution. 
Inactive  CORM-A1  was  prepared  as  stock  solution  in  water,  followed  by 
addition  of one drop of concentrated  HCI  (state concentration)  and bubbling of 
the  solution  with  nitrogen  gas  for  2  min.  CORM-2  was  obtained  from  Sigma 
Aldrich  and  was  prepared  freshly  as  stock  solution  dissolved  in  DMSO. 
RuCL2(DMSO)4 is the negative control for CORM-2 that is soluble in water and 
referred to as the inactive form,  iCORM-2 (Motterlini et al., 2002a).
ADP was from  Boehringer Mannheim (Lewes,  UK) and all other reagents were 
obtained  from  Sigma  Aldrich  (Poole,  Dorset,  UK)  unless  otherwise  specified. 
Celsior,  a universal cold storage solution used for preservation of intra-thoracic 
and  intra-abdominal  organs  (Marcen  et  al.,  2005)  was  obtained  from  Imtix- 
Sangstat (Lyon,  France).  UW solution was a gift from Royal Free Hospital.
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2.2  Detection of CO Release
The release of CO from CO-RMs in the mitochondrial respiratory buffer (30 °C), 
Krebs  buffer  perfusion  solution  (37  °C)  and  in  Celsior  (4  °C)  solutions  was 
assessed  spectrophotometrically  by  measuring  the  conversion  of 
deoxymyoglobin  (deoxy-Mb)  to  carbonmonoxy  myoglobin  (MbCO)  using  a 
method previously described by our group (Motterlini  et al.,  2002a;  Motterlini  et 
al.,  2004).  Deoxy-Mb  was  converted  to  -100%  MbCO  after  bubbling  the 
myoglobin solution (66 pmol/L) for 45 seconds with  1  % CO gas. The amount of 
MbCO  formed  was  quantified  by  measuring  the  absorbance  at  540  nm 
(extinction  coefficients 5.4  mmol/L'1   x  cm'1).  Myoglobin  solutions  (66  pmol/L 
final  concentrations)  were  prepared  fresh  by  dissolving  the  protein  in  the 
solution.  Sodium dithionite (0.1%) was added to convert myoglobin to deoxy-Mb 
prior  to  each  reading.  All  the  spectra  were  recorded  using  a  Helios 
spectrophotometer and the amount of CO released was measured over 30 min 
in  respiratory buffer at 30 °C,  over 45 min  in  Krebs perfusion  solution at 37 °C 
and  for  24  h  in  the  preservation  solution  at  4  °C.  Since  both  CORM-3  and 
CORM-A1  liberate 1   mole of CO per mole of compound and because we used 1  
ml  of solution  containing  myoglobin,  the  maximum  amount of CO  that  can  be 
released from 50 pM CO-RMs into the solution is 50 nmoles. Therefore, the rate 
of CO release was expressed as nmol/hr.
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2.3  Studies on Isolated Mitochondria
2.3.1  Isolation of Mitochondria
Male  Sprague-Dawley rats (400-500 g) were obtained from the Animal  Facility 
Unit of Northwick  Park  Institute for Medical  Research.  Rats were  sacrificed  by 
cervical  dislocation  and  kidneys were  harvested  for  mitochondrial  isolation  as 
described  below.  Kidneys  were  immediately  flushed  with  cold  saline  and  the 
organ was cut in half longitudinally followed by removal of the medulla, while the 
remaining cortex was minced in high EDTA buffer containing: 210 mM mannitol, 
70  mM  sucrose,  50  mM  Tris  and  10  mM  Na2EDTA  (pH  7.4).  The  cortex was 
homogenized  using  a  glass  teflon  potter  homogenizer  and  the  lysate  was  re­
suspended  in  50  ml  high  EDTA-containing  buffer and  centrifuged  at  1000g for 
10 min at 4 °C  in a refrigerated centrifuge (Beckman,  Avanti  TM30 centrifuge). 
The  supernatant was  centrifuged  again  at  10,000g for  10  min  to  obtain  a first 
mitochondrial  pellet  which  was  re-suspended  in  low  EDTA-containing  buffer 
consisting  of:  225  mM  mannitol,  75  mM  sucrose,  10  mM  Tris  and  0.1  mM 
Na2EDTA  (pH=7.2).  The  pellet was  further  homogenized  using  a  glass  teflon 
homogenizer  and  the  volume  of  the  homogenate  adjusted  to  50  ml  with  low 
EDTA-containing  buffer  prior  to  centrifugation  at  10,000g  for  10  min.  The 
mitochondrial  pellet  was  finally  re-suspended  in  500  pL  low  EDTA-containing 
buffer and kept in Eppendorf tubes in ice at 4 °C until use.
2.3.2  Measurement of Respiration in Isolated Mitochondria
All  experiments  were  carried  out  using  a  2  ml  capacity  incubation  chamber 
maintained  at  30  °C  and  a  Clark  electrode  attached  to  an  oxygen  monitoring 
system (USI model 5300) connected to a chart recorder (Servoger,  124 flatbed),
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calibrated to give a full scale deflection of 1   voltage and set at a chart speed of 
1   cm  min'1.  The  buffer  in  the  chamber  was  stirred  constantly  using  an 
electromagnetic  stirrer.  All  experiments were  carried  out  using freshly  isolated 
mitochondria (0.5 mg protein, final concentration) re-suspended in a respiratory 
buffer  containing:  100  mM  KCI,  75  mM  mannitol,  25  mM  sucrose,  50  pM 
Na2EDTA,  10  mM  Tris-HCI  and  10  mM  KhhPO^Tris  (pH=7.4)  supplemented 
with  0.5  mg  bovine  serum  albumin.  Mitochondrial  respiration  was  measured 
using different substrates and inhibitors (Table 2-1). Where CO-RMs were used, 
10 pi of CO-RMs stock solutions were added to the mitochondrial suspension to 
obtain a final concentration of 10, 50 and 100 pM, respectively.
The following mitochondrial functional parameters were measured:
1)  State  3,  which  is  the  active  respiring  state  representing  oxygen  uptake 
during oxidative phosphorylation or the production of ATP from ADP,
2)  State 4, the rate of oxygen uptake after the complete exhaustion of ADP and 
represents  the  fraction  of  oxygen  consumed  by  the  mitochondria  but  not 
used for ATP synthesis; and
3)  The  respiratory  control  index  (RCI),  which  is  the  ratio  of  O2  utilization 
between  state  3  and  state  4  and  indicates  the  tightness  of  the  coupling 
between respiration and phosphorylation.
State 3  respiration was  initiated  by adding 300 nM ADP  1   min  after addition of 
CO-RM and state 4 respiration was measured after all the ADP was  converted 
to ATP  (Figure 2-1).  The mitochondria were cycled through two state 3-state 4 
cycles by addition of two aliquots of ADP.  State 3 and state 4 respirations were 
calculated as ng  02/mg  protein/min and data represented as percentage of the 
initial values.
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Figure 2-1: Oxygen electrode recording
This  graph  represents  isolated  renal  cortical  rat mitochondrial  oxygen  consumption  as 
a  function  of  time.  Mitochondria  were  incubated  in  a  respiratory  buffer  together with 
substrate  and  reagent.  State  3  mitochondrial  respiration  rate  was  initiated  by  the 
addition of ADP resulting in rapid oxygen consumption as the ADP is converted to ATP. 
The  mitochondria  are  in  state  4  after  the  added  ADP  is  phosphorylated,  state  4 
represents oxygen  consumption that is not used for ATP  regeneration.  The respiratory 
control  index  (RCI),  which  is  the  ratio  of  state  3  to  state  4,  reflects  the  degree  of 
coupling between oxidative phosphorylation and ATP production.
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2.3.3  Lipid Peroxidation Assay
Lipid  peroxidation  is  a complex process  known to occur in  plants  and  animals 
(Buege and Aust,  1978).  Malondialdehyde (MDA), formed from the breakdown 
of polyunsaturated fatty acids,  serves  as  convenient  index for determining  the 
extent of lipid  peroxidation (Draper and  Hadley,  1990),  and was quantitated as 
thiobarbituric  acid  (TBA)  reactive  material  according  to  reference  (Lash  et  a!.,
2001).  Mitochondria were incubated for 30 min at 30 °C in a medium containing 
20mM  Tris-HCI,  175mM  KCI,  pH  7.4,  supplemented  with  5  mM  malate  and 
glutamate  as  substrate,  in the  presence of  1   mM ADP,  and  0.1  mM  FeS04 to 
enzymatically  induced  peroxidation  and  various  concentrations  of  CO-RMs  or 
iCO-RMs.  The ethanolic solution of butylated hydroxytoluene (BHT) was added 
to the  reaction  mixture  at the  end  of incubation  (final  concentration,  5  mM)  to 
terminate lipid peroxidation during sample processing. Aliquots of mitochondrial 
suspensions (0.5 mL) were mixed with 0.5 mL of 10% (w/v) trichloroacetic acid 
and  1.0  mL of 0.76%  (w/v) 2-thiobarbituric acid,  and the  mixtures were  heated 
in a boiling water bath for  15  min.  After cooling to room temperature,  insoluble 
material was removed by centrifugation at 1000g for 10 min,  and absorbance of 
supernatants  was  measured  at  532  nm.  The  amount  of  MDA  formed  was 
calculated  using  a  molar  extinction  coefficient  of  1.56  X105  mol'1  cm'1   and 
expressed  as  nmol  MDA  per  mg  of  protein  (Buege  and  Aust,  1978).  Lipid 
peroxidation  measurements  were  linear  with  respect  to  mg  of  mitochondrial 
protein.
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2.3.4  Detection of Hydrogen Peroxide Production
Mitochondria  are  the  major  generators  of  ROS  in  cells  and  tissues  (Degli,
2002). Measurement of mitochondrial hydrogen peroxide (H2O2) production was 
determined  using  the  Amplex®  red-horseradish  peroxidase  assay  kits 
(Molecular  Probes,  Eugene,  OR)  (Zhou  et  al.,  1997).  Amplex  red  is  a 
fluorogenic substrate with very low background fluorescence;  it reacts with H2O2 
with a 1:1  stoichiometry to produce highly fluorescent resorufin.  Stock solutions 
were  prepared  according  to  the  assay  kit  instructions.  Mitochondria  were 
incubated  at -0.5  mg  of protein  per ml  in the respiratory buffer with  or without 
CO-RMs  for  30  min  at  30  °C.  Mitochondrial  H2O2  production  was  initiated  in 
using  glutamate  (5  mM)  and  malate  (5  mM),  or  succinate  (10  mM)  as 
substrates.  At the end of mitochondrial  incubation,  aliquots of each sample (50 
pi) were pipetted  into microplate well.  Reaction was  initiated  by the addition of 
50  pi  of  a  working  solution  of  100  pM  Amplex  red  and  0.2  U/ml  horseradish 
peroxidase.  The  reactions  were  incubated  at  room  temperature  for  30  min, 
protected from  light. Absorbance measurements were recorded  in a microplate 
reader at 560 nm.  Standard curves obtained by adding known amounts of H2O2 
to assay medium  in the presence of the reactants (amplex red and horseradish 
peroxidase,  Figure  2-2B).  Background  absorbance  was  measured  in  the 
absence of mitochondria and data presented as pmol/mg of protein/30 min.
2.3.5  Protein Assay for Mitochondria
The  protein  content  of  the  mitochondrial  pellet  was  determined  by  using  a 
commercial  kit  based  on  a  modified  Lowry  method  (Cadman  et  al.,  1979). 
Standard  curve  was  prepared  using  bovine  serum  albumin  at  different 
concentration (Figure 2-2A).
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Figure 2-2: Standard curves of assays used in the Materials and Methods
A)  Protein assay standard curve,  B)  Hydrogen peroxide (H20 2) assay standard curve, 
and C) Nitrite assay standard curve.  Each line represents the mean ± SEM of n=2 for 
each assay.
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2.4  Studies on Isolated Perfused Rabbit Kidney
2.4.1  Animals
Male  New Zealand White rabbits  (2.5-4 kg)  supplied  by  Harlan  Ltd.  (UK) were 
used.  They  were  kept  at  room  temperature  and  fed  with  a  normal  diet  and 
drinking  water for  at  least  one  week  before  the  experiments.  All  experiments 
were  performed  under  the  Home  Office  license  and  conformed  to  the  UK 
regulations under the Animal (Scientific Procedures) Act,  1986.
2.4.2  Anaesthesia
General anaesthesia was induced by intramuscular injection of Hypnorm® (0.25 
ml  kg'1,  containing  0.315  mg  ml'1   fentanyl  citrate  and  10  mg  ml'1   fluanisone, 
Janssen-Cilag  Ltd,  UK)  followed  5  min  later  by  intravenous  (IV)  injection  of 
diazepam  (0.1  ml  kg'1,  Phoenix  Pharma)  and  Heparin  (1000  units,  CP 
Pharmaceuticals  Ltd,  UK). The anaesthesia was  maintained with  100% oxygen 
(2 L min'1) via a facemask.
2.4.3  Surgical Procedure
A midline abdominal  incision was  made,  the bowel was  reflected to the  side of 
the rabbit and the kidney was exposed after being mobilized  by removal  of the 
surrounding  tissue  and  fat.  The  ureter was  divided  leaving  about  3  cm  length 
attached  to  kidney.  The  renal  artery was  ligated  first  and  then  the  renal  vein. 
The  renal  vein  was  cut  and  the  renal  artery  was  cannulated  with  a  specially 
constructed  5  cm  long,  1.6  mm  O/D  stainless  steel-5  F.G  cannula.  The 
cannulation was performed with the aid of an operating microscope (Wild M650, 
Wild  Heerbrugg,  Switzerland).  The cannulation procedure usually took 1-2 min, 
a  period  accepted  as  warm  ischaemia  for  the  kidney.  After  removal,  both
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kidneys were weighed immediately and flushed via the arterial cannula with 30 
ml perfusion solution at 37 °C at a height of 100 cm to remove all the blood. The 
kidney  was  perfused  either  immediately,  after  cold  storage,  or  after  warm 
ischaemia  on  the  isolated  perfused  circuit.  After  removal  of  both  kidneys,  the 
rabbit was sacrificed by lethal dose of sodium pentobarbitone (200 mg/kg IV).
2.4.4  Isolated Perfused Rabbit Kidney Circuit Model
The kidney was perfused using a closed perfusion circuit (Figure 2-3) built from 
nylon tubing connected by a silicon connector based on the system used for the 
assessment  of  kidney  function  (Fuller  et  al.,  1977).  The  kidney  Krebs  buffer 
perfusion  solution  was  aspirated  via  a  peristaltic  pump  (Watson  and  Marlow, 
model  505U)  from  a  one-litre  glass  container  sited  in  a  water  bath  at  37  °C 
through  two  alternative filters  (8  pm  pore  size,  Millipore,  UK)  to  remove  small 
debris from the circulation. The solution passed through a bubble trap (Harvard 
company,  UK),  which was constantly warmed  by water at 37 °C  and was then 
directed  to  the  renal  arterial  cannula  which  was  attached  to  a  pressure 
transducer  (model  PT300,  Grass)  via  its  side  for  monitoring  of  mean  arterial 
perfusion  pressure  (PP).  The  PP  was  always  maintained  at  100  mmHg  by 
adjusting  the  perfusion  flow  rate  (PFR)  using  the  peristaltic  pump  and  was 
simultaneously  recorded  on  a  monitor  using  the  Power  Lab  software  (Chart 
v4.2.2,  ADInstruments  Pty  Ltd,  UK).  The  perfusate  in  the  reservoir  was 
constantly gassed with  95%  O2 and 5%  CO2.  The renal  artery was attached to 
the  cannula while  the  renal  vein  was  kept  open  to  allow the  perfusate  to  run 
from  it  through  the  organ  chamber  where  the  kidney  was  placed  and  then 
through a tube to the reservoir to and then re-circulated again. Thirty minutes of
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initial  stabilization  and  equilibration  period  was  allowed  to  establish  stable 
baselines in perfusion and urine flow rates.
2.4.5  Kidney Perfusion Solution
The  Krebs  buffer  perfusion  solution  (adjusted  to  pH=7.4)  consisted  of  (in 
mmol/L):  155 Na*,  139 HC03~ , 6.8 K*.  139 Cf,  1.2 Mg2+' 2 Ca2*, 0.1  creatinine 
in  500  ml  Dulbecco’s  Modified  Eagle  Medium  (DMEM),  500  ml  Hespan  by 
Fresenius,  100 ml Gelofusine (4 g protein/100 ml) and 900 ml distilled water.
2.4.6  Kidney Preservation Solution
The  composition  of  Celsior  in  mmol  per  one  litre  water  for  injection  were  60 
mannitol,  80  lactobionic  acid,  20  glutamic  acid,  100  sodium  hydroxide,  0.25 
calcium chloride,  15 potassium chloride,  13 magnesium chloride,  30 histidine, 3 
mmol glutathione, osmolality 320 mosmol/kg,  pH 7.3,  stored at 4 °C (Table 1-1, 
Imtix  Sangstat,  France).  The  properties  of the  solution  and  the  reasons  for  its 
use were described in Chapter 1   (Heading 1.5.3).
2.4.7  Isolation of Rabbit Kidney Mitochondria
At  the  end  of  the  reperfusion  studies  on  the  isolated  system,  cortical 
mitochondria  from  rabbit  kidney  were  isolated  by  homogenization  and 
differential  centrifugation  as  described  above  (Heading  2.3.1)  (Sammut  et  al., 
2000).  Mitochondrial  pellets  were  immersed  in  ice-cold  isolation  medium 
consisting  of:  225  mM  mannitol,  75  mM  sucrose,  10  mM  Tris  and  0.1  mM 
K2EDTA (pH=7.2). Oxygen consumption was measured in isolated mitochondria 
as described  in  Heading 2.3.2.  Incubation was carried out using approximately 
1   mg  protein  of  isolated  mitochondria  re-suspended  in  1   ml  respiratory  buffer 
supplemented with 0.5 mg bovine serum albumin.  Mitochondrial respiration was
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measured  using  malate  (5  mM)  plus  glutamate  (5  mM)  as  substrates.  State  3 
and  state  4  respirations  were  calculated  and  represented  as  ng  0 2/mg 
protein/min.
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Figure 2-3:  Isolated Perfused Rabbit Kidney Circuit
Schematic diagram  illustrating the  isolated  perfused  method for assessment of kidney 
function  ex vivo.  Kidneys  were  attached  to  the  circuit  immediately  or  after 24  hr cold 
storage and were perfused for 2 hr via the renal artery.  The solution was perfused  in a 
closed,  thermostatically stable circuit at 37 °C via a  peristaltic pump,  and then through 
two  alternative filters  to  a  bubble trap  and  back to the  kidney and  perfusate  reservoir. 
The perfusion rate was adjusted to maintain the renal arterial perfusion pressure at 100 
mmHg,  while  the  perfusate  was  oxygenated  with  a  gas  mixture.  Urine  and  perfusate 
samples were collected every 15 min.
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2.4.8  Functional Assessment
2.4.8.1  Perfusion and Urine Flow Rate
Sampling  of perfusate for biochemical  analysis  and  measurement  of PFR was 
undertaken at set intervals. The ureter was directed  into a small collection tube 
at  these  times  to  allow  measurement  of  urine  flow  rate  (UFR)  and  similar 
biochemical  analyses.  PFR  and  UFR  were  calculated  at  15  min  intervals  by 
measuring the volume excreted over 1   min and the flow rate was expressed as 
ml/min/g for PFR and as pl/min/g for UFR.
The samples were kept in Eppendorf tubes at -  80 °C  until the time of analysis. 
Glucose,  Na+,  creatinine  and  gamma  glutamyl  transpeptidase  (GGT)  levels 
were measured using a biochemical analyser (Cobas Mira,  Roche).
2.4.8.2  Glomerular Filtration Rate
The  glomerular filtration  rate  (GFR,  expressed  as  pl/min/g)  was  calculated  by 
measuring urine and perfusate creatinine according to the following formula:
GFR =
Urine flow rate (ml min'1) X urine creatinine [mM] / perfusate creatinine [mM]
2.4.8.3  Reabsorption of Glucose and Sodium
The  tubular  reabsorption  of glucose  and  Na+   was  calculated  according  to  the 
following formula:
Filtered load = perfusate [solute] (mM) X GFR
Excreted load = urine [solute] (mM) X urine flow
% Reabsorption = (Filtered load -  Excreted load) / Filtered load X 100
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2.4.8.4  Nitrite Assay
Nitrite  levels were determined  in the  urine  using the Griess  method  (Foresti  et 
al.,  1997).  Here,  50  pi  of the  urine  sample  were  placed  into  a  96-well  plate, 
equal  volume  of  the  Griess  reagent  (0.5%  sulfanilamide,  0.05%  A/-(1- 
naphthyl)ethylenediamine  dihydrochloride  in  2.5%  H 3 P O 4 )  was  added  to  each 
well to begin the reaction, the plate was shaken at room temperature for 10 min 
and the absorbance  read  at 550nm  on  a  Molecular Devices VERSAmax plate 
reader.  The  nitrite  level  in  each  sample was  calculated from  a  standard  curve 
generated with sodium nitrite solution (Figure 2-2C).
2.4.8.5  Protein Leakage
Protein  leakage  was  assessed  by  measuring  the  protein  concentration 
appearing  in the  urine  and  the  results were expressed  as  a  percentage  of the 
perfusate  protein  concentration.  The  protein  concentration  was  measured 
spectrophotometrically using a modified Lowry method.
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2.5  Cell Culture
2.5.1  Overview of Cell Culture Studies
The  LLC-PKi  cell  line  is  derived from the tubular epithelium  of pig  kidney and 
was  between  the  200th  and  230th  passages  of a  seed  stock  purchased  from 
the  European  Collection  of  Animal  Cell  Culture  (Salisbury,  UK).  Cells  were 
grown  in  DMEM  containing  10%  fetal  bovine  serum,  0.1  mg/ml  streptomycin, 
100U/ml  penicillin,  2  mM  L-Glutamine.  Cells  were  grown  in  75  cm2  tissue 
culture flasks and maintained in an incubator at 37 °C  in an atmosphere of 5 % 
CO2 balanced with air.  The confluent monolayer cells were subcultured every 4 
days  using  0.25  %  trypsin.  For experimental  studies,  cells were  transferred  in 
DMEM to 24-well plates.
2.5.2  Alamar Blue Assay
Alamar  Blue  is  a  sensitive  oxidation-reduction  indicator  that  fluoresces  and 
changes  colour  upon  reduction  by  living  cells  (Hamid  et  al.,  2004).  The 
reduction of Alamar Blue is believed to be mediated  by mitochondrial enzymes 
(O'Brien  et  al.,  2000).  However,  recent  data  suggest  that  cytosolic  and 
microsomal enzymes also contribute to the reduction of Alamar Blue (Gonzalez 
and Tarloff, 2001). A colorimetric assay kit from Serotec (Oxford,  UK) was used 
to  assess  cell  viability  according  to  the  manufacturer’s  instructions.  In  brief, 
Alamar  Blue  solution  was  diluted  with  assay  medium  yielding  a  final 
concentration of 10% Alamar Blue. A volume of 250 pi per well was transferred 
into  each  well  and  the  24-well  plates  were  returned  to  incubator.  After  5  hr 
incubation,  aliquots  of supernatant  (200  pi) were  pipetted  into  microplate well 
and  the absorbance was  read  at an  excitation wavelength of 570  nm,  and  the
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emission at 600 nm.  The percent of viability was expressed as a percentage of 
control.
2.5.3  Lactate Dehydrogenase Assay
Cell  death  is  classically  assessed  by  the  quantification  of  plasma  membrane 
damage.  Lactate dehydrogenase (LDH) is a stable cytoplasmic enzyme present 
in  all  cells.  It  is  rapidly  released  into  the  supernatant  of  cell  culture  upon 
damage  of  plasma  membrane.  LDH  was  evaluated  using  the  Cytotoxicity 
Detection  Kits  and  assay  was  performed  according  to  the  manufacturer’s 
instruction (Roche,  UK).  LLC-PK1  were incubated in 24 well plates,  cell culture 
supernatant  was  transferred  to  Eppendorf  at  the  end  of  at  the  indicated 
incubation times and centrifuged for 5 min at 500g at 25 °C to remove crystals 
and  cellular  debris.  Aliquots  of  cell  free  culture  supernatant  (100  pi)  were 
pipetted into microplate well.  Reaction was initiated by the addition of 100  pi of 
a  reaction  mixture  and  incubated  for  15  min  at  25  °C,  protected  from  light. 
Absorbance was  measured at 690 nm wavelength and  all  determinations were 
made  against  appropriate  reagent  blanks  that  lack  the  cells.  Results  were 
presented as percentage of LDH release in the supernatants compared to LDH 
release  from  cells  treated  with  1%  Triton  X-100.  None  of  the  test  agents  or 
vehicles interfered with the assay for LDH.
2.5.4  Cell Treatment
For experimental  studies,  cells were  grown  to  confluence  in  DMEM  in  24 well 
plates.  Confluent  monolayers  of  LLC-PK1  cells  were  used  on  days  2-3  after 
seeding.  The  experiments  were  carried  out  in  1%  FBS  medium  or  the 
preservation solutions for determination of LDH.
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2.6  Statistical Analysis
Statistical analysis was performed using one-way analysis of varience (ANOVA) 
combined  with  Bonferroni  test.  When  differences  were  established  between 
groups,  unpaired  two-tailed  t-test  was  used  to  assess  statistical  significance 
between two groups at each time  point.  Data were presented  as mean  ± SEM 
and  differences were considered  significant at P <  0.05.  All  calculations were 
performed  using a commercially available statistical  package  (GraphPad  Prism 
version  4  for  Windows,  GraphPad  Software,  San  Diego  California  USA, 
www.graphpad.com).
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3  Carbon Monoxide-Releasing Molecules (CO-RMs) Modulate 
Respiration of Isolated Kidney Mitochondria in Male 
Sprague-Dawley Rats
3.1  Introduction
CO  is  a  product  of the  activity of haem  oxygenases,  ubiquitous  enzymes that 
act as the first and rate-limiting step in haem catabolism by degrading the haem 
molecule to one equivalent of CO,  biliverdin and ferrous iron (Maines,  1997). To 
date,  different  types  of  haem  oxygenase  have  been  characterized  including 
constitutive isoforms (HO-2) (Maines,  1997) and an inducible heat shock protein 
(HO-1) which  possesses the  peculiar feature of being finely up-regulated  in  all 
tissues by stimuli that cause moderate or severe oxidative stress such as  UVA 
radiation,  NO,  cytokines,  ischaemia  and  hypoxia  (Abraham,  2003;  Foresti  and 
Motterlini,  1999;  Katori  et  al.,  2002b;  Motterlini  et  al.,  1995;  Motterlini  et  al., 
1996).  The induction of HO-1  and the consequent increase in endogenous CO 
production  play  important  roles  in  vasorelaxation  (Sammut  et  al.,  1998a), 
inhibition  of  cellular  proliferation  (Morita  et  al.,  1997),  blockade  of  apoptotic 
pathways  (Brouard  et al.,  2000),  suppression of inflammation  (Otterbein  et al., 
2000),  protection  against  organ  rejection  (Sato  et  al.,  2001)  and  l-R  injury 
(Akamatsu  et  al.,  2004).  Both  the  use  of  potent  HO-1  inducers  as  well  as 
administration of low doses of CO gas have been recently employed to evaluate 
the potential therapeutic role of CO  in a variety of disease states,  including  l-R 
injury  in  kidneys,  which  is  commonly  experienced  during  surgery  or  organ 
transplantation (Nakao et al., 2005).
As a novel approach to deliver CO,  our group has recently identified a class of 
compounds,  termed  CO-releasing  molecules  (CO-RMs),  which  are  able  to
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transport and release CO both in vivo and in vitro in a controllable fashion under 
physiological  conditions  (Motterlini  et  al.,  2002a).  Different  types  of  CO-RMs 
have  been  characterized  and  their  biological  activities  evaluated.  Firstly, 
CORM-2,  which  is  soluble  in  organic  solvents  such  as  DMSO,  contains  two 
ruthenium atoms  and  is capable of releasing CO once  DMSO  has coordinated 
to  the  transition  metal  (Motterlini  et  al.,  2003).  Secondly,  CORM-3,  a  newly 
synthesized  metal  carbonyl  that  has  been  rendered  water  soluble  by 
coordinating a biologically compatible ligand (glycine) onto the metal centre and 
is able to rapidly liberate CO in physiological buffers (Clark et al., 2003). Thirdly, 
CORM-A1,  the  most  recent water-soluble generator of CO  identified,  does  not 
contain  a  transition  metal  and  liberates  CO  at  a  much  slower  rate  under 
physiological  conditions  (Motterlini  et  al.,  2004).  By  using  a  myoglobin  assay 
and  an  amperometric  CO  sensor  (Clark  et  al.,  2003;  Motterlini  et  al.,  2002a; 
Motterlini  et al.,  2004),  our group  demonstrated  that these three  types  of CO- 
RMs liberate approximately one mole of CO per mole of compound.  In addition, 
our laboratory specifically designed inactive compounds (iCO-RMs) that do not 
release CO and can be used as negative controls (Clark et al.,  2003;  Motterlini 
et al., 2004).
The central  role of mitochondria  in the cell  is the  production  of energy through 
oxidative  phosphorylation  of  ADP  (Balaban  et  al.,  2005).  In  this  process, 
electrons create  an electrochemical  gradient by  sequentially flowing through a 
series  of  complexes  in  the  inner  mitochondrial  membrane  and  the  energy 
formed  through  this  process  is  used  by  ATP  synthase  to  generate  ATP,  the 
main  provider  of  energy  in  the  cell  (Balaban  et  al.,  2005).  Impairment  in  the 
activity of mitochondrial complexes is considered to be an indicator of ischaemic
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injury  of  rat  mitochondria  and  the  respiratory  control  index  (RCI)  has  been 
established  as  a  reliable  parameter  to  assess  mitochondrial  respiration  and 
function  (Hartung  et  al.,  1985).  Mitochondria  also  play  a  crucial  role  in 
controlling apoptotic events  (Bernardi  et al., 2001;  Green and  Reed,  1998) and 
are  the  main  site  of  generation  of  reactive  oxygen  species  (ROS)  in  all 
eukaryotic cells (Cadenas and Davies, 2000).
3.2  Hypothesis
Since  CO  preferentially  binds  to  metal-centred  proteins,  it  is  reasonable  to 
hypothesize  that  haem-dependent  cytochromes  present  in  mitochondria  are 
likely targets for the action of CO-RMs. We also tested the hypothesis that CO 
released  from  CO-RMs  will  enhance  the  production  of  ROS  from  certain 
upstream sites in the electron transport chain.
3.3  Objectives
•  To  assess  the  influence  of  CO  liberated  from  CO-RMs  on  renal 
mitochondrial function.
•  To  investigate the mechanism  by which  CO affect isolated  mitochondria 
function.
•  To  study the  effect  of cold  storage  on  rat  kidney  mitochondrial  oxygen 
consumption,  and  to  investigate  any  possible  effect  of  CO  on 
mitochondrial function after cold storage.
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3.4  Materials and Methods
3.4.1  Mitochondrial Oxygen Consumption and Experimental Protocol
Mitochondrial  isolation  and  oxygen  consumption  measurement  have  been 
discussed  in  detail  in  the  Materials  and  Methods  Chapter  (Heading  2.3). 
Mitochondrial respiration was measured using different substrates and inhibitors 
(Table 2-1). Where CO-RMs were used,  10 pi of CO-RMs stock solutions were 
added to the mitochondrial  suspension to obtain a final concentration of 10,  50 
and 100 pM, respectively.
The  following  respiratory  parameters  were  measured  and  calculated  (Figure 
2-1):  1) state  3  respiration,  the  actively  respiring  state  which  represents  the 
rate  of  O2  consumption  in  mitochondria  after  adding  ADP;  2)  state  4 
respiration,  the  slower  respiring  state  which  represents  the  rate  of  O2 
consumption after all ADP has been phosphorylated to form ATP; and 3) RCI as 
the  ratio of state  3 to state 4  respirations rate,  which  represents the degree of 
coupling  between  mitochondrial  electron  transport  and  ATP  synthesis.  The 
mitochondria  were  cycled  through  two  state  3-state  4  cycles  by  addition  of 2 
aliquots of ADP.  State 3 and state 4 respirations were calculated as  ng  02/mg 
protein/min  and  data  represented  as  percentage  of the  initial  values  (Heading 
2.3.2).  In  some  set  of  experiments  the  effects  of  CO-RMs  on  uncoupled 
respiration was also evaluated.
3.4.2  Lipid Peroxidation
MDA  content  was  measured  as  an  index  of  lipid  peroxidation,  and  was 
quantitated  as  thiobarbituric  acid-reactive  (TBA)  material,  as  described  in  the 
Materials  and  Methods  Chapter  (Heading  2.3.3).  Briefly,  mitochondria  were
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incubated for 30  min at 30 °C  in a  medium containing 20mM Tris-HCI,  175mM 
KCI,  pH 7.4, supplemented with 5 mM malate and glutamate as substrate, in the 
presence  of  1   mM  ADP,  and  0.1  mM  FeSC>4  to  enzymatically  induced 
peroxidation  and  various  concentrations  of  CO-RMs  or  iCO-RMs.  Aliquots  of 
mitochondrial  suspensions  (0.5  ml)  were  mixed  with  0.5  ml  of  10%  (w/v) 
trichloroacetic  acid  and  1.0  ml  of  0.76%  (w/v)  2-thiobarbituric  acid,  and  the 
mixtures were heated at 100 °C for 15 min. After cooling and centrifugation, the 
absorbance of supernatants was measured at 532 nm.
3.4.3  H2O2 Production
The  rate  of H2O2 production  in  mitochondria was  determined  by  using Amplex 
red  assay as described  in the Materials and Methods  (Heading 2.3.4).  In  brief, 
mitochondria were  incubated  at ~0.5  mg  of protein/ml  in  the  respiratory  buffer 
with or without CO-RMs for 30 min at 30 °C. Mitochondrial  H2O2 production was 
initiated  in  using  glutamate  (5  mM)  and  malate  (5  mM),  or succinate  (10  mM) 
and  rotenone  (5  pM)  as  substrates.  At  the  end  of  mitochondrial  incubation, 
aliquots  of each  sample  (50  pi)  were  pipetted  into  microplate  wells.  Reaction 
was  initiated  by  the  addition  of  50  pi  of  the  assay  working  solution.  The 
reactions were incubated at room temperature for 30 min,  protected from  light. 
Absorbance measurements were recorded in a microplate reader at 560 nm.
3.4.4  Cold Storage Protocol
For cold  storage  experiments,  the  kidneys were washed  out  immediately after 
nephrectomy  with  10  ml  Celsior  solution  and  preserved  in  20  ml  of the  same 
solution  for  24  and  48  hr  at  4  °C,  while  control  kidneys  were  harvested  and 
isolated  at  0  hr.  In  additional  groups,  kidneys  were  flushed  with  Celsior
118itcl 3. EFFECTS OF CO-RMs ON MITOCHONDRIAL RESPIRATION
supplemented  with  50  pM  CORM-A1  or  iCORM-A1  and  stored  for 24  hr.  The 
mitochondria were then  isolated  and  O2 consumption was  measured  by  using 
malate and glutamate as substrates.
3.5  Statistical Analysis
Statistical  analysis  was  performed  using  one-way  ANOVA  combined  with 
Bonferroni  test.  Data  were  presented  as  mean  ±  SEM  and  differences  were 
considered significant at P < 0.05.
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3.6  Results
3.6.1  The Effect of CO-RMs on NAD-Linked Mitochondrial Respiration
We examined the effect of CO liberated from CO-RMs (10,  50 and  100 pM) on 
isolated  cortical  mitochondria  from  normal,  untreated  kidneys,  using  malate- 
and  glutamate-dependent  respiration.  State 3 respiration  in  renal  mitochondria 
was reduced significantly by all CO-RMs in a concentration-dependent manner 
(Figure 3-1).  For instance, at the concentration of 100 pM, the decrease in state 
3 respiration was as follows: 65% by CORM-2 (Figure 3-1 A), 43.5% by CORM- 
3  (Figure  3-1B)  and  39%  by  CORM-A1  (Figure  3-1C).  The  corresponding 
negative controls (iCO-RMs) were ineffective suggesting that CO liberated from 
the active molecules is responsible for the decreased respiration.
State 4  respiration was  measured  after all  ADP  has  been  exhausted  and was 
significantly  affected  by  CO-RMs.  CORM-2  increased  state  4  respiration  by 
37%  at  10  pM  and  by  98%  at 50  pM,  whereas  it was  unchanged  by  100  pM 
(Figure 3-2A).  CORM-3 significantly increased state 4 respiration at 50 and  100 
pM (P < 0.05 vs. the negative control iCORM-3),  but no changes were observed 
at 10 pM (Figure 3-2B).  An increase in state 4 respiration was also observed in 
the presence of CORM-A1  but it was not statistically significant compared to the 
negative control,  iCORM-A1  (Figure 3-2C).
In general,  the decrease in state 3 and the increase in state 4 respiration  rates 
mediated  by  CO-RMs  resulted in  a concentration-dependent and  a  statistically 
significant reduction  in the calculated RCI values.  In the presence of CORM-2, 
the RCI decreased from 6 to 2.4 at 10 pM,  1.3 at 50 pM and 1.1  at 100 pM (P < 
0.001,  Figure 3-3A).  Similarly,  treatment with CORM-3 reduced the  RCI values
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to 3.7 at 10 |jM,  1.8 at 50 pM and 1.2 at 100 | jM (Figure 3-3B).  Finally,  CORM- 
A1  reduced  RCI  in  a  concentration-dependent  manner  when  compared  to 
iCORM-A1  (P< 0.05,  Figure 3-3C).
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Figure  3-1:  Effect  of  CO-RMs  on  state  3  respiration  rate  in  isolated  renal 
mitochondria
Mitochondria were isolated from rat kidneys as reported in Materials and Methods. The 
respiratory  activity  was  assessed  in  mitochondria  pre-incubated  with  CORM-2  (A), 
CORM-3 (B) or CORM-A1  (C) in the presence of malate and glutamate as substrates 
and ADP.  iCO-RMs  represent the  negative controls,  which  do  not release CO.  Each 
bar represents the mean ± SEM of 5 experiments. **P < 0.001 vs. iCO-RMs.
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Figure  3-2:  Effect  of  CO-RMs  on  state  4  respiration  rate  in  isolated  renal 
mitochondria
Mitochondria were isolated from rat kidneys as reported in Materials and Methods. The 
respiratory  activity  was  assessed  in  mitochondria  pre-incubated  with  CORM-2  (A), 
CORM-3 (B) or CORM-A1  (C) in the presence of malate and glutamate as substrates 
and ADP.  iCO-RMs  represent the negative controls,  which  do  not release  CO.  Each 
bar represents the mean ± SEM of 5 experiments. * P < 0.05, **P <0.001 vs. iCO-RMs.
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Figure 3-3:  Effect of CO-RMs on the respiratory control  index (RCI) in  isolated 
renal mitochondria
Mitochondria were isolated from rat kidneys as reported in Materials and Methods. The 
respiratory  control  index  (RCI)  was  assessed  in  mitochondria  pre-incubated  with 
CORM-2 (A),  CORM-3 (B) or CORM-A1  (C) in the presence of malate and glutamate 
as substrates and ADP. iCO-RMs represent the negative controls, which do not release 
CO. Each bar represents the mean ± SEM of 5 experiments. * P < 0.05, **P < 0.001 vs. 
iCO-RMs.
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3.6.2  Effect of CO-RMs on Uncoupled Respiration
In the living cell,  respiration and ATP synthesis are very closely interconnected 
or coupled since either reaction proceeds only when the other is active. This link 
can  be  disrupted  using  drugs  that  uncouple  the  two;  these  uncouplers  allow 
respiration to proceed even in the presence of a phosphorylation inhibitor such 
as  oligomycin.  In  addition,  when  an  uncoupler  is  added  to  the  electrode 
chamber it allows  maximal  respiration  until the  remaining  O2 in the chamber is 
consumed.  The  effect  of CO-RMs  on  uncoupled  mitochondrial  respiration was 
studied  by  addition  of  CO-RMs  to  the  mitochondrial  suspension  5  min  before 
the  addition  of  uncoupler.  Using  2,4-dinitrophenol  as  uncoupler,  renal 
mitochondrial  uncoupled  respiration  rate  was  significantly  and  concentration- 
dependently  decreased  by  CO-RMs  compared  to  control  (Figure  3-4).  For 
example,  at  50  pM  CORM-2,  there  was  a  72%  reduction  in  respiration  (P  < 
0.001),  whereas,  at  100  pM  uncoupled  respiration  was  reduced  by  93%  (P < 
0.001).  Additionally,  CORM-3  significantly  decreased  uncoupled  respiration  at 
50 and  100 pM (P < 0.05 vs.  control),  but no changes were observed at 10 pM 
(Figure 3-4B).  Similarly, a reduction in uncoupled respiration was also observed 
in  the  presence  of  CORM-A1,  which  was  statistically  significant  compared  to 
control. The negative controls (iCO-RMs) had no significant effect on uncoupled 
respiration when  compared to control,  indicating that CO  is  responsible for the 
reduction in respiration.
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Figure  3-4:  Effect  of  CO-RMs  on  uncoupled  respiration  rate  in  isolated  renal 
mitochondria
Mitochondria were isolated from rat kidneys as reported in Materials and Methods. The 
respiratory  activity  was  assessed  in  mitochondria  pre-incubated  with  CORM-2  (A), 
CORM-3 (B) or CORM-A1  (C) in the presence of dinitrophenol as uncoupler. iCO-RMs 
represent the  negative  controls,  which  do  not release  CO.  Each  bar  represents  the 
mean ± SEM of 5 experiments. *P < 0.05, **P < 0.001 vs. control.
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3.6.3  Detection of CO Release from CO-RMs in Respiratory Buffer
Given  the  fact  that  CO-RMs  affect  isolated  mitochondria  significantly  and 
differently,  we  tested  the  ability  of 40  | jM  CO-RMs  to  release  CO  at  30  °C  in 
respiratory buffer.  The addition of iCO-RMs to deoxymyoglobin solution did not 
form carbonmonoxy myoglobin (MbCO) over 30 min of incubation (Figure 3-5A). 
On  the  other  hand,  CORM-2  and  CORM-3  rapidly  increased  MbCO  formation 
and reached a  maximal  level within minutes of release (MbCO concentration ~ 
39  pM,  while  saturated  MbCO=  40.16  pM,  Figure  3-5A),  which  indicates  that 
CO-RMs  liberate  approximately  one  mole  of  CO  per  mole  of  compound. 
Interestingly,  a  more  gradual  increase  in  MbCO  concentration  was  observed 
over  the  30  min  incubation  with  CORM-A1  (CO  release  rate=  31.8  nmol/hr, 
Figure 3-5A).  Absorption spectrum of MbCO after interaction of myoglobin with 
CO released from 40 pM CORM-2, CORM-3, and CORM-A1  were compared to 
saturated MbCO (Figure 3-5B).
1263. EFFECTS OF CO-RMs ON MITOCHONDRIAL RESPIRATION
50
40
30
||} ..—-4 B ~ «
o
o
n
□  CORM-2 
♦  CORM-3 
-•-CORM-A1
a  iCORM-2 
-e>-iCORM-3V 
-o- iCORM-A1
20
10
0
10 15 20 25 0 5 30
Time (min)
B
0.7
0.6
8  05 
C
5   0.4 .Q
8  03 
n
<  0.2
0.1
0.0J
M bC O =  40.16  nM
f / S
500
CORM-2 
CORM-3 
CORM-A1 
iCO-RMs 
Saturated  MbCO
550
k (nm)
600
Figure 3-5:  Detection of CO released from CO-RMs using the myoglobin assay
CO  release  was  assessed  spectrophotometrically  by  measuring  the  conversion  of 
deoxymyoglobin to  carbonmonoxy  myoglobin  (MbCO).  Determination  of the amount of 
MbCO  was  measured  after  interaction  of  deoxymyoglobin with  CO  liberated  from  40 
pM of various CO-RMs.  A) Time course showing the amount of CO released from CO- 
RMs  in  respiratory  buffer,  B)  Spectra  of MbCO formation  after addition  of CO-RMs  to 
myoglobin  solution.  Myoglobin  prepared  in  respiratory  buffer  plus  40  pM  CORM-2, 
CORM-3 and CORM-A1  (pH = 7.4) at 30 °C was used.
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3.6.4  The  Effect of CORM-3  on  Complex  II  and  IV-Linked  Mitochondrial 
Respiration
As  CORM-3  is  a  water  soluble  CO  releaser  and  significantly  affects  the 
glutamate and malate (complexes I,  III and  IV) supported respiration of isolated 
renal mitochondria in a concentration-dependent fashion as reported above, we 
used  this  CO-RM  to  study  the  influence  of  CO  on  mitochondrial  respiration 
mediated by complex II and IV-linked substrates.  Firstly,  by using rotenone and 
succinate, the addition of rotenone stops oxidation by complex  I then succinate 
enters  the  electron  transport  chain  and  is  oxidized  by  passage  through 
complexes  II,  III,  and  IV.  When compared with control, succinate-linked state 3 
respiration was  significantly decreased with  CORM-3  by 23.5%  at  50  pM  and 
31.2%  at  100  pM  (Figure  3-6A).  In  addition,  CORM-3  significantly  increased 
succi,nate-linked  state  4  at  50  and  100  pM  (P  <  0.001,  Figure  3-6B).  The 
decrease  in  state  3  and  the  increase  in  state 4  respiration  rates  resulted  in  a 
concentration-dependent  and  a  statistically  significant  decrease  in  the 
calculated  RCI  with  succinate  as  substrate when  compared  to  control  (Figure 
3-6C).  In isolated renal cortical mitochondria, the RCI for the control group was 
4.56 with succinate as substrate. The RCI was then reduced to 3.91  with 10 pM 
CORM-3,  to  1.68  at 50  pM  and to  1.18  at  100  pM.  As observed  before,  there 
was a non-significant change in the respiratory parameters with iCORM-3 when 
compared to control.
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Figure  3-6:  Effect  of  CORM-3  on  complex  ll-linked  respiration  in  isolated  renal 
mitochondria
Mitochondria were isolated from rat kidneys as reported in Materials and Methods. The 
following  respiratory  parameters  were  assessed  in  mitochondria  pre-incubated  with 
CORM-3, (A) State 3 (B) State 4 (C) and RCI in the presence of rotenone as inhibitor, 
succinate as substrate and ADP.  iCORM-3 represent the negative controls,  which do 
not release CO. Each bar represents the mean ± SEM of 5 experiments. *P < 0.05, **P 
< 0.001 vs. control.
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Secondly, by using tetramethyl-p-phenylenediamine (TMPD) and ascorbate, the 
addition  of  antimycin  A  inhibits  complex  III,  while  TMPD  is  an  ascorbate- 
reducible redox carrier that transfers electrons directly to cytochrome c.  Hence, 
the  addition  of  TMPD  and  ascorbate  to  the  antimycin  A-inhibited  reaction 
mixture  results  in  oxygen  consumption  through  complex  IV.  The  TMPD  and 
ascorbate dependent respiration of isolated renal mitochondria appears affected 
by  CORM-3  when  compared  to  control.  State  3  was  significantly  decreased 
with  CORM-3  by 21.4%  at  100  pM  (Figure 3-7A).  State 4  respiration was  also 
increased by 47% and 37% at 50 and 100pM CORM-3 (P < 0.05,  Figure 3-7B). 
The  decrease  in  state  3  and  the  increase  in  state  4  respiration  resulted  in  a 
concentration-dependent  reduction  of  the  calculated  RCI  when  compared  to 
control  (Figure  3-7C).  The  RCI  was  significantly  reduced  from  1.93  in  control 
group to  1.36,  1.19 and  1.12 with  10,  50 and  100  pM  CORM-3.  As  observed 
with  -the  previous  data  using  inactive  CO-RMs,  iCORM-3  did  not  affect 
mitochondrial activity when compared to control.
130A 3. EFFECTS OF CO-RMs ON MITOCHONDRIAL RESPIRATION
ro  S
&   I   60
“ I  40
LZJ iCORM-3
CORM-3
B
150
125
^  f   100
(1)  c  
+ 1   o
S ;7 5
“   50
25
[»JM ]
□  ICORM-3 
H  CORM-3
□  Control
[yMJ
CORM-3
□  Control
10  5 0   1 0 0   1 0 0
[MM]
Figure  3-7:  Effect  of  CORM-3  on  complex  IV-linked  respiration  in  isolated  renal 
mitochondria
Mitochondria were isolated from rat kidneys as reported in  Materials and  Methods.  The 
following  respiratory  parameters  were  assessed  in  mitochondria  pre-incubated  with 
CORM-3:  (A) State 3 (B) State 4 (C) and  RCI  in the presence of antimycin as inhibitor, 
TMPD  and  ascorbate  as  substrates  and  ADP.  iCORM-3  represent  the  negative 
controls,  which  do  not  release  CO.  Each  bar  represents  the  mean  ±  SEM  of  5 
experiments. *P < 0.05, **P < 0.001  vs. control.
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3.6.5  The  Role  of  CO-RMs  on  hydrogen  peroxide  production  in  renal 
mitochondria oxidizing complex I and complex II substrates
Mitochondria are considered as the major site of production of reactive oxygen 
species (Chen et al., 2003).  In the present study, we tested the hypothesis that 
inhibition  of cytochrome  c oxidase  by  CO-RMs will  enhance the  production  of 
ROS from certain upstream sites in the electron transport chain.  Therefore,  we 
used  mitochondria  prepared from  Sprague-Dawley rat kidneys to assess  if CO 
released  from  CO-RMs  stimulates  H2O2  generation  during  the  oxidation  of 
complex  I  or  complex  II  substrates.  It  is  worth  mentioning  that  complex  IV 
substrates interfere with the assay reagents.  By oxidizing malate and glutamate 
(complex I substrates),  mitochondria generated minimal  H2O2 in the absence of 
inhibitors  In  addition,  the  complex  I  inhibitor  rotenone  in  the  presence  of 
succinate  (complex  II  substrate),  lead  to  an  additional  increase  in  H2O2 
production  (Figure  3-8).  Surprisingly,  H20 2  generation  was  increased  in  CO- 
RMs-treated  mitochondria  oxidizing  complex  I  and  complex  II  substrates.  For 
instance,  CORM-2  produced a significant increase of H2O2 generation  (pM  per 
mg protein per 30 min) from 7.36 to 10.33 with complex l-linked respiration and 
from  10.65 to 12.90 with complex II substrates (Figure 3-8A).  Similarly,  CORM- 
3  markedly  increased  H2O2  production  from  mitochondria  oxidizing  complex  I 
and II substrates (Figure 3-8B). The corresponding negative controls (iCO-RMs) 
were  ineffective  suggesting  that  CO  liberated  from  the  active  molecules  is 
responsible for the  increase in  H2O2 production.  In contrast to results obtained 
with  CORM-2  and  CORM-3,  CORM-A1  did  not  increase  H2O2  generation  in 
isolated renal mitochondria.
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Figure 3-8:  Effect of CO-RMs on H20 2  production in isolated rat mitochondria
The rate of H20 2  production in mitochondria was determined as described in Materials 
and  Methods.  H20 2   was  measured  in  mitochondria  pre-incubated  for  30  min  with 
CORM-2 (A),  CORM-3 (B) or CORM-A1  (C) in the presence of malate and glutamate 
(complex I) or succinate and rotenone (complex II) as substrates.  iCO-RMs represent 
the negative controls, which do not release CO. Each bar represents the mean ± SEM 
of 5 experiments. * P < 0.05, ** P < 0.001 vs. control.
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3.6.6  Effect of CO-RMs on Lipid Peroxidation
Accumulation  of  MDA,  an  index  of  lipid  peroxidation,  was  determined  in 
mitochondria  isolated  from  control  or  mitochondria  induced  by  ADP/Fe2+  and 
various  concentrations of CO-RMs or iCO-RMs  in the  presence of malate  and 
glutamate as substrates. The results reported in Figure 3-9 show that the  level 
of MDA  in  mitochondria from  untreated  control  kidney  mitochondria  increased 
significantly  in  mitochondria  induced  by  ADP/Fe2+  (P  <  0.001).  Interestingly, 
both CORM-2 and CORM-3 decreased the MDA level of isolated kidney cortex 
mitochondria  in  a  concentration-dependent  manner  if  compared  to  iCO-RMs. 
For  example,  Figure  3-9A  shows  that  in  the  absence  of  oxidants  the  level  of 
MDA  was  0.6  nmol/mg  protein,  but  the  oxidation  by  ADP/Fe2+  increased 
significantly the production of MDA in rat mitochondria to  13.6 nmol/mg protein. 
Incubation  with  50  and  100  pM  CORM-2  caused  a  significant  (P  <  0.001) 
decrease  in  the  extent  of  oxidation  to  7.8  and  5.7,  respectively.  Similarly, 
CORM-3 also reduced  lipid  peroxidation from  12.8  nmol/mg  protein  at 0  pM to 
10.7,  6.1  and  4.1  at  10,  50  and  100  pM,  respectively  (P  <  0.05).  CORM-A1 
appears  to  have  minor  effects  (P >  0.05)  on  lipid  peroxidation  (Figure  3-9C). 
The  negative  controls  (iCO-RMs)  did  not cause  significant differences  in  MDA 
levels when compared to control mitochondria induced by ADP/Fe2+.
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Figure 3-9: Effect of CO-RMs on lipid peroxidation in isolated rat mitochondria
Lipid peroxidation was measured in mitochondria pre-incubated for 30 min with CORM- 
2  (A),  CORM-3  (B)  or  CORM-A1  (C)  in  the  presence  of  malate  and  glutamate  as 
substrates  and  supplemented  with  1   mM  ADP,  and  0.1  mM  FeS04  to  enzymatically 
induced  peroxidation.  Control  represent  mitochondria  without  CO-RMs  or  inducers. 
iCO-RMs  represent  the  negative  controls,  which  do  not  release  CO.  Each  bar 
represents the mean ± SEM of 5 experiments. * P < 0.05, ** P < 0.001  vs. 0 pM CO- 
RMs.
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3.6.7  The Effect of Cold Storage on Isolated Renal Cortical Mitochondria
In  order  to  assess  the  influence  of  cold  ischaemia  on  mitochondrial  O2 
consumption  and  viability,  the  respiration  rate  of  isolated  rat  kidney  cortical 
mitochondria  was  measured  using  glutamate  and  malate  as  substrates.  In 
addition, 50 pM CORM-A1  was added to the flushing solution for kidneys stored 
for 24 hr to investigate any possible effect of CO on mitochondrial function after 
cold  storage.  Cold  preservation  of  the  kidney  resulted  in  a  predominant 
decrease  of  state  3  oxygen  consumption  after  24  and  48  hr  (Figure  3-10A). 
Twenty-four  hours  of  cold  storage  decreased  state  3  respiration  by  47%, 
whereas  a  reduction  of  60%  was  observed  after  48  hr  cold  ischaemia 
(P<0.001),  while CORM-A1  appeared not to affect state 3 respiration.  The low 
temperature during in vitro ischaemia induced an increase in state 4 respiration 
of 38%  and  84%  at 24  and 48  hr,  respectively without any observed  changes 
with CORM-A1  (Figure 3-1 OB).  It is also remarkable that the decrease in state 3 
and  the  increase  in  state  4  resulted  in  a  statistically  significant  depression  of 
RCI values of cold-stored kidneys as indicated by RCI values of 2.4 at 24 hr and 
1.37 after 48 hr (Figure 3-10C).
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Figure 3-10: The effect of cold storage on mitochondrial oxygen consumption
Mitochondria were isolated from rat kidneys as reported  in  Materials and Methods.  The 
following  respiratory parameters were assessed in mitochondria after cold flushing with 
or without CORM-A1  and preservation for 24 h (4 °C) of rat kidneys in Celsior solution: 
(A)  State  3  (B)  State  4  (C)  and  RCI  in  the  presence  of  malate  and  glutamate  as 
substrates.  In addition,  respiratory parameters were also evaluated after storage for 48 
hr  in  Celsior.  iCORM-A1  represents  the  negative  controls,  which  do  not  release  CO. 
Each column  represents the mean ± SEM,  n=6 in each group.  *P  < 0.05,  **P < 0.001 
vs.  control.
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3.7  Discussion
Increasing  experimental  evidence  demonstrates  that  endogenous  CO 
generated in response to stimulation of the HO-1  pathway plays a crucial role in 
the modulation of several physiological processes (Akamatsu et al., 2004;  Kaide 
et  al.,  2001;  Motterlini  et  al.,  1998).  This  notion  has  been  corroborated  by the 
recent  discovery  and  characterization  of  CO-RMs,  compounds  that  liberate 
controlled  amounts  of  CO  in  biological  systems  and  simulate  many  of  the 
bioactivities elicited by HO-1-derived CO (Motterlini et al.,  2005).  In the present 
study,  we  report the  influence of CO  liberated from  CO-RMs  on  mitochondrial 
respiratory  function  in  rat  kidneys  and  the  possible  mechanisms  behind  it. 
Although  the  effect  of  CO  gas  delivered  at  supra-physiological  levels  on 
mitochondrial function,  energy metabolism  and  activity of the  respiratory chain 
complexes  has  been  extensively  studied  (Miro  et  al.,  1998;  Zhang  and 
Piantadosi,  1992),  no data are available on the influence of low concentrations 
of CO on mitochondrial state 3 and state 4 respirations as well as RCI.
Our results show that low concentrations of CORM-2,  CORM-3 and  CORM-A1 
modulate  the  respiratory  activity  of  mitochondria.  When  respiration  was 
activated  using  malate  and  glutamate  as  substrates  and  ADP,  the  respiratory 
control index (RCI) was significantly reduced by CO-liberating compounds. This 
was  specifically  associated  with  a  significant  decrease  in  state  3  (active 
respiration in the presence of ADP) indicating that oxygen uptake and oxidative 
phosphorylation were affected.  State 4,  which  under normal  conditions reflects 
the  proton  leakage  across  the  mitochondrial  inner  membrane  and  the  rate  of 
oxygen  consumption  after depletion  of ADP,  was  markedly increased  at some 
concentrations of CO-RMs suggesting that in the presence of CO more oxygen
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is consumed when not used for ATP synthesis.  In general, the RCI values were 
significantly  decreased  in  the  presence  of  CO-RMs  but  remained  unchanged 
when  mitochondria  were  incubated  with  the  inactive  forms  (iCO-RMs).  In 
addition,  CO-RMs  also  reduced  uncoupled  mitochondrial  respiration.  These 
data  reveal  that  CO  liberated from  CO-RMs  reduces  the  tightness  of coupling 
between electron transport and ATP synthesis.  As  CO  released from  CO-RMs 
significantly  affects  the  glutamate  and  malate  (complexes  I,  III  and  IV) 
supported  respiration  of  isolated  renal  mitochondria  in  a  concentration- 
dependent fashion as reported above, we also demonstrated that CO  liberated 
from  CORM-3  inhibited  mitochondrial  respiration  mediated  by  complex  II  and 
IV-linked  substrates.  Interestingly,  H2O2 generation was  increased  in  CO-RMs- 
treated  mitochondria  oxidizing  complex  I  and  complex  II  substrates. 
Surprisingly,  CO-RMs  also  reduced  the  MDA  level  of  isolated  mitochondria 
indubed by ADP/Fe2+ in a concentration-dependent manner.  In contrast,  CO did 
not appear to affect the function of mitochondria from kidneys subjected to cold 
storage.
The intensity of the inhibition in mitochondrial respiration was different between 
the  CO-RMs  utilized.  CORM-2 was  the  most  effective  agent to  decrease  RCI, 
followed  by  CORM-3  and  CORM-A1,  respectively.  These  relative  differences 
may be explained by the different stability of CO-RMs in solution, their inherent 
chemical  properties  and  their  ability  to  liberate  CO  with  a  specific  rate  of 
release.  Here, we showed that both CORM-2 and CORM-3 are fast releasers of 
CO  in the respiratory buffer at 30 °C, while CORM-A1  liberates CO very slowly. 
This  is  in  agreement  with  previous  studies  from  our  laboratory.  For  instance, 
CORM-3  has  been  shown  by our group to be a “fast”  CO  releaser in  aqueous
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solutions at pH=7.4 (t1 /4=1-5) (Clark et al., 2003;  Motterlini et al., 2003), whereas 
under the  same  conditions  CORM-A1  acts  preferably as  a  “slow”   CO  releaser 
(Motterlini et al.,  2004).  In addition,  CORM-2 can actively lose a carbonyl group 
once  solubilized  in  DMSO,  which coordinates to the metal  centre to favour the 
rapid  release of CO (Motterlini et al.,  2002a;  Motterlini et al.,  2003). Thus,  both 
the quantity and rate of CO release appear to dictate the bioactivity of CO-RMs 
(Motterlini et al., 2004) and may as well differently affect mitochondrial function. 
The  future  of  CO-RMs  lies  in  their  characteristic  as  novel  CO  carriers  in  a 
manner similar to  NO donors (Keefer,  2003)  by facilitating the pharmacological 
delivery of minute amounts of CO for the treatment of a number of pathological 
conditions  (Motterlini  et  al.,  2005).  Unlike  CO  gas  which  cannot  be  easily 
controlled,  the  key  aspect  of these  compounds  is  that  they  may  enhance  the 
specificity  of  CO  delivery  in  a  measurable,  safe  and  controllable  fashion 
(Motterlini et al.,  2004).  In fact, the majority of reports on CO gas highlighted its 
potential  toxicity  and  the  ability  to  alter  mitochondrial  function.  For  instance, 
data  indicate  that  the  intracellular  uptake  of  CO  can  impair  cerebral  energy 
metabolism  (Brown  and  Piantadosi,  1992)  and  a  decrease  in  oxidative 
phosphorylation as well as cytochrome c oxidase activity have been observed in 
various  organs from  both  animals  and  humans  during  acute  carbon  monoxide 
poisoning (Alonso et al., 2003; Shigezane et al.,  1989). The well known fact that 
CO  binds  to  haem  proteins  make  cytochrome  c  oxidase  or complex  IV  in  the 
respiratory chain a likely target for CO.  Here, we demonstrated that CO reduces 
mitochondrial function in the presence of complex IV only substrates,  indicating 
that cytochrome c oxidase is one of the CO targets in the  mitochondrial  chain. 
However,  this  effect  does  not  exclude the  effect  of CO  on  other mitochondrial
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complexes.  In  support,  the  binding  of  CO  to  cytochrome  c  oxidase  in  the 
respiratory chain  has been  long recognized to be a contributor of mitochondrial 
dysfunction but its physiological significance is unknown (Brown and Piantadosi, 
1990).  Cytochrome c oxidase  is the terminal  acceptor in the electron transport 
chain;  if  its  activity  is  blocked,  then  electrons  would  stop  flowing  through  the 
chain with  a consequent decrease in ATP  production and  an  increase  in ADP, 
AMP,  and  Pi,  all  metabolites  capable  of  regulating  a  number  of  important 
cellular  processes  including  protein  synthesis  and  ion  transport  (Alonso  et  al., 
2003).  On  the  other  hand,  a  protective  way  of  detoxifying  CO  cannot  be 
excluded  a  priori  as a previous study showed  the presence of CO  oxygenase 
activity  in  isolated  mitochondria  demonstrating  that  cytochrome  c  oxidase 
catalyzes  the  oxygenation  of  minute  amounts  of  CO  to  CO2  (Young  and 
Caughey,  1986).  Whether high  and small  concentrations of CO  can  differently 
affect mitochondrial function in vivo remains to be determined but it is tempting 
to  speculate  that  small  quantities  of  CO  liberated  by  CO-RMs  could  be 
beneficial after all.
Another  generally  accepted  concept  is  that,  irrespective  of  the  concentration 
used,  CO  mediates  a  negative  effect  on  mitochondria  by  increasing  the 
generation of oxygen free radicals.  In this study,  H2O2 generation was increased 
in CO-RMs-treated mitochondria oxidizing complex I and complex II substrates. 
Mitochondria are an important cellular source of reactive oxygen species (ROS) 
(Balaban et al., 2005) and they can also be a target of free radical attack, which 
may  result  in  mitochondrial  swelling,  lipid  peroxidation,  inactivation  of  the 
electron transport chain  and  inhibition  of mitochondrial  respiration  (Radi  et al., 
1994). The inhibition of cytochrome c oxidase enhances the production of ROS
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from different sites in the respiratory chain,  mostly from complex I and  III  (Chen 
et  al.,  2003).  It  has  been  shown  that exogenously applied  CO  gas  (1%  for 30 
min) generates oxidative stress in rat brain and this effect has been attributed to 
the  increased  generation  of  partially  reduced  oxygen  species  at  the 
mitochondrial  level  (Balaban  et  al.,  2005).  Furthermore,  ROS  generated  by 
mitochondria  or  from  other  sites  within  the  cell  may  cause  damage  to 
mitochondrial  components  and  initiate  degradative  processes  (Cadenas  and 
Davies,  2000).  Hydroxyl  radical formation with consequent oxidative stress has 
also  been  shown  in  the  brain after CO  hypoxia  (Piantadosi  et al.,  1995);  once 
again,  this  and  related  studies  reveal  the  pathological  events  occurring  after 
exposure to concentrations of CO that are incompatible with biological systems. 
Despite the  increase  in  H2O2 production  by  CO-RMs,  our  results  showed  that 
CO-RMs  decrease  oxidative  stress  as  evidenced  by  a  reduction  in  lipid 
peroxidation  induced  by ADP/Fe2+.  The mechanism  of this  protection  by CO  is 
unclear,  but a previous study showed that dual-treatment with biliverdin and CO 
gas  was  effective  in  decreasing  lipid  peroxidation  and  providing  protection 
against transplant-associated  cold  l-R  injury of heart and  kidney grafts  (Nakao 
et al., 2005).
Our results leave open the question of what benefits CO-induced modulation of 
mitochondrial function  might  have in  vivo.  From  our data,  a fall  in  RCI  by  CO- 
RMs is often accompanied by a decrease in uncoupling of respiration from ATP 
production  via  enhanced  proton  leakage  across  the  inner  mitochondrial 
membrane.  Intuitively,  as outlined  above,  this  is  seen  as a  problem  in  aerobic 
mammalian systems because it is depressing energy supply to the cell.  Indeed, 
long-lasting  irreversible  uncoupling  is  likely to be  lethal to the cell.  However,  a
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reversible,  controlled  change  in  respiratory  coupling  may  in  some 
circumstances  be  helpful  (Brand,  2000).  As  stated,  low  concentrations  of  CO 
have  been  found  to  have  beneficial  effects  in  several  pathological  conditions, 
such  as  inflammation and  l-R injury (Akamatsu et al.,  2004;  Clark et al.,  2003; 
Otterbein  et al.,  2000),  where  increased  ROS  production  play a central  role  in 
the exacerbation  of these diseases.  Mitochondria are  known to  be responsible 
for some 90% of basal  ROS  production  (Balaban  et al.,  2005) and this can  be 
significantly  increased  after  damage.  Controlled  uncoupling  has  been 
suggested  as  an  important  mechanism  for  reducing  ROS  liberation  (Brand  et 
al., 2004).  Similarly, the concept that a continuous mild production of ROS from 
mitochondria  is  essential  for  life  is  fully  supported  by  experimental  evidence 
(Becker,  2004).  These might be some of the  mechanisms  by which  CO  exerts 
its beneficial  effects.  Further work will  be  needed to  investigate these  possible 
mechanisms of action but preliminary studies from our group and collaborators 
reveal that both  mitochondrial respiratory chain and free radical generation  are 
targets for the anti-proliferative effect of CO-RMs (Taille et al., 2005).
In  support of the effect of CO  on respiratory parameters,  mitochondria  isolated 
from  haemin-treated  rats  showed  a  significant  reduction  in  RCI  which  was 
mainly  due  to  a  decrease  in  state  3  respiration  (Sandouka  et  al.,  2005).  The 
administration  of  haemin  was  associated  with  an  increase  in  HO-1  protein 
expression  in  renal tissue;  these data  are not surprising  as  haemin  is a potent 
inducer of HO-1  and  has  been  consistently used to  increase the  production of 
endogenous  CO  (Motterlini  et  al.,  2002a).  Electron  microscopy  analysis  also 
showed  that  the  mitochondrial  ultrastructure  was  preserved  after  HO-1  up- 
regulation  by haemin  as  no visible  sign  of mitochondrial  swelling  or rupture of
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membranes was observed following haemin treatment (Sandouka et al.,  2005). 
This  is  in  agreement  with  a  previous  study  performed  by  our  group  showing 
maintenance  of  mitochondrial  function  in  cardiac  tissue  after  treatment  with 
haemin  (Clark et al.,  2000b).  The increase in  HO-1  protein  expression  and the 
consequent  modulation  of  mitochondrial  respiration  would  suggest  a  direct 
contribution of enhanced CO production.
The effect of cold ischaemia on respiratory function has been already shown in 
the  literature  (Sammut  et  al.,  1998b;  Southard  et  al.,  1977).  Nonetheless,  no 
data  have  been  reported  on  the  effectiveness  of  Celsior  solution  on  isolated 
mitochondria.  The  results  clearly  showed  that  when  the  mitochondrial 
respiration  was  initiated  by  malate  and  glutamate  and  ADP,  the  RCI  was 
significantly depressed after 24 and 48 hr cold storage.  Significant inhibition of 
state 3 was observed, whereas the alteration in state 4 or resting state was less 
significant  than  the  other  two  parameters  considered.  These  results  are  in 
agreement with early findings showing that a decreased active-state respiration 
is the main cause of lower RCI values after a cold ischaemia event (Hartung et 
al.,  1985).  Indeed,  RCI values after 24 hr of cold ischaemia have been reported 
to  be  nearly 2  (Hartung  et al.,  1985),  in  accordance with  the  results  obtained 
here.  In addition, a previous study by our group demonstrated that cold storage 
of rabbit kidneys caused a reduction in the RCI values because of a decrease in 
state  3  respiration  (Sammut  et  al.,  2000).  A  major  aspect  related  to  the 
protection  elicited  by  cold  preservation  is  the  cessation  of the  active  pumping 
processes in renal tubules cells, leading to the hypothesis that ATP is preserved 
to  maintain  energy  for  cellular  metabolism.  Thus,  the  inhibition  of  the 
mitochondrial  respiratory chain and energy production  by CO could be of great
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significance  against  l-R  injury  if the gas will  show to  preserve ATP  levels  in  a 
way similar to cold  preservation.  However,  it  is  notable that  CO  released from 
CORM-A1,  which  affect  mitochondrial  RCI  values  of  freshly  isolated 
mitochondria did  not appear to affect the function of mitochondria from kidneys 
subjected to cold storage.
Finally,  an  interesting  question  arises  from  this  study:  can  modulation  of 
mitochondrial  respiration  by  a  controlled  release  of  CO  be  of  physiological 
relevance? The answer cannot be fully addressed at present but it is interesting 
to note that NO,  like CO,  has been shown to affect mitochondrial respiration via 
inhibition  of cytochrome  c  oxidase  by  competing  with  O2  (Brown,  1999).  The 
inhibition appears to be reversible suggesting that NO could be a physiological 
regulator of oxygen availability in the respiratory chain (Brown,  1995;  Moncada 
and  Erusalimsky,  2002).  Considering  that  not  only  NO  but  also  CO  binds 
reversibly  to  cytochrome  c  oxidase  in  competition  with  O2  and  decrease  its 
enzymatic activity (Boelens et al.,  1982),  the hypothesis that  CO  may  also  act 
as a physiological regulator of cell metabolism cannot be excluded a priori.
In  summary,  the major findings of this study are that  CO released by CO-RMs 
inhibits  respiratory  activity  in  a  concentration-dependent  manner  in  fresh 
kidneys.  Specifically, a marked depression of state 3 (active respiration) and an 
increase  of  state  4  (resting  state)  was  observed  resulting  in  a  significant 
decrease  of  RCI  values  and  uncoupled  respiration.  In  addition,  CO  also 
increases H2O2 production,  but on the other hand,  decreases lipid peroxidation. 
From the results obtained, it is difficult to postulate a final regulatory mechanism 
of CO on  mitochondria and further studies on the effect of CO on the activity of 
mitochondria complexes will  be  necessary.  It is tempting to speculate that  CO
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may  act  as  an  energy  preserver  rather  than  energy  inhibitor  by  regulating 
mitochondrial  function  and  maintenance  of  cellular  anti-oxidant  defence 
mechanisms.  By doing  so,  CO  may  be  used  as  a  novel  agent for kidney and 
organ preservation in the setting of transplantation procedures.
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4  Effect of Carbon Monoxide-Releasing Molecules (CO-RMs) 
on Kidney Biochemistry and Function Using an Isolated 
Perfused Rabbit Kidney Circuit Model
4.1  Introduction
Kidneys  harvested  from  cadaveric donors  for transplantation  are  preserved  to 
reduce  the  ischaemic  injury.  Simple  hypothermia  in  conjunction  with 
intravascular flush  is the most important strategy to reduce ischaemic injury for 
solid organ preservation (McLaren and Friend, 2003).  CO, formerly regarded as 
a toxic waste product of HO enzyme reaction, has taken on new significance as 
a  possible  biological  messenger.  With  the  increasing  evidence  and  changing 
views  about  CO  and  the  recent  findings  about  its  role  in  vasorelaxation, 
inhibition  of  cellular  proliferation,  the  blockade  of  apoptotic  pathways  and  the 
suppression  of  inflammation  (Durante,  2002).  The  hypothesis  that  CO  may 
provide protection in inflammatory diseases,  l-R injury,  organ transplant models 
and  preservation  of  these  organs  seems  plausible.  As  a  result,  it  has  been 
shown recently that exogenous CO at low concentration has a protective role in 
organ transplantation models, graft rejection, and in various models of l-R injury 
(Motterlini et al., 2005).  Based on the evidence that CO provides such defence 
mechanisms,  all  of the  above  studies  strongly  suggest the  possibility  of using 
exogenous  CO  as  a  novel  therapeutic  in  organ  preservation  and 
transplantation.  Considering the central role of the kidney in the present Thesis 
and  in  particular the  aspect  of renal  preservation,  this  Chapter was  aimed  to 
determine  whether  CO  could  be  involved  in  the  regulation  of  kidney  function 
and  biochemistry.  Therefore,  this  study  has  been  designed  to  evaluate  the
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biochemical  and  physiological  effects  of  CO  liberated  from  CO-RMs  during 
normothermic perfusion on kidney function at reperfusion of freshly isolated and 
cold-stored kidneys.
4.2  Hypothesis
In this study, we examined the hypothesis that CO liberated from CO-RMs may 
affect renal function and could be protective against cold l-R injury.
4.3  Objectives
•  To  evaluate the  biochemical  and  physiological  effects  of CO  liberated from 
CO-RMs  on  kidney  function  during  normothermic  perfusion  of  freshly 
isolated kidneys.
•  To evaluate the  biochemical  and  physiological  effects  of CO  liberated from 
CORM-A1  on  kidney  function  during  normothermic  perfusion  after  cold 
storage of kidneys for 24 hr.
•  To investigate the mechanism by which CO affects renal function.
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4.4  Materials and Methods
4.4.1  Isolated Perfused Rabbit Kidney Circuit
The experimental  animals were  male  New Zealand White rabbits weighing 2.5 
to 4  kg;  they were terminally anesthetized with  Hypnorm  IM,  diazepam  IV,  and 
O2 via a face mask.  The abdomen was entered via a midline  incision, followed 
by kidney exposure and  cannulation of the  renal  artery.  Kidneys were flushed, 
removed,  and  either  stored  for 24  hr  or  perfused  immediately  on  an  isolated 
perfused  kidney circuit for 2  hr.  The technique  of isolated  perfused kidney has 
been  described  in  detail  in  Chapter  2  (Heading  2.4).  Briefly,  the  freshly 
harvested  kidney  was  perfused  with  a  peristaltic  pump  in  a  closed  isolated 
perfused kidney circuit (Figure 2-3).  The perfusate temperature was kept at 37 
°C  and  the  perfusion flow  rate was  adjusted  to  maintain  the  arterial  perfusion 
pressure at 100 mmHg. The perfusate was oxygenated with a gas mixture of 0 2 
(95%) and C 02 (5%).
4.4.2  Functional and Biochemical Parameters
Perfusion  (PFR) and  urine flow (UFR) rates were measured every  15 min after 
a period of initial  stabilization and expressed as  ml/min/g tissue.  Perfusate and 
urine samples from renal vein and ureter were collected at the same time points 
for biochemical  study  (see  Heading 2.4.8 for details).  Glomerular filtration  rate 
(GFR)  was  calculated  by  measuring  urine  and  perfusate  creatinine  levels 
according  to  the  following  formula:  GFR  =  UFR  X  Urine  creatinine/  Perfusate 
creatinine.  Glucose,  Na+,  and  creatinine  were  measured  using  a  biochemical 
analyser.
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4.4.3  Experimental Protocols
Isolated kidneys were divided in two major protocols:
In protocol A (n=6 for each group),  kidneys were not subjected to cold storage 
but were immediately perfused on the circuit at 37 °C.  Baseline renal functions 
were  measured  after  an  initial  period  of  stabilisation  (30  min);  thereafter, 
CORM-A1  (10,  25  and  50  pM),  CORM-3  (50  pM),  or  iCO-RMs  (50  pM)  were 
added  to the  perfusion  solution as a single dose  in the  last 45  min  of the 2 hr 
perfusion  period to investigate their effects on  kidney function.  In  an  additional 
set  of experiments,  1H-[1,2,4]oxadiazolo[4,3-alpha]quinoxalin-1-one  (ODQ,  30 
pM),  a soluble guanylate cyclase inhibitor, was perfused 30 min before addition 
of CORM-A1  in freshly isolated kidneys at 37 °C.
In  protocol  B  (n=5  for  each  group),  kidneys  were  flushed  with  60  ml  cold 
Celsior solution alone and bathed at 4 °C for 24 h in Celsior.  The kidneys were 
then  perfused  on  the  circuit  at  37  °C,  and  baseline  renal  functions  were 
measured after an initial period of stabilisation (30 min). Thereafter,  50 pM each 
of  CORM-A1  or  iCORM-A1  were  added  to  the  perfusion  solution  as  a  single 
dose  in  the  last  45  min  of  the  2  hr  perfusion  period  to  evaluate  their 
haemodynamic functions on the isolated system.
At  the  end  of  the  perfusion  times,  in  selected  groups,  kidney  tissues  were 
prepared for mitochondrial isolation.
4.4.4  Detection of CO Release
The  release  of  CO  from  CO-RMs  in  Krebs  buffer  perfusion  (37  °C)  was 
assessed  spectrophotometrically  by  measuring  the  conversion  of 
deoxymyoglobin (deoxy-Mb) to carbonmonoxy myoglobin (MbCO) as described 
in the Materials and Methods (Heading 2.2).
150UCL 4. EFFECT OF CO-RMs ON RENAL FUNCTION
4.4.5  Isolation of Rabbit Kidney Mitochondria
At  the  end  of  the  reperfusion  studies  on  the  isolated  system,  cortical 
mitochondria from each kidney were isolated by homogenization and differential 
centrifugation  and  oxygen  consumption  was  measured  as  reported  before  in 
detail  in the Materials and Methods Chapter (Heading 2.4.7).  State 3 and state 
4 respirations were calculated and represented as ng 02/mg protein/min.
4.4.6  Statistical Analysis
Statistical analysis was performed using one-way analysis of variance (ANOVA) 
combined with Bonferroni test for multiple comparisons. When differences were 
established  between  groups,  an  unpaired two-tailed  t-test was  used  to  assess 
statistical  significance  between  two  groups  at  each  time  point.  Data  were 
presented  as  mean  ±  SEM  and  differences  considered  to  be  statistically 
significant at P < 0.05.
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4.5  Results
4.5.1  Effects  of  CO-RMs  on  Renal  Function  in  Freshly  Isolated  Rabbit 
Kidneys
To  obtain  preliminary  evidence  that  CO  released from  CO-RMs  can  positively 
affects renal function and to decide upon the effective dose range to be used in 
the  cold  preservation  protocols  (Chapter  5),  CO-RMs  were  added  to  the 
perfusate of freshly harvested kidneys and renal physiological parameters were 
evaluated on the isolated system. The effect of 0,  10, 25,  and 50 pM CORM-A1 
was  examined  over  a  45  min  perfusion  time  on  the  isolated  perfused  kidney. 
We found that the addition of 50 pM CORM-A1  significantly increased perfusate 
flow rate  (PFR)  compared  to  control  (Figure 4-1 A).  On  the  other  hand,  there 
was  no  detectable  increase  in  PFR  with  10  and  25  pM  CORM-A1.  Notably, 
iCORM-A1  (50  pM),  which  does  not  release  CO,  was  also  totally  ineffective 
(Figure 4-1B).  CORM-A1  also significantly increased urine flow rate (UFR) (P < 
0.05)  in  a  time  and  concentration-dependent  fashion  when  compared  to  the 
control group (Figure 4-1C,  D). After 45 min perfusion,  UFR increased from the 
baseline values by 7.1%,  17.4% and 34.6 % with  10,  25 and 50 pM CORM-A1, 
respectively.  No significant increase in UFR was observed with iCORM-A1  (P < 
0.05).  Similarly,  perfusion  of  isolated  kidneys  in  the  presence  of  CORM-A1 
resulted in a marked concentration and time-dependent increase in GFR but no 
significant changes were observed with the negative control,  iCORM-A1  (Figure 
4-1F,  E).
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Figure  4-1:  Effect  of  CORM-A1  on  renal  physiological  parameters  in  freshly 
isolated kidney
Perfusion  flow  rate  (A),  urine  flow  rate  (C)  and  glomerular  filtration  rate  (GFR,  see 
graph  E)  were  measured  in  freshly  isolated  rabbit  kidneys  perfused  for 45  min  in  the 
presence  of  increasing  concentrations  of  CORM-A1  (see  Materials  and  Methods  for 
details).  Changes  in these  physiological  parameters were also followed over time after 
addition  of 50  pM  CORM-A1  (see graphs  B,  D and  F,  respectively).  iCORM-A1,  which 
does  not  release  CO,  was  used  as  negative  control.  Each  bar or  line  represents  the 
mean ± SEM of 6 independent experiments. * P < 0.05 vs.  0 pM CORM-A1  or control.
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In addition,  the effect of 50 |jM  CORM-3 on renal physiological parameters was 
also  examined  over  a  45  min  perfusion  time  on  the  isolated  perfused  kidney 
(Figure 4-2).  Interestingly,  CORM-3 did not cause any significant change in the 
renal  PFR of freshly isolated  kidneys (Figure 4-2A).  In contrast to  PFR,  50  pM 
CORM-3 increased UFR in a time dependent fashion when compared to control 
(P < 0.05).  For instance,  UFR increased significantly by 14.2% and  16.7% after 
30 and  45  min  of perfusion,  respectively (P < 0.001  vs.  control).  No significant 
increase was observed with iCORM-3 when compared to control.  In parallel, ex- 
vivo  isolated  kidneys  showed  a  dramatic  increase  in  GFR  in  the  presence  of 
CORM-3  when  compared  to  control.  As  shown  in  Figure  4-2C,  GFR  was 
significantly  increased  by  15%  and  16.8%  in the  presence  of 50  pM  CORM-3 
after 30 and 45 min perfusion, respectively.  In contrast, 50 pM iCORM-3 caused 
a non-significant elevation of the GFR when compared to control.
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Figure  4-2:  Effect  of  CORM-3  on  renal  physiological  parameters  in  freshly 
isolated kidneys
Perfusion  flow  rate  (A),  urine  flow  rate  (C)  and  glomerular filtration  rate  (GFR,  see 
graph  C) were  measured  in freshly isolated  rabbit kidneys perfused for 45  min  in the 
presence  of  50  fxM  CORM-3  (see  Materials  and  Methods  for  details).  Changes  in 
these  physiological  parameters  were followed  over time.  iCORM-3,  which  does  not 
release CO,  was  used  as negative control.  Each  line  represents the mean ± SEM  of 
6 independent experiments. * P < 0.05 vs. 0 pM CORM-3 or control.
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4.5.2  Effects  of CO-RMs  on  Tubular  Reabsorption  in  Freshly  Isolated 
Rabbit Kidneys
We  examined  whether  renal  tubular  reabsorption  of  glucose  and  Na+   was 
altered with  CO-RMs.  Figure 4-3 summarizes the effect of 0,  10,  25,  and 50 
pM CORM-A1  on renal glucose and Na+  reabsorption in the isolated perfused 
kidney  model.  When  compared  to  control,  CORM-A1  reduced  glucose 
reabsorption (R glu)  in a time and concentration-dependent fashion.  At 50 pM 
CORM-A1,  Rglu decreased significantly by 21.1%, 30.1% and 30.5% after 15, 
30  and  45  min  perfusion,  respectively  (Figure  4-3B).  In  contrast,  10  and  25 
pM  CORM-A1  caused  a  non-significant  reduction  of  RGlu  by  11.2%  and 
15.4%  at  the  end  of  the  perfusion  time  when  compared  to  control  (Figure 
4-3A).  No  significant  difference  was  observed  with  iCORM-A1  compared  to 
control.
In  the  same  way,  CORM-A1  decreased  sodium  reabsorption  (Rna)  in  a time 
and  concentration  dependent-manner  when  compared  to  control.  For 
example,  RNa was decreased  by 33.2%  and 43.8%  at 25 and 50 pM  CORM- 
A1  at the end of the perfusion time (P < 0.05),  whereas,  10  pM  CORM-A1  a 
non-significant  decrease  of  RN a  by  14%  was  obtained  (Figure  4-3C). 
Additionally,  50 pM CORM-A1  reduced RN a by 36.6%, 45.2% and 43.8% after 
15,  30  and  45  min  of  perfusion,  respectively  (P  <  0.001,  Figure  4-3D).  No 
significant increase was observed with iCORM-A1  when compared to control. 
In addition, the effect of 50 pM CORM-3 on Rglu and RN a was examined over 
45 min perfusion time on the isolated perfused kidney (Figure 4-4).
156rci. 4. EFFECT OF CO-RMs ON RENAL FUNCTION
Interestingly and in contrast to CORM-A1,  CORM-3 did not cause any change 
in the renal tubular reabsorption of glucose and Na+  in freshly isolated kidneys 
(P > 0.05,  Figure 4-4).
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Figure  4-3:  Effect  of  CORM-A1  on  tubular  reabsorption  in  freshly  isolated 
kidneys
Glucose  reabsorption  (A)  and  sodium  reabsorption  (C)  were  measured  in  freshly 
isolated  rabbit *   kidneys  perfused  for  45  min  in  the  presence  of  increasing 
concentrations of CORM-A1  (see Materials and  Methods for details).  Changes in the 
reabsorption  rate  were  also  followed  over  time  after  addition  of  50  pM  CORM-A1 
(see  graphs  B  and  D,  respectively).  iCORM-A1,  which  does  not  release  CO,  was 
used  as  negative  control.  Each  bar  or  line  represents  the  mean  ±  SEM  of  6 
independent experiments.  * P < 0.05, ** P < 0.001  vs.  0 pM CORM-A1  or control.
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Figure 4-4:  Effect  of CORM-3 on  renal tubular reabsorption  in freshly  isolated 
kidneys
Glucose  reabsorption  (A)  and  sodium  reabsorption  (B)  were  measured  in  freshly 
isolated  rabbit  kidneys  perfused  for 45  min  in  the  presence  of 50  pM  CORM-3  (see 
Materials  and  Methods  for details).  Changes  in  the  reabsorption  rate  were  followed 
over time.  iCORM-3, which does not release CO, was used as negative control.  Each 
line represents the mean ± SEM of 6 independent experiments.
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4.5.3  Effects of CO-RMs on  Mitochondrial  Function in  Freshly Isolated 
Rabbit Kidneys
As CO changes mitochondrial respiration significantly as observed in Chapter 
3,  and  to  study  the  mechanism  by  which  CO  affects  renal  function,  we 
examined  the  influence  of  CO  released  from  CO-RMs  on  respiratory 
parameters  from  mitochondria  isolated  from  rabbit  kidneys  at  the  end  of 
perfusion  time.  Oxygen  consumption  of  isolated  rabbit  kidney  cortical 
mitochondria was measured using glutamate and malate as substrates. When 
compared  with  control  kidneys,  state  3  respiration  (ng  oxygen/  min/  mg  of 
protein) was significantly decreased from 52.1  to 28.3 with  50  pM  CORM-A1 
(Figure 4-5A).  In addition,  CORM-A1  reduced state 4  respiration  (ng oxygen/ 
min/ mg of protein) from  13.3 for control to 8.1  at 50 pM CORM-A1  (P < 0.05, 
Figure 4-5B). The decrease in state 3 and state 4 respiration rates resulted in 
a  non-significant  decrease  in  the  calculated  RCI  when  compared  to  control 
(Figure  4-5C).  With  iCORM-A1,  there  was  a  non-significant  change  in  the 
respiratory  parameters  when  compared  to  control.  In  contrast  to  CORM-A1, 
50 pM CORM-3 did not affect state 3, state 4 or RCI values (Figure 4-6).
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Figure 4-5:  Effect of CORM-A1  on the  respiratory  parameters in  isolated  renal 
mitochondria
Mitochondria  were  isolated  from  rabbit  kidneys  perfused  with  50  pM  CORM-A1  or 
iCORM-A1  as  reported  in  Materials  and  Methods.  The  following  respiratory 
parameters  were  assessed  in  the  isolated  mitochondria  in  the  presence  of  malate 
and glutamate as substrates and ADP:  (A) State 3 (B) State 4 (C) and the respiratory 
control  index  (RCI).  iCORM-A1  represents  the  negative  control,  which  does  not 
release CO.  Each bar represents the mean ± SEM,  n=6 in each group.
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Figure  4-6:  Effect  of CORM-3  on  the  respiratory  parameters  in  isolated  renal 
mitochondria
Mitochondria  were  isolated  from  rabbit  kidneys  perfused  with  50  pM  CORM-3  or 
iCORM-3 as reported in Materials and Methods. The following  respiratory parameters 
were assessed  in the  isolated  mitochondria  in the  presence of malate and glutamate 
as  substrates  and ADP:  (A)  State  3  (B)  State 4  (C)  and the  respiratory control  index 
(RCI).  iCORM-3  represents  the  negative  control,  which  does  not  release  CO.  Each 
bar represents the mean ± SEM,  n=6 in each group.
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4.5.4  Detection of CO Release from CO-RMs in Krebs Perfusion Buffer
The  rate  and  amount  of  CO  liberated  from  CO-RMs  were  measured  in  the 
kidney perfusion  solution.  Using the  myoglobin assay to detect the formation 
of MbCO as described in Chapter 2, we found that the rate of CO  release by 
CORM-A1  in  Krebs  solution  at  37  °C  directly  correlates  with  the 
concentrations  used  (Figure  4-7).  Specifically,  the  calculated  rates  of  CO 
release  were  6.16(±0.12),  14.50(±0.66)  and  30.16(±1.33)  nmol/hr for  10,  25 
and  50  pM  CORM-A1,  respectively.  Predictably,  the  inactive  compound 
(iCORM-A1) did not release any detectable CO in the Krebs solution at 37 °C 
(Figure 4-7A).
As  observed  with  iCORM-A1,  we  found  that  the  addition  of  iCORM-3  to 
deoxymyoglobin  dissolved  in  Krebs  solution  at  37  °C  did  not  produce  any 
detectable  MbCO  over  a  45  min  period  (Figure  4-8).  Interestingly,  and  in 
contrast to CORM-A1, the increase in MbCO formation after addition of 50 pM 
CORM-3 to the Krebs solution was faster and reached almost a maximal  level 
after  5  min.  The  calculated  rate  of  CO  release  from  the  time  of  addition  of 
CORM-3  was  6.23(±1.40)  nmol/hr  (Figure  4-8A).  Absorption  spectrum  of 
MbCO after interaction of myoglobin with CO released from 10, 25, and 50 pM 
CORM-A1  (Figure 4-7B) and 50 pM CORM-3 (Figure 4-8B) were compared to 
saturated MbCO and to iCO-RMs.
1624. EFFECT OF CO-RMs ON RENAL FUNCTION
50
40
30
o
o
n   20
10
B
10  jiM   CORM-A1 
25  nM  CORM-A1
•  50  CORM-A1
♦  50  |j.M  iCORM-A1
15  30
Time (min)
0.8
0.7
0) 0.6
O c 0.5 C 0
A
k- 0.4
o
< />
n 0.3
< 0.2
0.1
0.0
500  550  600
X (nm)
Figure 4-7:  Detection of CO released from CORM-A1  in perfusion solution
CO  release  was  assessed  spectrophotometrically  by  measuring  the  conversion  of 
deoxymyoglobin to  carbonmonoxy  myoglobin  (MbCO).  Determination  of the  amount 
of  MbCO  was  measured  after  interaction  of  deoxymyoglobin  with  various 
concentrations of CO liberated from CORM-A1.  A) Time course showing the amount 
of  CO  released  from  CORM-A1  in  the  perfusion  solution.  B)  Spectra  of  MbCO 
formation  at  45  min  after  addition  of  CORM-A1  to  myoglobin  solution.  Using 
myoglobin  prepared  in the  respiratory buffer,  10,  25 and 50  pM  CORM-A1  or 50  pM 
iCORM-A1  (pH = 7.4) at 37 °C were used.
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Figure 4-8:  Detection of CO released from CORM-3 in perfusion solution
CO  release  was  assessed  spectrophotometrically  by  measuring  the  conversion  of 
deoxymyoglobin to  carbonmonoxy  myoglobin  (MbCO).  Determination  of the  amount 
of  MbCO was  measured  after interaction  of deoxymyoglobin with  CO  liberated  from 
50 pM CORM-3.  A) Time course showing the amount of CO  released from CORM-3 
in  the  perfusion  solution.  B)  Spectra  of  MbCO formation  at 45  min  after addition  of 
CORM-3  to  myoglobin  solution.  Using  myoglobin  prepared  in  the  respiratory  buffer, 
50 pM CORM-3 or 50 pM iCORM-3 (pH = 7.4) at 37 °C were used.
164UCL 4. EFFECT OF CO-RMs ON RENAL FUNCTION
4.5.5  Effect  of  a  Guanylate  Cyclase  Inhibitor  (ODQ)  on  CORM-A1- 
mediated Changes in Renal Function and Biochemistry in Freshly 
Isolated Kidneys
To  determine  whether  the  observed  changes  with  CO-RMs  in  renal 
physiological  and  biochemical  parameters  were  through  the  cyclic  GMP 
dependent  mechanism,  we  measured  renal  parameters  in  the  presence  of 
1H-[1,2,4]oxadiazolo[4,3-alpha]quinoxalin-1-one (ODQ),  an inhibitor of soluble 
guanylate  cyclase  (Hussain  et  al.,  1997).  Here,  we  investigated  whether 
addition of ODQ to the perfusion solution would prevent the changes in renal 
parameters  mediated  by CO  liberated from  CORM-A1.  Figure 4-9A presents 
PFR  of  freshly  kidneys  at  the  end  of  perfusion  time.  In  particular,  kidneys 
supplemented with 50 pM CORM-A1  and 30 pM ODQ had similar PFR values 
to the control  group,  indicating that ODQ  prevented  the vasodilatory effect of 
CORM-A1.  In  contrast,  kidneys  supplemented  with  CORM-A1  and  ODQ 
showed  no  significant  differences  in  UFR,  GFR  and  glucose  and  Na+  
reabsorption  and  mitochondrial  function  when  compared  to  kidneys 
supplemented with CORM-A1  alone.4. EFFECT OF CO-RMs ON RENAL FUNCTION
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Figure 4-9:  Effect of ODQ, a guanylate cyclase inhibitor, on CORM-A1-mediated 
changes of renal parameters in freshly isolated kidneys
ODQ  (30  pM),  a  soluble  guanylate  cyclase  inhibitor,  was  perfused  30  min  before 
addition  of  50  pM  CORM-A1  in  freshly  isolated  kidneys  at  37  °C.  Changes  in  (A) 
perfusion  flow  rate,  (B)  urine  flow  rate,  (C)  glomerular  filtration  rate  (GFR),  (D) 
glucose  reabsorption  and  (E)  Na+   reabsorption  were  then  measured  in  the  isolated 
perfused  rabbit kidney system at the end of perfusion (see Materials and Methods for 
details).  The  respiratory  control  index  (RCI,  see  figure  F)  was  also  assessed  in 
isolated  rabbit  kidney cortical  mitochondria  in  the  presence of malate  and  glutamate 
as substrates and ADP.  Each bar represents the mean ± SEM of n=5 for each group. 
* P < 0.05 vs.  control (CON).
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4.5.6  The  Effect  of  CORM-A1  on  Kidney  Parameters  during 
Normothermic Perfusion after Cold Storage of Kidneys for 24 hr
In  this  study,  we  investigated  whether  CO  will  have  similar  effects  on 
ischaemic  kidneys  as  observed  with  freshly  isolated  kidney.  Therefore, 
physiological  and  biochemical  parameters  were  evaluated  in  isolated  rabbit 
kidneys which were flushed and cold-stored for 24 hr at 4 °C without CORM- 
A1.  Thereafter,  50  pM  each  of CORM-A1  or  iCORM-A1  were  added  to  the 
perfusion  solution  as  a  single  dose  in  the  last  45  min  of the  2  hr  perfusion 
period.  Interestingly,  CORM-A1  increased  PFR  in  a  time  dependent fashion 
when  compared  to  control  (Figure  4-10A).  At  50  pM  CORM-A1,  PFR 
increased by 8.2% and 7.8% after 30 and 45 min of perfusion,  respectively (P 
<  0.05).  No  significant  increase  was  observed  with  iCORM-A1  when 
compared  to  control.  In  addition,  UFR  and  GFR  appeared  to  increase 
dramatically with CORM-A1  over the 45 min of perfusion.  For instance,  at 45 
min perfusion,  UFR was increased by 21.1  % and GFR was elevated by 20% 
(P < 0.05), while iCORM-A1  had no obvious effect.
Figure  4-11  summarizes  the  effect  of  CORM-A1  on  renal  glucose  and  Na+  
reabsorption. When compared to control,  CORM-A1  reduced RGlu and RN a in 
a time dependent manner.  At 50 pM CORM-A1,  RGlu decreased significantly 
by 37.4%  and 46.2%  after 30 and 45 min perfusion,  respectively (P < 0.001, 
Figure 4-11 A).  Similarly,  CORM-A1  decreased RN a markedly by 37% after 30 
min  of  perfusion  (Figure  4-11B).  In  contrast,  no  significant  differences  in 
tubular  reabsorption  were  observed  with  iCORM-A1  when  compared  to 
control.
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Figure  4-10:  Effect  of CORM-A1  on  renal  physiological  parameters  in  isolated 
kidneys after cold storage
Perfusion  flow  rate  (A),  urine  flow  rate  (C)  and  glomerular filtration  rate  (GFR,  see 
graph  C)  were  measured  in  isolated  rabbit  kidneys  which  were  flushed  and  cold- 
stored  for  24  hr  at  4  °C  without  CORM-A1  and  then  perfused  for  45  min  in  the 
presence  of  50  pM  CORM-A1  (see  Materials  and  Methods  for details).  Changes  in 
these  physiological  parameters  were  followed  over  time.  iCORM-A1  was  used  as 
negative  control.  Each  line  represents  the  mean  ±  SEM  of  at  least  5  independent 
experiments. ** P < 0.001, *P < 0.05 vs. 0 pM CORM-A1  or control.
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Figure 4-11:  Effect of CORM-A1  on  renal reabsorption  in  isolated  kidneys after 
cold storage
Glucose  reabsorption  (A)  and  sodium  reabsorption  (B)  were  measured  in  isolated 
rabbit kidneys which were flushed  and  cold-stored for 24  hr at 4 °C without CORM- 
A1  and then  perfused for 45 min  in the presence of 50  pM CORM-A1  (see Materials 
and  Methods for details).  Changes  in the  reabsorption  rate were followed over time. 
iCORM-A1,  which  does  not  release  CO,  was  used  as  negative  control.  Each  line 
represents the mean ± SEM of at least 5 independent experiments.  ** P < 0.001, * P 
< 0.05 vs. 0 pM CORM-A1  or control.
169IICL 4. EFFECT OF CO-RMs ON RENAL FUNCTION
4.6  Discussion
There is growing evidence indicating the protective  role of exogenous  CO  at 
low concentration  in organ transplantation  (Song  et al.,  2003),  graft rejection 
(Martins et al.,  2005;  Wang et al., 2005),  and  in various  models of l-R  injury 
(Nakao et al.,  2003a;  Neto et al.,  2004).  The present study was designed to 
evaluate the  biochemical  and  physiological  effects of CO  liberated from  CO- 
RMs  on  kidney  function  during  normothermic  perfusion  of fresh  (unstored) 
and 24  hr cold-stored  kidneys.  While the future experiments  planned for this 
Thesis will  attempt to  investigate the  role  of CO-RMs  during  cold  ischaemic 
preservation  and  reperfusion,  or during warm  renal  l-R  injury  in  the  isolated 
perfused kidney.  Consequently, we demonstrated that CO liberated from CO- 
RMs had significant effects on renal function of fresh and cold-stored kidneys 
by  using  isolated  perfused  rabbit  kidney  (IPRK)  model.  Furthermore,  in  this 
model  we  showed  that  CO  alters  the  renal  vascular  resistance  by activating 
soluble guanylate cyclase (sGC).
Renal  function  is  initiated  by  delivery  to  the  kidneys  of  a  flow  of  blood 
accounting for 20 to 25%  of the cardiac output.  The  alteration  in  renal  blood 
flow  following  reperfusion  plays  a  significant  role  in  initiating  the 
pathophysiology  of  ischaemic  injury  (Carden  and  Granger,  2000).  In  our 
study,  the  mean  perfusion  flow  rate  (PFR)  was  greater  for  kidneys 
supplemented  with  50  pM  CORM-A1.  Since  the  renal  vascular  resistance  is 
expressed  as  the  mean  perfusion  pressure  divided  by  PFR  and  as  the 
pressure is always kept at 100 mmHg, therefore the increase in PFR is mainly 
due  to  a  decrease  in  vascular resistance.  The fact that the  renal  vessels  in 
isolated perfused kidney may be close to maximal vasodilatation could explain
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the  minimum  increase  of  PFR  seen  with  CO;  however,  if a  vasoconstrictor 
drug had been used before adding CO-RMs, a more significant vasorelaxation 
and  increase  in  PFR  could  have  been  obtained,  but  we  did  not  test  this 
hypothesis.  The  increase  in  perfusate  flow  observed  with  CORM-A1  may 
afford  some  protection from  hypoxic renal  injury  and  ischaemia  by  restoring 
oxygen sufficiency.  In  support of a role for CO  in  renal  vasorelaxation,  it has 
been  suggested  that  endogenous  CO  has  a  renal  vasodilatory  influence  in 
chronically hypoxic rats (O'Donaughy and Walker, 2000).  Nowadays,  it is well 
known that CO induces vasorelaxation through a mechanism that may involve 
both  cGMP  pathway  and  Ca2+-activated  K+  channels  (Wang  et al.,  1997).  In 
our  study,  we  showed  that  CO  released  from  CORM-A1  induced  its 
vasodilatory  effect  via  the  cGMP  pathway.  However,  the  involvement  of  K+  
channel  pathway in CO-mediated protective effects in  IPRK model cannot be 
excluded as this pathway was  not investigated  in this study.  In agreement,  it 
has  been  shown  by  our  group  that  CORM-3  and  CORM-A1  produced  a 
concentration-dependent  relaxation  in  pre-contracted  aortic  vessels  in  a 
process  that  is  mediated  by  K+   channels  and  guanylate  cyclase  activation 
(Foresti  et  al.,  2004b;  Motterlini  et  al.,  2004).  Additionally,  we  have 
demonstrated  that  HO-1  induction  in  aortic  tissue  is  correlated  with  an 
increased endogenous release of CO that suppresses vascular contractility by 
activation  of  sGC  (Sammut  et  al.,  1998a).  Furthermore,  it  has  been 
demonstrated  that  CO  gas  causes  a  cGMP-dependent  relaxation  of  both 
rabbit  cavernosal  and  urethral  smooth  muscle  (Naseem  et  al.,  2000).  In 
contrast,  CO  of  vascular  origin  attenuates  the  sensitivity  of  renal  arterial
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vessels to vasoconstrictors via a mechanism that involves  K+  channel  (Kaide 
et al., 2001).
CO  released  by  CO-RMs  increases  UFR  in  a  time  and  concentration- 
dependent fashion when compared to control kidneys. This effect in UFR was 
due to an  increase in  urine volume,  which  may be attributed to the presence 
of  large  amounts  of  unabsorbed  solutes  such  as  Na+   and  glucose  in  the 
presence of CO,  leading to the so called “osmotic diuresis”.  The mechanism 
underlying this  phenomenon  lies  in the fact that the  concentration  of solutes 
that are not reabsorbed in the proximal tubules will exerts an osmotic effect by 
holding  more water in the tubules,  hence  reducing water reabsorption  in the 
tubular lumen and increasing urine volume.  In fact,  there is a limited gradient 
against which Na+  can be pumped out of the proximal tubules; normally, water 
movements  out  of  the  proximal  tubules  prevent  the  development  of  any 
gradient,  but  the  amount  of  Na+   in  the  urine  decreases  when  water 
reabsorption  decreases  because  of  increased  amounts  of  unreabsorbed 
solutes.  As  a  result,  the  limiting  concentration  gradient  is  reached  and  more 
Na+   will  remain  together  with  water  in  the  tubule,  so  the  net  result  will  be 
decreased  reabsorption of both water and  Na+.  As  more fluids  pass through 
the distal tubules and because of the decrease in the osmotic gradients along 
the medullary pyramids,  less water will  be reabsorbed  in the collecting ducts. 
The  final  result  is  an  increase  in  urine  volume  as  a  consequence  of  a 
decrease  in  water  reabsorption  and  increase  in  excretion  of  Na+   and  other 
electrolytes (Ganong,  1999).  In view of the above considerations,  these data 
suggest  that  CO  may  act  as  an  osmotic  diuretic  in  a  way  similar  to  other 
diuretics  such  as furosemide  and  mannitol  which  provide  a  pharmacological
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protection  of  rabbit  kidneys  from  normothermic  ischaemia  (Green  et  al., 
1979).  Interestingly,  mannitol  produces an  osmotic diuresis  by  inhibiting  Na+  
and  water  reabsorption  in  the  proximal  tubule  and  the  loop  of  Henle  and 
increasing  renal  blood  flow  64  Furosemide  improved  kidney  function  by 
preventing  renal  vasoconstriction  (Green  et  al.,  1979),  also  acting  as  a 
vasodilator,  as  specific  inhibitor  of  the  Na+-K+-2CI'-cotransporter  in  the 
medullary  thick  ascending  tubules,  and  directly  inhibiting  the  electron 
transport in the  mitochondrial  chain (Lane et al.,  1996).  Thus CO may act as 
an osmotic diuretic by increasing the urine volume in a way similar to mannitol 
and furosemide and may have a similar protective effect after oxidative stress. 
As the GFR is calculated by multiplying the creatinine clearance by the UFR, 
GFR  was  also  significantly  increased  with  CO  released  from  CO-RMs.  The 
improvement  in  GFR was  mainly due to the  increase  in  UFR.  However,  the 
increase  in  the  renal  PFR  may  also  be  attributed  to  the  elevation  of  GFR. 
These findings  suggest the  potential  protective effects  of CO  since  profound 
reduction  in  GFR  is  a  major  characteristic  after  l-R  injury  (Alejandro  et  al., 
1995a).
In this study,  CORM-A1  decreased glucose (Rglu) and Na+  reabsorption (RN a) 
in  a  time and  concentration-dependent fashion  and  in  order to  explain these 
findings,  RGlu  and  RNa  in the renal tubular cells should be reviewed first.  Na+  
is actively transported out of all parts of the renal tubules except the portion of 
the  loop  of  Henle.  This  active  transport  pumps  Na+   by  the  Na+-K+   ATPase 
from  the  tubular  cell  into  the  interstitium,  the  Na+-K+   ATPase  catalyze  the 
hydrolysis  of  ATP  to  ADP  and  for  each  ATP  hydrolyzed  three  Na+  will  be 
transported  out of the tubular cell  and two  K+  will  be transported  into the cell
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(Ganong,  1999).  In normal adult humans, the percentage of Na+  reabsorbed is 
about  99.4%  (Ganong,  1999).  Glucose  is  reabsorbed  along  with  Na+   in  the 
early portion of the proximal tubules by a secondary active transport and this 
means that glucose reabsorption is necessarily coupled to the active transport 
of  Na+   (Figure  4-12).  In  a  normal  human,  the  percentage  of  glucose 
reabsorption  is  100%.  Considering  that  the  Na+-K+   ATPase,  which  utilizes 
around  80%  of the  total  O2  consumed  by  the  kidney  (Korner  et  al.,  1994), 
yields energy to the coupled transport of Na+  and glucose in the tubular cells. 
The  decrease  in  O2  consumption  in  isolated  mitochondria  after  CO-RMs 
(Chapter 3)  and  the  decrease  in  state  3  in  this  study,  suggest  that  the  CO- 
induced  decrease  in  Rn3  and  Rglu,  may  partly  be  caused  by  changes  in 
mitochondrial functions and decreased energy production.  In other words,  the 
inhibition  of O2 consumption  and ATP  production  by  CO  released  from  CO- 
RMs could inhibit the Na+-K+  ATPase.  Because the Na+-K+  ATPase activity is 
coupled to the activity of the Na+ /glucose cotransporter, this will decrease RN a 
and  Rglu  and  hence the observed  increase of Na+   and  glucose  in  the  urine 
will  attract more water,  promoting an osmotic diuresis.  The  results  presented 
here  are  in  agreement  with  previous  findings  showing  that  haem  induced 
diuresis  and  natriuresis  via  HO-dependent  mechanisms  (Rodriguez  et  al.,
2003).  The  inhibition  of tubular  RN a  and  the  increase  in  urine  volume  could 
potentially  be attributed to the  inhibition  of mitochondrial  O2  consumption  by 
CO (Rodriguez et al., 2003).
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Figure 4-12: Glucose and sodium reabsorption in the tubular cell
First,  glucose  and  Na+   move  from  the  tubular  lumen  into  the  tubular  cell  by  a 
cotransporter called  SGLT2.  Second,  Na+   is  pumped  out  by  the  Na+-K+   ATPase  as 
described above, and lastly glucose is transported out of the cell to the interstitium by 
a second cotransporter called GLUT2. Adapted from (Ganong,  1999).
•
Others  and  we  have  shown  that  CO  and  NO  have  many  similarities  as 
signalling gases.  It has been shown that inhibition of NO synthase results in a 
decrease  in  renal  blood  flow,  urinary  output,  urinary  sodium  excretion, 
fractional sodium excretion and GFR (Gabbai and Blantz,  1999;  Haynes et al., 
1997;  Mashiach et al.,  1998),  suggesting that the activity of the NO system in 
the kidney is essential for normal  renal function.  Here,  our data suggest that 
CO may have similar importance to NO on renal function.
In freshly isolated  kidneys,  the addition of CORM-A1  in  doses of 10,  25,  and 
50  pM  to  the  perfusate  significantly  increased  PFR,  UFR,  GFR  and  tubular 
reabsorption,  whilst  CORM-3  did  not  elicit  a  similar  obvious  effect.  This  is 
somewhat  surprising  since  both  agents  are water-soluble  CO  releasers  that 
release  one  mole  of  CO  per  mole  of the  compound.  However,  the  reasons
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may  lie  in the kinetics of release of CO from the drugs at 37 °C.  CORM-3  is 
known to release CO almost instantaneously at 37 °C. Given the large volume 
of recirculating perfusate used in IPRK model, open to atmospheric exchange, 
the CO liberated by adding CORM-3 to the perfusate may have been lost from 
the system before reaching the renal circulation in an effective concentration. 
With  the  slower  release  from  CORM-A1,  it  may  have  allowed  a 
pharmacologically  active  CO  concentration  to  be  delivered  to  the  kidney  as 
the  agent  was  recirculated  through  the  IPRK  circuit.  However,  despite  the 
recent observation that CORM-A1  spontaneously liberates CO at 37 °C with a 
different  rate  compared with  CORM-3,  the  results  confirm  the  ability  of both 
CO-RMs  to  elicit  pharmacological  effects  that  are  typical  of  CO  gas  and 
suggest that CO  released from  CO-RMs confers significant changes  in  renal 
function.
The  results of this  Chapter show that 24 hr cold  preserved  kidneys  are  also 
able to respond to CO released from CORM-A1  during the reperfusion period 
in  a  similar  way  to  freshly  isolated  kidneys,  which  suggests  that  low 
concentrations of CO may be beneficial when given to recipient patients at the 
time  of  transplantation  by  improving  early  renal  function.  In  this  study,  we 
used  CORM-A1  during  the  reperfusion  period  after  24  hr  cold  ischaemia; 
however,  the  time  of  administration  of  CO-RMs  is  an  important  factor  to 
maximize  their  beneficial  effects  against  the  combined  effects  of  injury 
sustained  during  ischaemia  and  reperfusion  in  the  kidney.  Therefore,  the 
future experiments planned for this Thesis will attempt to investigate the effect 
of CO-RMs administered in the cold flush before the cold l-R injury.
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In  this  study,  our  experimental  results  demonstrate  that  CO  affects  renal 
function at least in part by modulating mitochondrial function and activation of 
sGC.  Here,  we  show  that  mitochondrial  respiration  rate  was  significantly 
changed with CORM-A1.  The mechanism is unclear but these findings are in 
agreement  with  preliminary  studies  from  our  group  and  collaborators  which 
reveal  that  both  mitochondrial  respiratory  chain  and  free  radical  generation 
are  targets  for  the  anti-proliferative  effect  of  CO-RMs  (Taille  et  al.,  2005). 
Furthermore,  we  reported  that  CORM-3  protects  against  hypoxia 
reoxygenation  injury  in  cardiac  cells  via  activation  of  mitochondrial  K a tp  
channels (Clark et al., 2003). Very recently, we have demonstrated that HO-1 
induction  can  modulate  mitochondrial  respiration  in  isolated  rat  kidneys 
(Sandouka et al., 2005).
In  summary,  the  results  show  that  CO  liberated  from  CO-RMs  has  a 
protective  vasodilatory  effect,  improving  renal  function  and  changing 
mitochondrial  respiration.  The  fact  that  RN a  and  Rglu  by  the  kidney  are  an 
energy-dependent  process,  leads  us  to  hypothesize  that  CO-reduced 
mitochondrial  energy  production  is responsible for the reduction  in  RNa,  RGlu 
and water reabsorption.  The  questions that arise  are whether these findings 
indicate  an  irreversible  damage  on  mitochondrial  and  kidney  functions  or 
whether a reperfusion of the kidney will initiate a recovery of the mitochondrial 
respiration  and  improve  renal  function.  The  future  experiments  planned  for 
this Thesis will attempt to answer these questions by investigating the effects 
of  CO-RMs  during  cold  ischaemic  preservation  and  reperfusion  or  during 
warm renal l-R injury in the isolated perfused kidney.
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5  Treatment of Kidneys with Carbon Monoxide-Releasing 
Molecules (CO-RMs) During Cold Preservation Improves 
Renal Function at Reperfusion
5.1  Introduction
Kidney transplantation  is the treatment of choice for end-stage  renal  disease 
(Salahudeen,  2004).  Most  kidneys  prior to  transplantation  are  exposed  to  a 
period  of cold  storage which  can  limit  but not  completely avoid  tissue  injury 
and graft dysfunction in transplanted patients (Perico et al.,  2004).  Therefore, 
new strategies for mitigating  cold  ischaemic damage and  novel  therapies for 
successful  kidney  transplantations  are  required.  Cold  storage  (CS) 
procedures  are  widely  used  for  preserving  cadaveric  kidneys  prior  to 
transplant;  these  techniques  involve  intravascular  flushing  of  the  isolated 
organ  using  a  hypothermic solution followed  by storage  at  low temperatures 
for the time required to transfer the graft to the surgery unit.  In addition to the 
injury imposed by CS,  kidneys are subjected to further damage at reperfusion 
when  warm  oxygenated  blood  (37  °C)  is  reintroduced  into  the  transplanted 
graft.  The  pathophysiological  consequences  of  CS  followed  by  warm 
reperfusion  are  varied  and  complex;  however,  it  has  been  established  that 
preservation  at  low temperatures  leads  to  cellular  oedema  and  triggers  the 
generation  of reactive  oxygen  species  (ROS) which would  exacerbate  acute 
inflammatory responses and promote apoptosis once the graft is transplanted 
(Burns  et  al.,  1998;  McLaren  and  Friend,  2003).  Mitochondria  are  a  key 
contributor  to  cell  survival,  as  mitochondrial  respiration  and  oxidative 
phosphorylation  are  essential  for  keeping  the  ATP  demands  and  restoring
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cellular  energy  after  ATP  depletion  caused  by  ischaemia  (Jassem  et  al., 
2002).
Several approaches have been used to counteract the damaging mechanisms 
of  CS-mediated  injury  and  consequently  ameliorate  renal  function  at 
transplantation.  Perhaps  one  of  the  most  surprising  and  an  unforeseen 
strategy  involves  the  use  of CO,  which  has  recently attracted  attention  as  a 
fundamental  cell  signalling  mediator  and  cytoprotective  agent  against 
apoptosis  and  l-R  injury  (Neto et al.,  2004).  Low  levels  of CO  are  produced 
endogenously  in  mammalian  tissues by haem  oxygenase  (HO),  the first and 
rate-limiting step in  haem catabolism (Maines,  1997). To date,  different types 
of  HO  enzymes  have  been  characterized  including  constitutive  (HO-2)  and 
inducible  (HO-1)  isoforms.  HO-1  is  a  stress  protein  that  possesses  the 
peculiar feature of being finely up-regulated by stimuli  or pathological  events 
that trigger oxidative and nitrosative stress (Foresti et al.,  2004a;  Motterlini et 
al.,  2002b).  The  induction  of  HO-1  and  the  consequent  increase  in 
endogenous  CO  production  play important roles  in  vasorelaxation  (Motterlini 
et al.,  1998;  Sammut et al.,  1998a), inhibition of cell proliferation (Durante and 
Schafer,  1998;  Morita et al.,  1997),  blockade of apoptotic pathways (Zhang et 
al.,  2003),  suppression  of  inflammation  (Otterbein  et  al.,  2000),  protection 
against organ rejection (Otterbein et al., 2003) and l-R injury (Akamatsu et al.,
2004).  In essence, both the use of potent HO-1  inducers and administration of 
low  doses  of  CO  gas  have  been  employed  to  evaluate  and  sustain  a 
therapeutic role of CO in  l-R injury in the kidney (Nakao et al., 2005;  Sikorski 
et al., 2004).
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As a novel approach to deliver CO, our group has recently identified a class of 
compounds,  termed  CO-RMs,  which  are  able  to  transport  and  release  CO 
both  in  vivo  and  in  vitro  in  a  controllable  fashion  under  physiological 
conditions  (Motterlini  et  al.,  2002a;  Motterlini  et al.,  2003).  Different types  of 
CO-RMs  have  been  characterized  and  their  biological  activities  assessed. 
Two  water-soluble  CO-RMs  have  recently  shown  promising  results  in  our 
studies:  CORM-3,  a  metal  carbonyl  complex  that  rapidly  liberates  CO  in 
physiological  buffers  (Clark  et  al.,  2003),  and  CORM-A1,  a  newly  identified 
generator of CO that does not contain a transition metal and liberates CO at a 
much  slower rate under physiological  conditions (Motterlini  et al.,  2004).  The 
specific  effect  of  CO  liberated  from  CO-RMs  in  modulating  important 
physiological  effects  has  been  confirmed  by  the  parallel  use  of  specific 
inactive  compounds  (iCO-RMs),  which  do  not  liberate  CO  in  the  cellular 
environment  (Motterlini  et  al.,  2002a;  Motterlini  et  al.,  2004).  Previous  data 
from  our  own  laboratory  and  results  provided  by  collaborators  support  a 
critical  role for CO-RMs  in  vasorelaxation  (Foresti  et al.,  2004b;  Motterlini  et 
al.,  2002a;  Motterlini  et al.,  2004),  suppression of inflammation  (Sawle et al.,
2005),  protection  against hypoxia-reoxygenation and  oxidative stress as well 
as  mitigation  of l-R injury (Clark et al.,  2003),  allograft  rejection  (Clark et al., 
2003) and myocardial infarction (Guo et al., 2004;  Stein et al., 2005).
5.2  Hypothesis
Our hypothesis  states that low concentrations of CO  released from  CO-RMs 
will  protect  against  cold  ischaemia-mediated  injury  and  used  as  a  novel 
therapeutic strategy for organ preservation and transplantation.
180m _________________ 5. EFFECT OF CO-RMs ON COLD RENAL l-R 1NURY
5.3  Objectives
•  This study was designed to assess how cold preservation of kidneys in the 
presence  of  CO-RMs  could  affect  renal  biochemical  and  physiological 
functions at reperfusion using an ex-vivo isolated kidney preparation.
•  To  investigate  the  mechanism  by  which  CO  affects  renal  functions  after 
cold preservation of kidneys in the presence of CO-RMs.
5.4  Materials and Methods
5.4.1  Surgical Procedure
Male New Zealand White rabbits (2.5-4 kg) were supplied by Harlan U.K.  Ltd. 
All  experiments were  performed  under Home  Office licenses  (UK)  under the 
Animal (Scientific Procedures) Act,  1986. After anaesthesia, the renal arteries 
were  cannulated  and  kidneys flushed with  30  ml  perfusion  solution  at  37  °C 
(see Heading 2.4.3 for details).
5.4.2  Isolated Perfused Rabbit Kidney Circuit Model
The  kidney  was  perfused  using  a  closed  perfusion  circuit  built  from  nylon 
tubing  based  on  a  system  previously  described  (Heading  2.4.4,  Figure  2-3) 
(Fuller et al.,  1977). The oxygenated Krebs solution was perfused at constant 
pressure (100  mmHg) through the renal  artery while the  renal vein was  kept 
open  to  allow the  perfusate to  run  through  the  organ  chamber  and  then  re­
circulated  again.  Sampling  of  perfusate  for  biochemical  analysis  and 
measurement of haemodynamic parameters were undertaken at set intervals.
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5.4.3  Kidney Perfusion and Preservation Solution
The  composition  of  the  Krebs  buffer  perfusion  solution  was  (in  mmol/L) 
adjusted to pH 7.40:  155 Na*.  139 H C 03', 6.8 K*.  139 Cl‘,  1.2 Mg2*' 2  Ca2*, 
0.1  creatinine in 500 ml  Dulbecco’s Modified  Eagle Medium  (DMEM),  500 ml 
Hespan  by  Fresenius,  100  ml  Gelofusine  (4  g  protein/100  ml)  and  900  ml 
distilled water.  One  litre  of perfusion  solution was  used  in  each  experiment. 
Celsior solution  (Table  1-1) was used  in this study as a preservation solution 
for the kidney (Montalti et al., 2005).
5.4.4  Experimental Protocol
After kidney removal, the following protocols were adopted:
Protocol A (n=5-7),  kidneys stored for 24 hr  in  60  ml  Celsior solution  at 4 °C
followed by 2 hr reperfusion on isolated perfused rabbit kidney (IPRK) circuit, 
Protocol B (n=5-7),  kidneys stored for 48 hr  in  60  ml  Celsior solution  at 4 °C
followed by 2 hr reperfusion on IPRK.
In  both  protocols,  the  kidney  was  weighed  immediately  and  flushed  via  the 
arterial cannula with 30 ml perfusion solution at 37 °C at a height of 100 cm to 
remove all the blood.  Kidneys were then further flushed with 60 ml Celsior at 4 
°C.  In both protocols, the kidneys were divided into three groups:
1.  Group CS (n=7), the kidneys were flushed with Celsior alone.
2.  Group  CS+CO-RMs  (n=6),  the  kidneys  were  flushed  with  Celsior 
supplemented with 50 pM CO-RMs.
3.  Group  CS+iCO-RMs  (n=6),  the  kidneys  were  flushed  with  Celsior 
supplemented with 50 pM iCO-RMs.
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In Protocol A only,  30 |jM of 1H-[1,2,4]oxadiazolo[4,3-alpha]quinoxalin-1-one 
(ODQ),  a  soluble  guanylate  cyclase  inhibitor,  was  added  together with  CO- 
RMs.
5.4.5  Functional and Biochemical Parameters
Perfusion  (PFR)  and  urine  flow  (UFR)  rates  were  measured  every  15  min 
after  30  min  of  initial  stabilization  and  expressed  as  ml/min/g  for  PFR  or 
pl/min/g  tissue  for  UFR.  Perfusate  and  urine  samples  from  renal  vein  and 
ureter  were  collected  at  the  same  time  points  for  biochemical  study  (see 
Heading  2.4.8  for  details).  The  samples  were  kept  at  -80  °C  until  further 
analysis.  Glomerular filtration  rate  (GFR)  was  calculated  by  measuring  urine 
and perfusate creatinine levels according to the following formula: GFR = UFR 
X  Urine  creatinine/  Perfusate  creatinine.  Glucose,  Na+,  creatinine  and 
gamma-glutamyltransferase (GGT) levels were measured using a biochemical 
analyser.  Nitrite levels were determined in the urine using the Griess method 
as previously described  (Heading 2.4.8.4).  Protein  leakage was assessed  by 
measuring  the  protein  concentration  (Lowry  method)  appearing  in  the  urine 
(Heading 2.4.8.5).
5.4.6  Detection of CO Release
The  release  of  CO  from  CO-RMs  in  Celsior  (4  °C)  solutions  was  assessed 
spectrophotometrically  by  measuring  the  conversion  of  deoxymyoglobin 
(deoxy-Mb)  to  carbonmonoxy  myoglobin  (MbCO)  as  reported  in  Chapter  2 
(Heading  2.2).  Myoglobin  solutions  were  prepared  fresh  by  dissolving  the 
protein  in  Celsior  at  4  °C.  Sodium  dithionite  (0.1%)  was  added  to  convert
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myoglobin  to  deoxy-Mb  prior  to  each  reading.  The  release  of  CO  was 
measured over 24 hr.
5.4.7  Isolation of Rabbit Kidney Mitochondria
At the end  of isolated  reperfusion time,  following the  removal  of the  medulla, 
cortical  mitochondria from  each  kidney were  isolated  by homogenization  and 
differential centrifugation as reported in Chapter 2 (Heading 2.4.7).
5.4.8  Measurement of Oxygen Consumption in Isolated Mitochondria
All  experiments  were  carried  out  using  a  2  ml  capacity  incubation  chamber 
maintained at 30 °C  and  a  Clark electrode  attached to an oxygen  monitoring 
system  connected  to  a  chart  recorder  as  described  in  Chapter  2  (Heading 
2.4.7).  Briefly,  incubation was carried out using approximately  1   mg protein of 
isolated  mitochondria  re-suspended  in  1   ml  respiratory  buffer.  Mitochondrial 
respiration  was  measured  using  malate  (5  mM)  plus  glutamate  (5  mM)  as 
substrates.  State  3  respiration  was  initiated  by  addition  of ADP  and  state  4 
respiration  was  measured  after  all  the  ADP  was  converted  to  ATP.  State  3 
and  state  4  respirations  were  calculated  and  represented  as  ng  02/mg 
protein/min.  RCI was calculated as the ratio between state 3 and state 4.
5.4.9  Statistical Analysis
Statistical  analysis  was  performed  using  one-way  analysis  of  variance 
(ANOVA)  combined  with  Bonferroni  test.  When  differences were  established 
between  groups,  we  used  unpaired  two-tailed  t-test  to  assess  statistical 
significance  between two groups at each time  point.  Data were  presented  as 
mean ± SEM and differences were considered significant at P < 0.05.
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5.5  Results
5.5.1  Detection of CO Release from CO-RMs in Celsior Solution at 4 °C
The rate and amount of CO liberated from CO-RMs were measured in Celsior 
solution,  which was  used  for  kidney  preservation.  Given  the fact  that  50  pM 
CO-RMs  affects  freshly  harvested  kidney  function  significantly  as  shown  in 
Chapter  4,  this  concentration  was  chosen  as  the  ideal  concentration  for 
preserving  kidneys  at  low  temperatures.  Therefore,  we  tested  the  ability  of 
CO-RMs to release CO at 4 °C  in Celsior solution and then we measured the 
kinetic of CO  release from  CORM-A1  and  CORM-3.  As observed  in  previous 
Chapters,  we  found  that  the  addition  of  iCO-RMs  to  deoxymyoglobin 
dissolved  in  Celsior  solution  at  4  °C  did  not  produce  any  detectable  MbCO 
over a 24 hr period.  Addition of CORM-3 (50 pM)  increased  MbCO formation 
over time  reaching  a  maximal  level  after 4  hr;  the  rate  of CO  release  in  the 
first 2  hr was calculated as  14.0±1.0 nmol/hr (Figure 5-1 A).  Interestingly,  and 
in contrast to CORM-3,  the increase in MbCO after addition of 50 pM CORM- 
A1  to  the  cold  Celsior  solution  was  slower  and  the  calculated  rate  of  CO 
release  was  only  1.39±  0.05  nmol/hr  (Figure  5-1 A).  Absorption  spectrum  of 
MbCO after interaction of myoglobin with CO released from 50 pM CORM-A1, 
CORM-3 and iCO-RMs were compared to saturated MbCO (Figure 5-1B).
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Figure 5-1:  Detection of CO released from CO-RMs in Celsior solution at 4 °C
(A) Time course of CO released from 50 pM CORM-A1  and CORM-3 after incubation 
in  Celsior  solution  (pH=7.4)  at 4  °C.  The  amount  of  CO  released  was  assessed 
spectrophotometrically  by  measuring  the  conversion  of  deoxymyoglobin  to 
carbonmonoxy  myoglobin  (MbCO).  (B)  Spectra  of  MbCO  formation  at  24  hr after 
addition of CO-RMs to myoglobin solution.  Each line represents the mean ± SEM of 
2  independent experiments.  The  rate  of CO  release was  calculated  from  the fitted 
curves  as  reported  in  the  Results  section.  iCORM-A1  and  iCORM-3,  which  do  not 
release CO, were used as negative control.
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MbCO= 53.29
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5.5.2  Effects of 24 hr Cold Storage of Kidneys  in the  Presence of CO- 
RMs on Renal Function at Reperfusion
Kidneys flushed in the presence of CO-RMs prior to 24 hr cold storage (CS) in 
Celsior solution (CS+CO-RMs)  produced a significantly higher perfusate flow 
rate (PFR) on the isolated system  at reperfusion  (P < 0.05).  For instance,  at 
90 min reperfusion,  PFR was 12.1  ml/min/g in CS+CORM-A1  compared to 7.5 
ml/min/g in CS alone (Figure 5-2A).  Similar data were obtained with CORM-3, 
as  the  increase  in  CORM-3  at  90  min  was  11.1  ml/min/g  (Figure  5-2B).  In 
addition,  the  use  of  both  CO-RMs  during  the flushing  procedure  of  kidneys 
prior to the  cold  storage  period  significantly  increased  urine flow  rate  (UFR) 
(Figure 5-3A and B) (P < 0.05).  For example, at 90 min reperfusion,  UFR was 
increased significantly to 377 pl/min/g with CS+CORM-A1  and to 459 pl/min/g 
with CS+CORM-3 when compared to CS alone (254 pl/min/g).  Consequently, 
reperfusion  of  the  24  hr  cold-stored  kidneys  flushed  with  CO-RMs  on  the 
IPRK circuit  resulted  in a  marked  increase  in glomerular filtration  rate  (GFR) 
(Figure  5-4).  The  GFR  (pl/min/g)  was  291  for  kidneys  flushed  with  Celsior 
alone,  486  with  CS+CORM-A1  (Figure  5-4A)  and  565  with  CS+CORM-3 
(Figure 5-4B) at the end of reperfusion time (P < 0.05).
Interestingly,  all  the  renal  parameters  evaluated  (PFR,  UFR  and  GFR) were 
not  affected  when  kidneys were flushed  with  Celsior  solution  supplemented 
with  the  negative  controls  (iCO-RMs)  indicating  that  CO  liberated  from  CO- 
RMs was directly involved in the improved renal function at reperfusion.
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Figure  5-2:  The  effect  of  CO-RMs  on  perfusate  flow  rate  during  reperfusion 
after 24 hr cold storage
Rabbit kidneys were initially flushed with Celsior solution alone or supplemented with 
50 pM CORM-A1  (A) or CORM-3 (B) and then subjected to a 24 h cold storage (CS) 
(see  Materials  and  Methods  for details).  Perfusion  flow  rate  was  then  measured  in 
isolated  kidneys  over  90  min  after  a  period  of  initial  equilibration.  iCORM-A1  and 
iCORM-3,  which  do  not  release  CO,  were  used  as  negative  controls.  Each  line 
represents the mean ± SEM of n=6 for each group.  * P <  0.05 vs.  CS group.
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Figure  5-3:  Effect  of CO-RMs  on  urine flow  rate  in  isolated  kidneys  after 24 hr 
cold storage
Rabbit kidneys were initially flushed with Celsior solution alone or supplemented with 
50  pM CORM-A1  (A) or CORM-3 (B) and then subjected to a 24 h cold storage (CS) 
(see  Materials  and  Methods  for  details).  Urine  flow  rate  was  then  measured  in 
isolated  kidneys  over  90  min  after  a  period  of  initial  equilibration.  iCORM-A1  and 
iCORM-3,  which  do  not  release  CO,  were  used  as  negative  controls.  Each  line 
represents the mean ± SEM of n=6 for each group. * P <  0.05 vs.  CS group.
189TTCI 5  EFFECT OF CO-RMs ON COLD RENAL l-R INURY
600
500
O )
O' c 400
LL
o 1
3 300
200
100
*******
a
-e-CS (24h)
♦  CS + CORM-A1 
-4-CS +  iCORM-A1
0  15  30  45  60  75  90
Time (min)
B
600
• ■
500
o >
O'  c 400
U -  V
O   |  
a . 300
200
100
r
— (j)~   jjj  _j
-B-CS (24h)
-•-C S  +  CORM-3 
^A-CS +  iCORM-3
0  15  30  45  60  75  90
Time (min)
Figure  5-4:  Effect  of  CO-RMs  on  glomerular  flitration  rate  (GFR)  in  isolated 
kidneys after 24 hr cold storage
Rabbit kidneys were initially flushed with  Celsior solution alone or supplemented with 
50  pM CORM-A1  (A)  or CORM-3 (B) and then subjected to a 24 h cold storage (CS) 
(see  Materials  and  Methods  for  details).  Glomerular  flitration  rate  (GFR)  was  then 
measured  in  isolated  kidneys  over  90  min  after  a  period  of  initial  equilibration. 
iCORM-A1  and  iCORM-3, which do  not release CO, were used as negative controls. 
Each  line  represents  the  mean  ±  SEM  of  n=6  for  each  group.  *  P  <  0.05  vs.  CS 
group.
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5.5.3  Effects of 24 hr Cold Storage of Kidneys  in the  Presence of CO- 
RMs on Renal Tubular Reabsorption at Reperfusion
We  examined  whether  treatment  with  CO-RMs  during  kidney  cold  storage 
affected  tubular  reabsorption  at  reperfusion.  As  shown  in  Figure  5-5A  and 
Figure  5-6A,  glucose  (Rglu)  and  Na+   (Rn3)  reabsorption  were  found  to  be 
significantly increased in kidneys that were previously flushed with CORM-A1. 
At  90  min  reperfusion,  kidneys  subjected  to  CS  alone  reabsorbed  54.8%  of 
total  glucose  and  16.4%  of  sodium,  whereas  Rqlu  and  RNa  in  kidneys 
subjected  to  CS  in  the  presence  of  CORM-A1  were  72.7%  and  29.3%, 
respectively (P < 0.05).  Both  Rglu and  Rn3  levels were unchanged in kidneys 
treated  with  iCORM-A1,  indicating  that  CO  released  from  CORM-A1  is 
responsible for the observed effects.
As  observed with  CORM-A1,  Rqlu  was  markedly  improved  with  CORM-3  in 
the first 45 min of reperfusion when compared to CS control (Figure 5-5B). At 
50  pM  CORM-3,  Rqlu  increased  significantly  from  55.2%  with  CS  alone  to 
71.8%  with  CS+CORM-3  after  45  min  reperfusion.  Unpredictably,  50  pM 
iCORM-3  caused  a  non-significant  increase  of  Rglu  when  compared  to  CS 
control  (Figure  5-5B).  Notably  and  in  contrast  to  CORM-A1,  both  CORM-3 
and  iCORM-3  did  not  significantly  affect  RN a  levels  compared  to  CS  control 
groups (Figure 5-6B).
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Figure 5-5:  Effect of CO-RMs on renal glucose reabsorption in  isolated kidneys 
after 24 hr cold storage
Rabbit kidneys were initially flushed with Celsior solution alone or supplemented with 
50 pM CORM-A1  (A) or CORM-3 (B)  and then subjected to a 24 h cold storage (CS) 
(see Materials and Methods for details).  Glucose reabsorption was then measured in 
isolated  kidneys  over  90  min  after  a  period  of  initial  equilibration.  iCORM-A1  and 
iCORM-3,  which  do  not  release  CO,  were  used  as  negative  controls.  Each  line 
represents the mean ± SEM of n=6 for each group.  * P < 0.05 vs.  CS group.
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Figure 5-6:  Effect of CO-RMs on renal sodium reabsorption in isolated kidneys 
after 24 hr cold storage
Rabbit kidneys were initially flushed with Celsior solution alone or supplemented with 
50 pM CORM-A1  (A)  or CORM-3 (B)  and then subjected to a 24 h cold storage  (CS) 
(see Materials  and  Methods for details).  Sodium  reabsorption was then  measured  in 
isolated  kidneys  over  90  min  after  a  period  of  initial  equilibration.  iCORM-A1  and 
iCORM-3,  which  do  not  release  CO,  were  used  as  negative  controls.  Each  line 
represents the mean ± SEM of n=6 for each group.  * P <  0.05 vs.  CS group.
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5.5.4  Effects of 24 hr Cold Storage of Kidneys  in the  Presence of CO- 
RMs on Renal Mitochondrial Respiration at Reperfusion
As mitochondrial function contributes significantly to the outcome of l-R injury 
in  organ  transplantation  (Jassem  et al.,  2002),  we  assessed the  influence  of 
CO liberated from CO-RMs during cold storage (CS) on mitochondrial oxygen 
consumption  and viability after 2  hr of reperfusion  (R)  in  IPRK;  respiration  of 
isolated  rabbit  kidney  cortical  mitochondria  was  measured  using  glutamate 
and  malate  as  substrates.  State  3  respiration  in  renal  mitochondria  was 
reduced  non-significantly after 24 hr CS/R,  with  CS/R+CO-RMs,  state  3 was 
not affected when  compared to freshly isolated  kidneys with 2  hr reperfusion 
(CON)  (Figure  5-7A  and  Figure  5-8A).  Additionally,  24  hr  CS/R  induced  an 
increase  in  state  4  respiration  without  any  observed  changes  with  CS+CO- 
RMs  (Figure  5-7B  and  Figure  5-8B)  when  compared  to  CON.  It  is  also 
remarkable that the  increase in state 3 and the decrease  in state 4 observed 
with  CO-RMs,  as  compared  to  24  hr  CS/R  group,  resulted  in  a  statistically 
significant  increase  of  respiratory  control  index  (RCI)  values.  For  instance, 
cold  preservation  (24 h) followed  by 2  hr reperfusion  resulted  in a significant 
decrease in the renal mitochondria RCI from 4 (CON) to 2.5.  Remarkably, the 
use  of  CO-RMs  during  CS  resulted  in  a  statistically  significant  (P  <  0.05) 
improvement of RCI values (RCI=4.6 with CORM-A1;  RCI=4.5 with CORM-3). 
The  corresponding  negative  controls  (iCO-RMs)  were  totally  ineffective  to 
improve  mitochondrial  function  suggesting  that  CO  liberated  from  the  active 
molecules is responsible for the increased respiration.
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Figure  5-7:  Effects  of 24  hr cold  storage of kidneys  in  the  presence  of CORM- 
A1  on renal mitochondrial respiration at reperfusion
Kidneys were freshly isolated  (CON)  or subjected to a 24 h  cold  storage  (CS)  period 
in  the  presence  or  absence  of  50  pM  CORM-A1  (see  Materials  and  Methods  for 
details).  Mitochondria  were  then  isolated  and  (A)  state  3,  (B)  state  4  and  (C)  the 
respiratory  control  index  (RCI)  were  assessed  in  the  presence  of  malate  and 
glutamate  as  substrates  and  ADP.  iCORM-A1,  which  do  not  release  CO,  was  used 
as  negative controls.  Each  bar represents the  mean  ± SEM  of n=5-6 for each group. 
*P < 0.05 vs.  control (CON); * P < 0.05 vs. CS group.
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Figure 5-8:  Effects of 24 hr cold storage of kidneys  in the presence of CORM-3 
on renal mitochondrial respiration at reperfusion
Kidneys were freshly isolated (CON) or subjected to a 24 h cold storage (CS) period 
in  the  presence  or  absence  of  50  pM  CORM-3  (see  Materials  and  Methods  for 
details).  Mitochondria  were  then  isolated  and  (A)  state  3,  (B)  state  4  and  (C)  the 
respiratory  control  index  (RCI)  were  assessed  in  the  presence  of  malate  and 
glutamate as substrates and ADP. iCORM-3, which do not release CO, was used as 
negative controls.  Each bar represents the mean ± SEM of n=5-6 for each group. *P 
< 0.05 vs. control (CON); *P < 0.05 vs. CS group.
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5.5.5  Effect  of  a  Guanylate  Cyclase  Inhibitor  (ODQ)  on  CO-RMs- 
mediated Changes in Renal Function and Biochemistry after 24 hr 
Cold Storage of Rabbit Kidneys
To  determine  whether  the  observed  changes  in  renal  function  and 
biochemistry  were  mediated  by  a  cGMP-dependent  mechanism,  we 
measured  renal  parameters  in  the  presence  of  ODQ,  an  inhibitor of  soluble 
guanylate  cyclase  (Foresti  et  al.,  2004b).  1H-[1,2,4]oxadiazolo[4,3-
alpha]quinoxalin-1-one  (ODQ,  30  pM)  was  added  to  the  flushing  Celsior 
solution  (4 °C)  in  combination with  CO-RMs prior to 24  hr cold  storage  (CS). 
Changes  in  PFR,  UFR,  GFR,  tubular reabsorption  and  mitochondrial viability 
were  measured  in  IPRK circuit at the end of 2 hr reperfusion  (Figure 5-9 and 
Figure  5-10).  As  shown,  the  effect  of  CORM-A1  treatment  on  PFR  was 
completely abolished  by the  presence of ODQ  (30  pM)  and  the values were 
similar to the control groups (Figure 5-9A). A similar decrease in PFR by ODQ 
was observed in kidneys stored in the presence of CORM-3 (Figure 5-10A).  In 
contrast,  kidneys  supplemented  with  50  pM  CO-RMs  and  30  pM  ODQ 
showed  no  significant  differences  in  UFR,  GFR  and  glucose  and  Na+  
reabsorption and mitochondrial  RCI when compared to kidneys supplemented 
with CO-RMs alone (Figure 5-9 and Figure 5-10,  B, C,  D,  E, and F).
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Figure 5-9:  Effect of ODQ, a guanylate cyclase inhibitor, on CORM-A1-mediated 
changes of renal parameters in 24 hr cold stored kidneys
ODQ  (30  pM)  was  added  to  the flushing  Celsior solution  (4  °C)  in  combination  with 
CORM-A1  prior  to  24  h  cold  storage  (CS).  Changes  in  (A)  perfusion  flow  rate,  (B) 
urine flow rate,  (C)  glomerular filtration  rate  (GFR),  (D)  glucose  reabsorption and  (E) 
Na+   reabsorption  were then  measured  in  the  isolated  perfused  rabbit kidney  system 
at the end of 2 hr reperfusion (see Materials and Methods for details).  The respiratory 
control  index  (RCI,  see figure  F) was  also assessed  in  isolated  rabbit kidney cortical 
mitochondria  in  the presence of malate and glutamate as  substrates  and ADP.  Each 
bar represents the mean ± SEM of n=5-6 for each group.  * P < 0.05 vs.  CS control.
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Figure 5-10:  Effect of ODQ, a guanylate cyclase inhibitor, on CORM-3-mediated 
changes of renal parameters in 24 hr cold stored kidneys
ODQ  (30  pM)  was  added  to  the flushing  Celsior solution  (4  °C)  in  combination  with 
CORM-3 prior to 24 h cold storage (CS). Changes in (A) perfusion flow rate,  (B) urine 
flow rate,  (C)  glomerular filtration  rate  (GFR),  (D)  glucose  reabsorption  and  (E)  Na+ 
reabsorption were then measured in the isolated perfused rabbit kidney system at the 
end  of  2  hr  reperfusion  (see  Materials  and  Methods  for  details).  The  respiratory 
control  index (RCI,  see figure  F) was also assessed  in  isolated  rabbit kidney cortical 
mitochondria  in the presence of malate and glutamate as substrates and ADP.  Each 
bar represents the mean ± SEM of n=5-6 for each group.  * P <  0.05 vs.  CS control.
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5.5.6  Effects of 24 hr Cold Storage of Kidneys in the  Presence of CO- 
RMs  on  Urinary  Release  of  Gamma-glutamyltransferase  at 
Reperfusion
The  urinary release of gamma-glutamyltransferase (GGT),  a  marker of renal 
tubular  injury  (Cutrin  et  al.,  2000),  was  measured  over  90  min  reperfusion 
after  24hr  CS.  As  shown  in  Table  5-1,  GGT  activity  was  increased  at 
reperfusion  after  CS  from  5.7±1.5  (control)  to  18.0  ±  9.2  U/l  at  the  end  of 
reperfusion  (T90).  Interestingly,  treatment with  CORM-A1  and  CORM-3  (but 
not  iCO-RMs)  reduced  GGT  values  by  more  than  twofold  (8.7±2.1  and 
6.4±2.7 U/l at T90, respectively, P > 0.05) as compared to 24 hr CS group.
Table  5-1:  Effect  of  CO-RMs  on  urinary  gamma-glutamyltransferase 
(GGT) at reperfusion after 24 hr cold storage (CS)
'^^^^P erfu sio n  Time 
Cold S to ra g ? ^ ^ ^ ^ ^ ^
0 min 45 min 90 min
Control (0 hr CS) 5.0 ±2.1 5.9 ±1.5 5.7 ±1.5
Cold storage (24 h CS) 35.4 ±15.7 15.8 ±5.1 18.0 ±9.2
CS + CORM-A1 (50 pM) 17.8 ±2.6 8.7 ±1.4 8.7 ±2.1
CS + iCORM-A1 (50 pM) 41.3 ±15.4 18.3 ±7.2 30.0 ±12.8
CS + CORM-3 (50 pM) 16.0 ±6.1 7.0 ±3.3 6.4 ±2.7
CS + iCORM-3 (50 pM) 50.6 ±16.6 16.0 ±4.9 15.8 ±5.5
Isolated  rabbit  kidneys  were flushed  with  Celsior solution  (4  °C)  alone  or Celsior 
supplemented with CORM-A1  or CORM-3. Kidneys were then stored at 4 °C for 24 h 
and  then  reperfused  ex-vivo  as  discussed  in  Materials and Methods.  GGT  levels 
were expressed as U/l. Values are means ± SEM, n=6.
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5.5.7  Effects of 24 hr Cold Storage of Kidneys  in the  Presence of CO- 
RMs on Urinary Release of Nitrite at Reperfusion
The  urinary  nitrite  levels,  the  stable  end  products  of  NO  metabolism,  were 
measured  over 90  min  reperfusion following 24 hr CS  (Table 5-2).  Renal  l/R 
injury caused  an  increase in urinary nitrite at TO,  T45 and T90 of reperfusion 
after 24 hr CS vs. the control group (P < 0.05). As compared to the CS group, 
urinary  nitrite was  significantly  reduced  (at T90) when  CORM-3 was  used  in 
the flushing solution,  but was unchanged after treatment with CORM-A1.  The 
negative  controls  or  iCO-RMs  were  ineffective  in  changing  the  nitrite  levels 
when compared to CS group.
Table 5-2:  Effect of CO-RMs on  urinary nitrite at reperfusion after 24 hr 
cold storage (CS)
^^^^^Perfusion Time 
Cold S to ra g e ^ ^ ^ ^ ^ ^
0 min 45 min 90 min
Control (0 h CS) 1.8 ±0.5 1.6 ±0.5 1.8 ± 0.5
Cold storage (24 h CS) 4.5 ±0.9* 4.3 ± 1.0* 3.8 ±0.5*
CS + CORM-A1 (50 pM) 6.0 ±0.5 4.5 ±0.7 3.4 ±0.4
CS + iCORM-A1 (50 pM) 6.1  ±0.5 4.7 ±0.9 3.4 ± 0.6
CS + CORM-3 (50 pM) 4.4 ±0.6 2.9 ±0.5 2.2 ± 0.4*
CS + iCORM-3 (50 pM) 5.4 ±0.6 5.9 ±0.2 5.8 ± 0.5
Isolated  rabbit  kidneys  were  flushed  with  Celsior  solution  (4  °C)  alone  or  Celsior 
supplemented with CORM-A1  or CORM-3.  Kidneys were then stored at 4 °C for 24 h 
and then  reperfused ex-vivo as discussed  in  Materials and Methods.  Urinary nitrite 
levels were expressed as pM. Values are means ± SEM, n=6. * P < 0.05 vs. control, 
# P < 0.05 vs. CS.
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5.5.8  Effects of 24 hr Cold  Storage of Kidneys  in the  Presence of CO- 
RMs on Protein Excretion at Reperfusion
Protein  excretion  was  used  to  evaluate  renal  tubular  injury.  Notably,  no 
differences  in  protein  excretion  levels  were  observed  among  the  various 
groups analyzed (Table 5-3).
Table 5-3:  Effect of CO-RMs on protein excretion at reperfusion after 24 
hr cold storage (CS)
^ ^ ^ ^ P e rfu s io n  Time 
Cold S to ra g e ^ ^ ^ ^ ^ ^
0 min 45 min 90 min
Control (0 hr) 6.0 ±0.5 5.9 ±0.5 6.2 ±0.4
Cold storage (CS) 7.0 ±0.4 6.9 ±0.3 7.0 ±0.2
CS + CORM-A1 (50 pM) 8.2 ±0.4 7.7 ±0.3 7.7 ±0.3
CS + iCORM-A1 (50 pM) 7.2 ±0.8 6.5 ±0.6 7.6 ±1.1
CS + CORM-3 (50 pM) 6.8 ±0.5 6.2 ±0.7 7.3 ±0.5
CS + iCORM-3 (50 pM) 8.1  ±0.5 7.7 ±0.5 8.0 ±0.6
Isolated  rabbit  kidneys  were  flushed  with  Celsior solution  (4  °C)  alone  or  Celsior 
supplemented with CORM-A1  or CORM-3. Kidneys were then stored at 4 °C for 24 h 
and  then  reperfused  ex-vivo  as  discussed  in  Materials  and  Methods.  Protein 
excretion  in the  urine was expressed as % perfusate protein concentration.  Values 
are means ± SEM, n=6.
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5.5.9  Effects of 48 hr Cold Storage of Kidneys in the Presence of CO-RMs 
on Renal Function at Reperfusion
The purpose of this study was to evaluate the renal function of isolated perfused 
rabbit  kidneys  after  48  hr  of cold  storage  with  Celsior  solution  alone  (CS)  or 
Celsior plus CO-RMs (CS+CO-RMs). Mean PFR (ml/min/g of tissue) was higher 
in the kidneys preserved with CS+CO-RMs:  7.1  in the CS group vs.  10.1  in the 
CS+CORM-3  group  (Figure  5-11B,  P  <  0.05)  and  8.4  in  the  CS+CORM-A1 
group  (Figure  5-11 A,  P >  0.05)  at 90  min  of reperfusion  (T90).  There was  no 
difference between  CS group and CS+iCO-RMs groups during reperfusion (7.4 
in CS+iCORM-3 and 6.6 in CS+iCORM-A1  at T90).
UFR (pL/min/g of tissue) was significantly higher in kidneys flushed with 50 pM 
CO-RMs  (Figure  5-12):  446.6  in  the  CS+CORM-3  (P <  0.05)  and  349.3  (P > 
0.05)  in  the  CS+CORM-A1  vs.  259.9  in  CS  alone  at  T90.  GFR  (pL/min/g  of 
tissue)  was  not  significantly  different  between  CS  group  and  CS+CORM-A1 
group  (Figure  5-13A).  In  contrast,  GFR  was  markedly  increased  in  the 
CS+CORM-3  group  when  compared  to  CS  alone  (514.1  vs.  316.4  at TO;  and
506.8  vs.  352.9  at  T90,  Figure  5-13B).  The  corresponding  negative  controls 
(iCO-RMs)  were  totally  ineffective  to  increase  UFR  and  GFR  suggesting  that 
CO  liberated  from  the  active  molecules  is  responsible  for  the  improved  renal 
function.
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Figure 5-11: The effect of CO-RMs on perfusate flow rate during reperfusion after 
48 hr cold storage
Rabbit  kidneys  were  initially  flushed  with  Celsior solution  alone  or  supplemented  with 
50  pM  CORM-A1  (A)  or CORM-3  (B)  and  then  subjected  to  a  48  h  cold  storage  (CS) 
(see  Materials  and  Methods  for  details).  Perfusion  flow  rate  was  then  measured  in 
isolated  kidneys  over  90  min  after  a  period  of  initial  equilibration.  iCORM-A1  and 
iCORM-3,  which  do  not  release  CO,  were  used  as  negative  controls.  Each  line 
represents the mean ± SEM of n=5 for each group. * P <  0.05 vs.  CS group.
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Figure  5-12:  Effect  of CO-RMs  on  urine flow  rate  in  isolated  kidneys  after 48  hr 
cold storage
Rabbit  kidneys were  initially flushed  with  Celsior solution  alone  or supplemented with 
50  pM  CORM-A1  (A)  or CORM-3  (B)  and then  subjected  to  a 48  hr cold  storage  (CS) 
(see  Materials and  Methods for details).  Urine flow rate was then  measured in  isolated 
kidneys  over  90  min  after  a  period  of  initial  equilibration.  iCORM-A1  and  iCORM-3, 
which  do  not  release  CO,  were  used  as  negative  controls.  Each  line  represents  the 
mean ± SEM of n=5 for each group.  * P < 0.05 vs.  CS group.
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Figure  5-13:  Effect  of  CO-RMs  on  glomerular  filtration  rate  (GFR)  in  isolated 
kidneys after 48 hr cold storage
Rabbit  kidneys were  initially flushed  with  Celsior solution  alone  or  supplemented  with 
50  pM  CORM-A1  (A)  or CORM-3  (B)  and  then  subjected  to a  48  h  cold  storage  (CS) 
(see  Materials  and  Methods  for  details).  Glomerular  filtration  rate  (GFR)  was  then 
measured  in  isolated kidneys over 90 min after a period of initial equilibration.  iCORM- 
A1  and  iCORM-3, which do not release CO, were used as negative controls.  Each line 
represents the mean ± SEM of n=5 for each group.  * P < 0.05 vs.  CS group.
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5.5.10  Effects of 48 hr Cold Storage of Kidneys in the Presence of CO-RMs 
on Renal Tubular Reabsorption at Reperfusion
Here, we examined the influence of CO released from CO-RMs on renal tubular 
reabsorption.  Glucose  and  sodium  reabsorption  were  measured  in  isolated 
rabbit  kidneys  over  90  min  reperfusion  after 48  hr cold  storage.  As  shown  in 
Figure  5-14,  the  cold-stored  (CS)  kidneys  with  CO-RMs  had  a  significantly 
higher Rglu when compared to CS kidneys alone.  For instance, the mean  RGlu 
(%) was increased from 49.1  in the CS group to 67.8 in the CS+CORM-A1  (P < 
0.05,  Figure  5-14A)  and  to  67.9  in  the  CS+CORM-3  group  (P  <  0.05,  Figure 
5-14B)  at 60  min  reperfusion  time  (T60).  Between  the  CS  and  CS+CORM-A1 
groups,  RN a  was  significantly  different  at  T45:  15.5%  vs.  22.2%  (P  <  0.05, 
Figure 5-14A).  In contrast,  CORM-3 had no effect on  RN a when compared with 
CS group (*P > 0.05,  Figure 5-14B).
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Figure 5-14:  Effect of CO-RMs on  renal glucose reabsorption  in  isolated  kidneys 
after 48 hr cold storage
Rabbit  kidneys  were  initially flushed  with  Celsior solution  alone  or supplemented  with 
50  pM  CORM-A1  (A)  or CORM-3  (B)  and  then  subjected  to  a  48  h  cold  storage  (CS) 
(see  Materials  and  Methods  for details).  Glucose  reabsorption  was  then  measured  in 
isolated  kidneys  over  90  min  after  a  period  of  initial  equilibration.  iCORM-A1  and 
iCORM-3,  which  do  not  release  CO,  were  used  as  negative  controls.  Each  line 
represents the mean ± SEM of n=5 for each group.  * P< 0.05 vs. CS group.
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Figure  5-15:  Effect of CO-RMs on  renal  sodium  reabsorption  in  isolated  kidneys 
after 48 hr cold storage
Rabbit  kidneys  were  initially flushed  with  Celsior solution  alone  or supplemented with 
50  pM  CORM-A1  (A)  or CORM-3  (B)  and  then  subjected  to  a  48  h  cold  storage  (CS) 
(see  Materials  and  Methods  for  details).  Sodium  reabsorption  was  then  measured  in 
isolated  kidneys  over  90  min  after  a  period  of  initial  equilibration.  iCORM-A1  and 
iCORM-3,  which  do  not  release  CO,  were  used  as  negative  controls.  Each  line 
represents the mean ± SEM of n=5 for each group.  * P < 0.05 vs.  CS group.
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5.5.11  Effects of 48 hr Cold Storage of Kidneys in the Presence of CO-RMs 
on Renal Mitochondrial Respiration at Reperfusion
In  order  to  assess  the  influence  CO  liberated  from  CO-RMs  on  48  hr  cold 
ischaemia  on  mitochondrial  oxygen  consumption  and  viability,  the  respiration 
rate of isolated rabbit kidney mitochondria was measured after 2 hr reperfusion 
(R)  using  glutamate  and  malate  as  substrates.  Cold  preservation  and 
reperfusion  of  the  kidney  resulted  in  a  predominant  decrease  of  state  3 
respiration (ng Oxygen/min/mg of protein) from 52.1  for fresh kidneys (0 hr CS/2 
hr  R)  to  37.2  for 48  hr  CS/R  (P<0.05),  while  CORM-A1  appears  not  to  affect 
state  3 respiration when compared to CS group (Figure 5-16A).  In addition,  no 
changes were observed in state 4 respiration after 48 hr CS/R or when CORM- 
A1  was  used  in  the flushing  solution  (Figure 5-16B).  It  is also  remarkable that 
the  decrease  in  state  3  resulted  in  a  statistically  significant  depression  of RCI 
values of 48  hr cold-stored  kidneys as indicated  by RCI  values of 4 for control 
and  2.7  after 48  hr  CS/R without any obvious changes with  CORM-A1  vs.  CS 
group  (Figure  5-16C).  In  contrast,  CORM-3  reduced  state  4  significantly while 
state  3  was  not  affected  when  compared  to  CS/R  group  (Figure  5-17).  As 
shown in Figure 5-17C, the decrease in state 4 observed with CORM-3 resulted 
in a  statistically significant  increase of RCI  values  (RCI=4 with  CORM-3+CS/R 
vs.  2.7  with  CS/R).  The  corresponding  negative  control  (iCORM-3)  was 
ineffective to  improve  mitochondrial function suggesting that  CO  liberated from 
the active molecules is responsible for the increased respiration.
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Figure 5-16:  Effects of 48 hr cold storage of kidneys in the presence of CORM-A1 
on renal mitochondrial respiration at reperfusion
Kidneys were freshly isolated (CON) or subjected to a 48 h cold storage (CS)  period  in 
the  presence  or  absence  of  CORM-A1  (see  Materials  and  Methods  for  details). 
Mitochondria  were  then  isolated  and  (A)  state  3,  (B)  state  4  and  (C)  the  respiratory 
control  index  (RCI)  were  assessed  in  the  presence  of  malate  and  glutamate  as 
substrates  and  ADP.  iCORM-A1,  which  do  not  release  CO,  was  used  as  negative 
controls.  Each  bar represents the  mean  ± SEM  of n=5-6 for each  group.  *P <0.05 vs. 
control (CON).
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Figure 5-17:  Effects of 48  hr cold storage of kidneys  in the  presence  of CORM-3 
on renal mitochondrial respiration at reperfusion
Kidneys were freshly isolated (CON) or subjected to a 48 hr cold storage (CS) period in 
the  presence  or  absence  of  CORM-3  (see  Materials  and  Methods  for  details). 
Mitochondria  were  then  isolated  and  (A)  state  3,  (B)  state  4  and  (C)  the  respiratory 
control  index  (RCI)  were  assessed  in  the  presence  of  malate  and  glutamate  as 
substrates  and  ADP.  iCORM-3,  which  do  not  release  CO,  was  used  as  negative 
controls.  Each  bar represents the mean ± SEM of n=5-6 for each  group.  *P < 0.05 vs. 
control (CON); * P< 0.05 vs.  CS group.
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5.5.12  Effects of 48 hr Cold Storage of Kidneys in the Presence of CO-RMs 
on Urinary Release of Gamma-glutamyltransferase at Reperfusion
The  urinary  release  of  gamma-glutamyltransferase  (GGT),  a  marker  of  renal 
tubular injury (Cutrin et al.,  2000), was measured over 90 min reperfusion after 
48  hr  CS.  GGT  activity  was  increased  at  reperfusion  after  CS  from  5.7±1.5 
(control) to 16.0 ± 4.9 U/l after 90 min reperfusion (T90).  Interestingly, treatment 
with CORM-A1  (but not CORM-3) reduced GGT values by about twofold at T90 
(P > 0.05).  It is also notable that GGT levels were high at TO for the CS groups 
with or without CO-RMs when compared to control.
Table 5-4: Effect of CO-RMs on urinary gamma-glutamyltransferase (GGT) 
at reperfusion after 48 hr cold storage (CS)
^^^^^Perfusion Time 
Cold S to ra g e ^ ^ ^ ^ ^ ^
0 min 45 min 90 min
Control (0 h CS) 5.0 ±2.1 5.9± 1.5 5.7 ±1.5
Cold storage (48 h CS) 33.6 ±4.7* 17.2 ± 4 .4 * 16.0 ± 4 .9 *
CS + CORM-A1 (50 pM) 47.8 ±12.3 14.5 ±2.2 8.8 ±1.1
CS + iCORM-A1 (50 pM) 45.3 ±17.7 27.8 ±12.3 28.3 ± 11.6
CS + CORM-3 (50 pM) 34.7 ±11.2 21.6 ± 2.8 24.4 ±2.8
CS + iCORM-3 (50 pM) 41.3 ± 4.1 25.7 ± 1.0 28.0 ± 1.2
Isolated  rabbit  kidneys  were  flushed  with  Celsior  solution  (4  °C)  alone  or  Celsior 
supplemented with CORM-A1  or CORM-3.  Kidneys were then stored at 4 °C for 48 h 
and then reperfused ex-vivo as discussed in Materials and Methods.  GGT levels were 
expressed as U/l. Values are means ± SEM, n=5. * P < 0.05 vs. Control.
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5.5.13  Effects of 48 hr Cold Storage of Kidneys in the Presence of CO-RMs 
on Urinary Release of Nitrite at Reperfusion
Urinary  nitrite  was  significantly  increased  after  48  hr  CS.  Interestingly,  when 
CORM-3  was  used  nitrite  levels  were  reduced  markedly  after  45  min 
reperfusion  when  compared  to  CS  group  (P <  0.05,  Table  5-5).  Urinary  nitrite 
levels were unchanged after treatment with CORM-A1  vs. the CS group.
Table  5-5:  Effect of CO-RMs  on  urinary  nitrite  at  reperfusion  after 48  hr 
cold storage (CS)
^ ^ ^ ^ P e rfu s io n  Time 
Cold S to ra g e ^ ^ ^ ^ ^ ^
0 min 45 min 90 min
Control (0 hr) 1.8 ± 0.5 1.6 ±0.5 1.8 ±0.5
Cold storage (48 h CS) 5.2 ±0.2* 5.4 ±0.5* 4.4 ±0.3*
CS + CORM-A1  (50 pM) 5.8 ±0.4 5.8 ±0.9 4.6 ±0.2
CS + iCORM-A1 (50 pM) 4.8 ±0.3 5.1  ±0.7 5.0 ±0.5
CS + CORM-3 (50 pM) 4.3 ±0.6 3.6 ± 0.5* 3.3 ±0.4
CS + iCORM-3 (50 pM) 4.3 ±0.7 4.8 ± 1.0 5.0 ±0.7
Isolated  rabbit  kidneys  were  flushed  with  Celsior  solution  (4  °C)  alone  or  Celsior 
supplemented with CORM-A1  or CORM-3.  Kidneys were then stored at 4 °C for 48 h 
and  then  reperfused  ex-vivo  as  discussed  in  Materials and Methods.  Urinary  nitrite 
levels were expressed as pM. Values are means ± SEM, n=5. * P < 0.05 vs. CS.
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5.5.14  Effects of 48 hr Cold Storage of Kidneys in the Presence of CO-RMs 
on Protein Excretion at Reperfusion
As  Table  5-6  shows,  48  hr  CS  increased  protein  leakage  significantly  as 
compared  to  control  groups  (0  hr).  Notably,  no differences  in  protein  excretion 
levels were observed among the various groups analyzed.
Table 5-6: Effect of CO-RMs on protein excretion at reperfusion after 48 hr 
cold storage (CS)
^^^^^Perfusion Time 
Cold Storagc^^^^^^^
0 min 45 min 90 min
Control (0 hr) 6.0 ±0.5 5.9 ±0.5 6.2 ±0.4
Cold storage (48 h CS) 10.4 ±0.1* 10.2 ±o.r 10.6 ±0.1*
CS + CORM-A1  (50 pM) 10.9 ±0.2 10.7 ±0.1 10.5 ±0.3
CS + iCORM-A1 (50 pM) 10.1 ±0.2 10.7 ±0.7 10.8 ±0.6
CS + CORM-3 (50 pM) 10.9 ±0.4 11.4 ±0.6 11.4 ±0.6
CS + iCORM-3 (50 pM) 11.4 ±0.8 11.4 ±0.9 11.6± 0.8
Isolated  rabbit  kidneys  were  flushed  with  Celsior  solution  (4  °C)  alone  or  Celsior 
supplemented with CORM-A1  or CORM-3.  Kidneys were then stored at 4 °C for 48 h 
and then reperfused ex-vivo as discussed in Materials and Methods.  Protein excretion 
in the urine was expressed as % perfusate protein concentration. Values are means ± 
SEM, n=5. * P < 0.05 vs. CS.
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5.6  Discussion
Ischaemia caused by cold storage (CS) and reperfusion of the kidney is a major 
cause  of  delayed  graft function  after transplantation.  Significant  attention  has 
been  focused  on  identifying  drugs,  which  are able to ameliorate the functional 
damage  that occurs  in  l-R injury.  Here we show that CO  liberated from water- 
soluble  CO-RMs  exerts  significant beneficial  effects on  renal  vascular function 
of  kidneys  stored  at  low  temperatures  (4  °C)  in  Celsior  solution,  a  clinical 
strategy  commonly  used  to  preserve  organs for  transplantation.  The fact  that 
CO-RMs were used only during the flushing procedure prior to CS indicates the 
feasibility of utilizing these CO carriers as adjuvants of preservation solutions to 
greatly limit the damage of donor organs.
Impairment of renal  blood flow during ischaemia-reperfusion  plays a significant 
role in the exacerbation of tissue injury in a number of kidney diseases (Regan 
et al.,  1995).  It  has  been  shown that a  persistent  reduction  in  renal  blood flow 
can  be  attributed  to  a  decreased  glomerular filtration  rate  (GFR)  observed  in 
renal  allografts  following  an  ischaemic  event  (Alejandro  et  al.,  1995a).  In 
addition,  intense  vasoconstriction  and  endothelial  damage  are  prominent 
features  of  CS-mediated  injury  (Molitoris  et  al.,  2002).  In  the  present  study, 
perfusion  flow  rate  (PFR)  was  markedly  increased  in  reperfused  isolated 
kidneys previously flushed with either CORM-A1  or CORM-3 and subjected to a 
24  h  or  48  h  CS  procedure.  The  fact  that  iCO-RMs  were  ineffective  clearly 
demonstrates that CO  is directly responsible for the observed pharmacological 
effects.  Since  the  perfusion  pressure  in  the  isolated  rabbit  model  was  kept 
constant  (100  mmHg),  we  conclude  that  the  increase  in  PFR  by  CO-RMs  is 
mainly  due  to  a  decrease  in  vascular  resistance.  We  also  found  that  the
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beneficial  vascular  effects  mediated  by  CO-RMs  were  lost  in  the  presence  of 
ODQ,  a  guanylate  cyclase  inhibitor.  These  results  are  supported  by  data 
showing  that  endogenous  CO  promotes  renal  vasodilatation  in  chronically 
hypoxic  rats  (O'Donaughy and Walker,  2000) and  are consistent with  previous 
studies  from  our  laboratory  demonstrating  that  both  CORM-3  and  CORM-A1 
exert  vasorelaxation  of pre-contracted  aortas  as  well  as  systemic  hypotension 
through stimulation of the cGMP pathway (Foresti et al., 2004b;  Motterlini et al.,
2004). We cannot exclude a priori that other mechanisms,  particularly activation 
of  K+   channels  (Kaide  et  al.,  2001)  and  modulation  of  the  vasoconstrictor 
endothelin  (Pollock,  2001),  could  participate  in  CO-mediated  renal 
vasorelaxation as these two pathways have been shown to be potential targets 
for CO-RMs  in cardiac and  smooth muscle cells (Clark et al.,  2003;  Stanford et 
al.,  2004).  Thus,  the  present  study  emphasizes  that  water-soluble  CO-RMs 
exert  a  positive  effect  on  the  vascular activity  of the  kidney  and  confirms that 
CO is crucial in maintaining renal haemodynamics after cold ischaemia.
The  beneficial  effects  of  CORM-A1  and  CORM-3  on  GFR  and  urine flow  rate 
(UFR)  at  reperfusion  following  preservation  at  low  temperature  indicate  a 
potential  therapeutic  role  of  CO  carriers  in  the  treatment  of  renal  dysfunction. 
Moreover,  the  increase  in  GFR  and  UFR  mediated  by  CO-RMs  was 
accompanied by a markedly improved glucose and sodium reabsorption as well 
as  reduced  GGT  activity  suggesting  that  CO  also  protects  tubular  function 
against the  detrimental  effect of cold  ischaemia  and  reperfusion.  Our data  are 
consistent  with  a  previous  report  by  Arregui  and  colleagues  showing  that 
Mn2(CO)io  (CORM-1),  a  light-sensitive  non-water  soluble  CO-RM  firstly 
identified  by  our group  and  found  to  possess  biological  activities  (Motterlini  et
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al.,  2002a;  Motterlini et al., 2003),  plays an important role in the control of renal 
haemodynamics  and  function  in  vivo.  The  authors  reported  that  an  intrarenal 
administration  of  CORM-1  in  Sprague  Dawley  rats  increases  renal  blood flow 
(+54%),  GFR  (+38%)  and  urinary cGMP  excretion  (+128%)  and that  inhibition 
of  HO  activity  progressively  compromises  renal  haemodynamics  leading  to 
acute renal failure,  an effect that was completely reversed by CORM-1  (Arregui 
et al.,  2004).  Similarly,  Vera and co-workers reported that CORM-3 significantly 
decreased the levels of plasma creatinine and limited renal damage in a mouse 
model  of ischaemia-induced acute renal failure (Vera et al., 2005).  Collectively, 
these  and  our  present  results  suggest that  CO  activation  of guanylate  cyclase 
are dynamically involved in counteracting renal dysfunction in a variety of stress 
conditions that affect the physiology of the kidney.
In  addition  to  its  well-established  beneficial  effects  on  vascular  activity,  CO 
promotes  anti-inflammatory  (Otterbein  et  al.,  2000)  and  anti-apoptotic  effects 
(Zhang et al., 2003) that can contribute to the defence against tissue injury. The 
molecular  mechanisms  underlying  these  cytoprotective  actions  by  CO  are  not 
fully understood at present but the emerging evidence highlights the pleiotropic 
properties of this gaseous molecule. Administration of CO gas in vivo has been 
shown to  improve  kidney graft function  in  part by decreasing the levels of pro- 
inflammatory  mediators  and  inhibition  of apoptosis  (Neto et  al.,  2004).  Recent 
studies from our group confirms the anti-inflammatory action of CO by showing 
that  CORM-3  inhibits  the  increase  in  TNF-a  and  NO  in  endotoxin-stimulated 
macrophages (Sawle et al., 2005).  Moreover, CORM-3 appears to modulate the 
production of reactive oxygen species (ROS) generated by NADPH oxidase and 
the  mitochondrial  respiratory chain  in  human  airway smooth  cells (Taille et al.,
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2005).  This is in line with the data presented  in this study showing that the use 
of CORM-3 during the CS procedure reduced urinary nitrite levels and improved 
kidney mitochondrial respiration at reperfusion.  Since CO preferentially binds to 
metal-centred  proteins,  heam-dependent  cytochromes  present  in  mitochondria 
could  potentially  serve as a  possible target for CO to confer protection  against 
oxidant-mediated  injury.  Indeed,  mitochondria  play  a  fundamental  role  in  l-R 
injury  in  organ  transplantation  (Jassem  and  Heaton,  2004)  by  controlling 
apoptotic events (Green and Reed,  1998) and the generation of ROS (Cadenas 
and  Davies,  2000).  In  this  context,  uncoupling  has  been  suggested  as  an 
important  mechanism  for reducing  ROS  generation  (Balaban  et al.,  2005)  and 
the  concept  that  a  continuous  mild  production  of  ROS  from  mitochondria  is 
essential  for  life  is  fully  supported  by  experimental  evidence  (Becker,  2004). 
Notably,  in  pig  hearts  subjected  to  cardiopulmonary  bypass  with  cardioplegic 
arrest,  treatment  with  CO  gas  showed  significantly  higher  ATP  and 
phosphocreatine  levels,  less  interstitial  oedema  and  reduced  apoptosis  of 
cardiomyocytes  suggesting  that  CO  can  improve  the  energy  status  of the  cell 
(Lavitrano et al., 2004).
The  ability  of  CO-RMs  to  confer  significant  protection  against  renal  cold 
ischaemia  and  reperfusion  damage  is  in  agreement with the  beneficial  effects 
mediated  by  CO  gas  and  HO-1 -derived  CO  against  kidney  dysfunction  in 
various  models  of disease.  Kidney grafts  preserved  in  UW solution  at 4  °C for 
24 h and orthotopically transplanted  into syngeneic rats  previously treated with 
CO gas displayed an  increased renal  cortical  blood flow and was accompanied 
by enhanced serum creatinine clearance and improved animal survival (Neto et 
al.,  2004).  Treatment of organ  donors and  long-term  recipients with  methylene
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chloride,  a  CO-generating  chemical,  ameliorated  renal  function  and  reduced 
histological  signs  of  deterioration  in  a  rat  model  of  kidney  allograft  rejection 
(Martins  et  al.,  2005).  Similarly,  induction  of  HO-1  preserved  kidney  graft 
function  and  prevented  post-reperfusion  apoptosis  after  cold  ischaemia,  an 
effect that was  completely  reversed  by inhibition of HO activity (Wagner et al.,
2003).  Moreover,  overexpression  of  HO-1  either  by  haemin  or  gene  transfer 
results  in  protection  against  renal  CS-mediated  damage  and  renders 
transplanted  kidneys  more  resistant  to  l-R  injury  (Katori  et  al.,  2002b; 
Salahudeen et al., 2001).
Here,  both CO-RMs were equally effective in preventing renal dysfunction when 
used  during  the  flushing  procedure  at 4  °C  prior to  24  hr  CS  and  reperfusion 
with more protection observed with CORM-3 after 48 hr CS. The reason may lie 
in  the  different  chemical  features  and  rate  of  CO  release  from  the  two  drugs 
used.  CORM-3,  a  ruthenium-based carbonyl  complex,  is  known to release  CO 
very rapidly in physiological buffers and plasma at 37 °C with a half-life ranging 
from  1   to  5  min  (Clark  et  al.,  2003).  In  contrast,  CORM-A1  liberates  CO  in  a 
slow  fashion  and  the  rate  of  CO  release  is  strictly  dependent  on  pH  and 
temperature  (Motterlini  et  al.,  2004).  In  fact,  the  half-life  of  CORM-A1  in 
phosphate buffer at 37 °C  is approximately 21  min (Motterlini et al., 2004).  The 
rate  of  CO  release  from  CO-RMs  in  Celsior  at  4  °C  is  dramatically  reduced 
despite  being  still  ten  times faster for CORM-3  (14.0±1.0 nmol/h) than  CORM- 
A1  (1,39±0.05 nmol/h).
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In  summary,  the  results  emphasize  that  CO  liberated  from  CO-RMs  has  a 
protective  vasodilatory  effect,  improves  renal  function  and  increases 
mitochondrial  respiration  after  cold  ischaemia  and  reperfusion.  These  findings 
suggest that CO-RMs could be used therapeutically in preservation solutions as 
an  efficacious  strategy  to  prevent  the  injury  sustained  by  organs  during  cold 
storage prior to transplantation.
221UCL 6  EFFECT OF CORM-A1  ON WARM RENAL l-R INURY
6  The Effect of CORM-A1 on Warm Ischaemia-Reperfusion Injury Using 
an Isolated Perfused Rabbit Kidney Circuit Model
6.1  Introduction
Delayed graft function is a major source of morbidity,  increased costs, and graft 
loss after kidney transplantation (Perico et al., 2004).  Deficits in kidney function 
occur  due  to  the  cumulative  effects  of  cellular  stresses  that  may  be  incurred 
prior to organ harvest,  during cold storage, or during normothermic reperfusion. 
One  critical  stressor  in  kidneys  is  warm  ischaemia  (Wl),  it  occurs  when  the 
blood supply to an area of tissue is cut off.  In the kidney,  a significant period of 
Wl  is  inevitable  in  cadaveric  non-heart  beating  donors,  who  have  already 
suffered  cardio-respiratory  arrest.  In  fact,  the  combination  of  warm  and  cold 
ischaemic damage represents the major obstacle to substantially expanding the 
organ  donor  pool  into  the  non-heart  beating  cadaveric  population.  In  addition, 
warm  renal  ischaemic  injury  also  occurs  during  transplantation  surgery  when 
renal  blood  vessels  are  cross-clamped.  Although  restoration  of  blood  supply 
was  expected  to  reduce  damage  caused  by Wl,  reperfusion  event  itself have 
shown  to  increase  the  extent  of  tissue  damage.  This  l-R  injury  is  a  leading 
cause  of  kidney  damage  and  a  major  cause  of  dysfunction  in  transplanted 
organs  through  several  cytoplasmic  and  mitochondrial  mechanisms.  These 
include production  of oxygen free radicals,  lipid peroxidation,  calcium overload, 
apoptosis and ATP depletion.
Several  approaches  and  drugs  have  been  used  to  counter  the  damaging 
mechanisms  and  ameliorate the  renal  ischaemic  injury.  Among these,  CO has 
recently  drawn  much  attention  as  a  physiological  regulator  and  a  novel
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protective  substance  against  l-R  injury  (Nakao  et  al.,  2003a;  Nowak  et  al.,
2004).  In  essence,  both  the  use  of  potent  HO-1  inducers  as  well  as 
administration  of  low  doses  of  CO  gas  have  been  employed  to  evaluate  the 
potential therapeutic role of CO in l-R injury in the kidney (Horikawa et al., 2002; 
Takahashi  et al.,  2004;  Tullius et al.,  2002).  Based  on the  emerging  evidence, 
there  is  a  supporting  role  for  CO  liberated  from  CO-RMs  in  vasorelaxation 
(Foresti  et  al.,  2004b;  Motterlini  et  al.,  2004)  and  additional  cytoprotective 
effects  ranging  from  suppression  of  inflammation  (Sawle  et  al.,  2005)  to 
protection  against  hypoxia-reoxygenation  and  oxidative  stress  (Clark  et  al., 
2003),  l-R  injury (Clark et al.,  2003),  allograft rejection  (Clark et al.,  2003) and 
myocardial infarction (Guo et al., 2004; Stein et al., 2005).
6.2  Hypothesis
The  results from  Chapter 5 suggest that the protective  role of CO-RMs  in cold 
storage and  reperfusion  injury may be extended to warm  ischaemic protection. 
It  is  hypothesized  that  low  concentration  of  exogenous  CO  released  from 
CORM-A1,  administered  before  the  ischaemic  insult,  may  provide  a  defence 
mechanism and beneficial effects against warm l-R injury.
6.3  Objectives
•  To  evaluate  the  effect  of warm  ischaemic period  of  I  hr on the  subsequent 
function exhibited during the isolated normothermic perfusion.
•  To  investigate  whether  flushing  with  CORM-A1  prior  to  Wl  will  protect 
against l-R injury in the isolated perfused rabbit kidney model.
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6.4  Materials and Methods
6.4.1  Isolated Perfused Rabbit Kidney Model
The  study  was  performed  in  isolated  perfused  rabbit  kidneys  as  previously 
described  in  the  Materials  and  Methods  Chapter  (Heading  2.4.4).  Briefly, 
immediately  or  at  the  end  of the  Wl  period,  the  kidney  was  perfused  via  the 
renal artery with freshly prepared Krebs solution at 37 °C,  pH was 7.4 (Heading 
2.4.5).  This  solution was  continuously gassed with  a  gas  mixture  (95%  02-5% 
CO2).  Renal  perfusate flow rate  (PFR) was  adjusted to  maintain  mean  arterial 
perfusion pressure at 100 mmHg.  Perfusion was provided by a peristaltic pump.
6.4.2  Functional Assessment
Once  a  steady  state  was  attained  after  30  min  equilibration,  the  following 
elements  were  monitored  every  15  min  interval  (TO,  15,  45,  60,  75,  90)  of 
normothermic  perfusion:  PFR,  UFR  (urine  flow  rate),  GFR,  and  tubular 
reabsorption  of  glucose  and  sodium  (Heading  2.4.8).  Urinary  gamma- 
glutamyltransferase  (GGT)  activity,  nitrite  levels  and  protein  excretion  in  urine 
were  determined  at  TO,  T45,  and  T90  (Heading  2.4.8).  The  renal  perfusion 
pressure and the  perfusion  rate were continuously monitored.  In addition,  PFR 
and  UFR  were  measured  by  timed  collection  of  perfusate  and  urine.  After 
reperfusion,  the  viability  of  the  kidney  was  determined  by  the  evaluation  of 
mitochondrial respiration using malate and glutamate as substrate.
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6.4.3  Experimental Protocol
Normothermic  isolated  perfused  rabbit  kidneys  were  randomized  into  four 
experimental groups:
•  Group  1   (CON,  n=6):  Control  kidneys  were  transferred  immediately  to  the 
perfusion  circuit,  undergoing  less than  2  min  of Wl  timed from  clamping  of 
the renal artery and vein to onset of perfusion.
•  Group 2 (Wl,  n=5):  Kidneys flushed with 60 ml  perfusion solution alone and 
were  placed  in a glass container filled with perfusion solution;  kidneys were 
maintained at 37 °C in a water bath for 1   hr and were then transferred to the 
perfusion circuit.
•  Group  3  (WI+CORM-A1,  n=5):  The  same  as  group  B,  but  kidneys  were 
flushed with perfusion solution containing 50 pM of CORM-A1.
•  Group  4  (WI+iCORM-A1,  n=5):  The  same  as  group  B,  but  kidneys  were 
flushed with perfusion solution containing 50 pM of iCORM-A1.
6.4.4  Statistical Analysis
Statistical analysis was performed using one-way analysis of varience (ANOVA) 
combined  with  Bonferroni  test.  When  differences  were  established  between 
groups,  unpaired two-tailed t-test to assess statistical significance between two 
groups at each time point was used.  Data were presented as mean ± SEM and 
differences were considered to be significant at P < 0.05.
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6.5  Results
6.5.1  Effect of Warm Ischaemia of Kidneys in the  Presence of C0RM-A1 
on Perfusate Flow Rate at Reperfusion
Given  the fact  that  50  pM  CORM-A1  affects freshly  harvested  kidney function 
significantly  (Chapter  4)  and  improved  renal  parameters  after  cold  l-R  injury 
(Chapter  5),  this  concentration  was  chosen  to  test  the  ability  of  CO  released 
from  CORM-A1  to  protect  against  warm  l-R  injury  in  IPRK  model.  Kidneys 
flushed in the presence of CORM-A1  prior to 1   hr warm ischaemia (Wl) at 37 °C 
(WI+CORM-A1)  produced a  higher PFR on the  isolated  system  at reperfusion, 
PFR  was  mainly  significant  in  the  last  30  min  of  reperfusion  (P  <  0.05).  For 
instance,  at  90  min  reperfusion,  PFR  was  9.2  ml/min/g  in  WI+CORM-A1 
compared to 6.3 ml/min/g  in the Wl  group (Figure 6-1).  The negative control or 
iCORM-A1  was unable to increase the PFR indicating that CO is responsible for 
the observed vasodilatory effect.  It is also notable that during the first 45 min of 
perfusion,  PFR  was  increased  dramatically  over  time  for  all  groups, 
subsequently;  the PFR started to stabilize and reached a plateau of around 8.2 
and  6.9  ml/min/g  for  the  control  and  WI+iCORM-A1  groups,  respectively. 
Generally,  there  was  a  significant  difference  in  PFR  between  control  (freshly- 
harvested  kidneys)  and  Wl  group  (P <  0.05),  but  no  marked  differences  were 
observed with CORM-A1  and iCORM-A1  as compared to control group.
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Figure 6-1: The effect of CORM-A1  on perfusate flow rate during reperfusion after 
1  hr warm ischaemia
Rabbit kidneys were  initially flushed with perfusion solution alone or supplemented with 
50  pM  CORM-A1  and  then  subjected  to  a  1 hr warm  ischaemia  (Wl)  at  37  °C,  while 
CON  represents  <  2  min  Wl  (see  Materials  and  Methods  for  details).  Perfusion  flow 
rate  was  then  measured  in  isolated  kidneys  over  90  min  after  a  period  of  initial 
equilibration.  iCORM-A1,  which  does  not  release  CO,  was  used  as  negative  control. 
Each line represents the mean ± SEM of n=5 for each group.  * P < 0.05 vs. Wl group.
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6.5.2  Effect of Warm Ischaemia of Kidneys in the  Presence of C0RM-A1 
on Urine Flow Rate and Glomerular Filtration Rate at Reperfusion
In  isolated  perfused  kidney,  the  urine flow  rate  (UFR)  and  glomerular filtration 
rate  (GFR)  appeared  to  increase  dramatically  over  the  first  45  min  of 
reperfusion for all groups (Figure 6-2).  Obviously, the one hour warm  ischaemic 
period  significantly  decreased  UFR  (Figure  6-2A,  P <  0.05)  and  GFR  (Figure 
6-2B,  P  <  0.05)  when  compared  to  freshly  harvested  kidneys  (CON).  For 
example,  at  90  min  reperfusion  (T90),  UFR  (pl/min/g)  was  decreased 
significantly  to  280±37  in  Wl  group,  218±56  in  WI+CORM-A1  group  and  to 
265±45  in  WI+iCORM-A1  group  when  compared  to  control  group  (419±43). 
Despite the fact the  UFR in WI+CORM-A1  group was lower than that in Wl and 
WI+iCORM-A1  groups;  the  difference  was  not  statistically  significant  (Figure 
6-2A).  Consequently,  reperfusion  of kidneys  on  the  IPRK circuit  after  1   hr Wl 
resulted in a marked decrease in GFR (Figure 6-2B). At T90, the GFR (pl/min/g) 
was reduced from 550±65 in the control group to 310±58 for kidneys exposed to 
1   hr Wl  alone,  to 276±71  with WI+CORM-A1  and  to 272±34 with WI+iCORM- 
A1. As observed with UFR,  no differences in GFR values were observed among 
the various Wl groups analyzed (Figure 6-2B).
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Figure  6-2:  The  effect  of  CORM-A1  on  urine  flow  rate  and  glomerular filtration 
rate during reperfusion after 1  hr warm ischaemia
Rabbit kidneys were initially flushed with perfusion solution alone or supplemented with 
50  pM  CORM-A1  and  then  subjected  to  a  1   hr warm  ischaemia  (Wl)  at 37  °C,  while 
CON  represents < 2 min Wl  (see Materials and Methods for details).  Urine flow rate (A) 
and  glomerular  filtration  rate  (GFR,  see  graph  B)  were  then  measured  in  isolated 
kidneys  over  90  min  after  a  period  of  initial  equilibration.  iCORM-A1,  which  does  not 
release  CO,  was  used  as  negative  control.  Each  line  represents  the  mean  ±  SEM  of 
n=5 for each group. * P < 0.05 vs. Wl group.
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6.5.3  Effect of Warm Ischaemia of Kidneys in the  Presence of C0RM-A1 
on Tubular Reabsorption at Reperfusion
Using the  isolated  perfused  kidney for the assessment of glucose reabsorption 
(Rglu),  it  was  noted  that  Rglu  decreased  gradually  over  the  whole  perfusion 
period  for  the  freshly  harvested  kidneys  (CON),  which  reabsorb  65.6%  and 
57.6%  of  the  total  glucose  at  TO  and  T90,  respectively.  In  contrast,  kidneys 
exposed to Wl  show an  increase  in  Rglu  in the first 45 min  of reperfusion with 
no further  increase thereafter.  Remarkably,  one  hour of Wl  depressed  Rglu  to 
such  an  extent  that  it  was  significantly  lower  than  that  found  in  the  control 
kidneys  through  out  the  perfusion  (Figure  6-3A,  P  <  0.05).  Comparing 
WI+CORM-A1  group with WI+iCORM-A1  or Wl groups,  the extent of Rglu was 
lower with WI+CORM-A1.  For instance,  Rglu at T90 was 23.4% in WI+CORM- 
A1  group,  33% in WI+iCORM-A1  group and 30%  in Wl group (Figure 6-3A,  P > 
0.05).
Figure 6-3B  shows  the  capacity  of the  isolated  kidneys  to  reabsorb  sodium,  a 
similar  pattern  to  that  described  for  Rglu  was  observed.  In  control  group,  a 
maximum  of 29.6%  of sodium was  reabsorbed  initially (TO)  and this decreased 
throughout  the  perfusion  (21.3%  at  T90).  With  I  hr  Wl,  sodium  reabsorption 
(Rnb)  was  impaired  to  a  significant  levels  with  all  the  Wl  groups  (P  <  0.05). 
However,  no obvious changes were detected among the different Wl groups (P 
> 0.05).
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Figure  6-3:  The  effect  of  CORM-A1  on  tubular  reabsorption  during  reperfusion 
after 1   hr warm ischaemia
Rabbit kidneys were initially flushed with perfusion  solution alone or supplemented with 
50  pM  CORM-A1  and  then  subjected  to  a  1 hr warm  ischaemia  (Wl)  at  37  °C,  while 
CON  represents  <  2  min  Wl  (see  Materials  and  Methods  for  details).  Glucose 
reabsorption  (A)  and  sodium  reabsorption  (B) were then  measured  in  isolated  kidneys 
over  90  min  after  a  period  of  initial  equilibration.  iCORM-A1,  which  does  not  release 
CO,  was  used  as  negative  control.  Each  line  represents  the  mean  ±  SEM  of  n=5 for 
each group. * P < 0.05 vs. Wl group.
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6.5.4  Effect of Warm  Ischaemia of Kidneys  in the  Presence of CORM-A1 
on Mitochondrial Respiration at Reperfusion
In  order  to  assess  the  influence  of  warm  ischaemia  (Wl)  on  mitochondrial 
oxygen  consumption  and  viability,  the  respiration  rate  of isolated  rabbit  kidney 
cortical  mitochondria was measured using glutamate and malate as substrates. 
In  addition,  isolated  kidneys  were  subjected  to  1   hr  Wl  in  the  presence  or 
absence  of CORM-A1  (50  pM) to  investigate any possible  protective effects of 
CO on  mitochondrial function after I hr Wl and 2 hr reperfusion (R).  Noticeably, 
warm  ischaemic injury of the kidney resulted in a predominant decrease of state 
3  respiration  after  1   hr  (Figure  6-4A).  One  hour  of Wl  decreased  state  3  (ng 
Oxygen/min/mg of protein) from 52.1  for control kidneys (0 hr WI/2 hr R) to 23.9 
for  1   hr  Wl/R  (P  <  0.05),  whereas  a  reduction  to  32.7  was  observed  in  the 
presence of CORM-A1  (P < 0.05 vs.  CON).  However,  CORM-A1  appears not to 
affect  state 3  respiration  as compared to Wl  group (P > 0.05).  Interestingly,  no 
differences  in  state 4  respiration were  observed  among  the  various Wl  groups 
as compared  to the  control  group  (Figure 6-4B).  It  is also  remarkable that the 
decrease  in  state  3  resulted  in  a  statistically  significant  depression  of  RCI 
values  after Wl  as  indicated  by  RCI  values  of 2.2  in the Wl  groups,  2.6  in  the 
WI+CORM-A1,  and  2.2  in  the  WI+iCORM-A1  vs.  4.0  in  the  control  group 
(Figure  6-4C).  Nevertheless  and  as  observed  with  state  3  respiration,  no 
differences  in  RCI  values  were  observed  among  the  various  Wl  groups 
analyzed (P > 0.05).
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Figure  6-4:  Effects  of 1  hr warm  ischaemia  of kidneys  in the  presence  of CORM- 
A1  on renal mitochondrial respiration at reperfusion
Kidneys  were  freshly  isolated  (CON)  or  subjected  to  1  h  warm  ischaemia  (Wl)  in  the 
presence  or  absence  of  C0RM-A1  (see  Materials  and  Methods  for  details). 
Mitochondria  were  then  isolated  and  (A)  state  3,  (B)  state  4  and  (C)  the  respiratory 
control  index  (RCI)  were  assessed  in  the  presence  of  malate  and  glutamate  as 
substrates  and  ADP.  iCORM-A1,  which  does  not  release  CO,  was  used  as  negative 
controls.  Each  bar represents the  mean  ± SEM of n=5-6 for each  group.  *P <  0.05 vs. 
control  (CON).
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6.5.5  Effects of Warm Ischaemia of Kidneys in the Presence of C0RM-A1 
on Urinary Release of Gamma-glutamyltransferase at Reperfusion
Table 6-1  shows that  1   hr of Wl had a significant effect on the urinary release of 
gamma-glutamyltransferase  (GGT),  a  marker of renal  tubular  injury.  In  the Wl 
groups,  the  activity  of  GGT  was  severely  increased  to  a  significant  extent 
compared  to  control  group  (P  <  0.05).  Interestingly,  treatment  with  CORM-A1 
(but not  iCORM-A1)  increased  GGT values  at TO and  T45 as compared  to Wl 
group (P >  0.05).  It  is also  notable that  GGT levels were  high at TO for the Wl 
groups and reduced gradually throughout reperfusion.
Table 6-1:  Effect of CO-RMs on urinary gamma-glutamyltransferase (GGT) 
at reperfusion after 1  hr warm ischaemia (Wl)
*^^Perfusion Time 
Group
0 min 45 min 90 min
Control (0 h Wl) 5.0 ±2.1 5.9 ± 1.5 5.7 ±1.5
Warm ischaemia (1  h Wl) 135.8 ±75.4 62.0 ± 26.8* 41.3 ±17.6*
Wl + CORM-A1  (50 pM) 220.2 ±34.1* 115.8 ±27.5* 50.4 ±10.0*
Wl + iCORM-A1  (50 pM) 190.5 ±79.8 52.0 ± 17.8* 50.3 ±14.7*
Isolated  rabbit kidneys were flushed with perfusion  solution  (37 °C)  alone or perfusion 
solution  supplemented  with  CORM-A1  or iCORM-A1.  Kidneys were then  subjected  to 
Wl  at  37  °C  for  1   hr  and  then  reperfused  ex-vivo  as  discussed  in  Materials  and 
Methods.  GGT  levels were  expressed  as  U/l.  Values  are  means  ± SEM,  n=5-6.  *  P < 
0.05 vs.  Control.
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6.5.6  Effects of Warm Ischaemia of Kidneys in the Presence of CORM-A1 
on Urinary Release of Nitrite at Reperfusion
Table 6-2 shows the urinary nitrite levels (pM) in the control and Wl groups over 
90  min  reperfusion  periods  (TO,  T45,  and  T90).  One  hour of renal  Wl  without 
CORM-A1  caused  an  increase  in  urinary  nitrite  at  TO,  T45  and  T90  of 
reperfusion as compared to the control group (P > 0.05).  Interestingly and when 
compared  to the Wl  group,  urinary  nitrite was  reduced  non-significantly  at T45 
and T90 when  CORM-A1  was used  prior to Wl (P > 0.05). The negative control 
was also ineffective in changing the nitrite levels vs. the Wl group.
Table  6-2:  Effect  of CORM-A1  on  urinary  nitrite  at reperfusion  after 1   hr 
warm ischaemia (Wl)
'^ ^ ^ ^ P e rfu s io n  Time 
Group
0 min 45 min 90 min
Control (0 h CS) 1.8 ± 0.5 1.6 ±0.5 1.8 ±0.5
Warm ischaemia (1  h Wl) 2.7 ±0.3 2.5 ±0.5 2.4 ±0.3
Wl + CORM-A1  (50 pM) 2.8 ±0.6 1.8 ±0.3 1.6 ±0.3
Wl + iCORM-A1  (50 pM) 3.1  ±0.6 2.1  ±0.1 2.0 ±0.2
Isolated  rabbit kidneys were flushed with  perfusion  solution  (37 °C)  alone  or perfusion 
solution  supplemented with  CORM-A1  or iCORM-A1.  Kidneys were  then  subjected  to 
Wl  at  37  °C  for  1  hr  and  then  reperfused  ex-vivo  as  discussed  in  Materials  and 
Methods.  Urinary nitrite  levels were expressed as pM.  Values are means ± SEM,  n=5- 
6.
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6.5.7  Effects of Warm Ischaemia of Kidneys in the Presence of C0RM-A1 
on Protein Excretion at Reperfusion
Protein  excretion  was  used  to  evaluate  renal  tubular  injury.  Apparently,  the 
protein  leakage  resulting  from  1   hr  Wl  was  significantly  worse  than  that  of 
control  kidneys  (Table 6-3).  Notably,  no  differences  in  protein  excretion  levels 
were observed among the various Wl groups analyzed.
Table 6-3: Effect of CORM-A1  on protein excretion at reperfusion after 1   hr 
warm ischaemia (Wl)
^ "'""'•■ ‘-^^Perfusion Time 
Group
0 min 45 min 90 min
Control (0 hr) 6.0 ±0.5 5.9 ±0.5 6.2 ±0.4
Warm ischaemia (1  h Wl) 9.6 ±0.8* 9.3 ±0.8* 9.6 ±0.7*
Wl + CORM-A1  (50 pM) 9.6 ±0.5* 9.7 ±0.3* 9.9 ±0.3*
Wl + iCORM-A1  (50 pM) 8.9 ±0.9* 9.2 ±0.7* 9.7 ±0.9*
Isolated  rabbit  kidneys were flushed with  perfusion  solution  (37 °C)  alone or perfusion 
solution  supplemented  with  CORM-A1  or iCORM-A1.  Kidneys were then  subjected  to 
Wl  at  37  °C  for  1  hr  and  then  reperfused  ex-vivo  as  discussed  in  Materials  and 
Methods.  Protein  excretion  in  the  urine  was  expressed  as  %  perfusate  protein 
concentration. Values are means ± SEM,  n=5-6. * P < 0.05 vs.  Control.
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6.6  Discussion
Kidney subjected to a period of warm  ischaemia (Wl) undergoes functional and 
morphological  damage  that  increases  during  the  reperfusion  phase;  this 
damage  is  an  essential  component  in  transplant  kidney  dysfunction.  One 
reason  for the  shortage  of donor  kidneys  is  the  inability to  utilize kidneys  after 
moderate  periods  of  Wl.  Kidneys  with  significant  Wl  more  frequently  have 
delayed  graft function  that  has  been  associated with  a shorter functional  life of 
the  transplant  (Nishikido  et  al.,  2004).  Currently,  most  donor  kidneys  are 
obtained  from  brain-dead  heart-beating  cadavers  and  have  negligible  warm 
ischaemic times.  However,  the  ability to  utilize effectively kidneys damaged  by 
severe Wl could provide increased numbers of kidneys for transplantation. 
Recently,  several  studies  have  been  published  indicating the  protective  role of 
exogenous  CO  at  low  concentration  in  various  models  of  l-R  injury  and  organ 
transplantation  (Nakao  et  al.,  2003a;  Neto  et  al.,  2004).  However,  there  has 
been no report about the importance of CO donors in renal  l-R injury. Thus, we 
conducted this study to investigate the ability of low concentration of exogenous 
CO  released  from  CORM-A1  and  administered  prior  to  1   hr warm  ischaemic 
insult to provide a defence mechanism and beneficial  effects on kidney function 
at  reperfusion.  Subsequently,  this  study  has  shown  that  treatment  of  isolated 
kidneys  with  CO  liberated  from  CORM-A1  prior  to  Wl  significantly  increased 
perfusate  flow  rate  (PFR)  by  using  isolated  perfused  rabbit  kidney  (IPRK) 
model.
A period of 1   hr of Wl caused a profound reduction in PFR, which has improved 
in the  presence  of CORM-A1  particularly during the  last 45 min  of reperfusion. 
This  increase in  PFR is compatible with  previous results from Chapter 4 and 5,
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which  showed  a  marked  increase  in  PFR  at  reperfusion  of freshly  isolated  or 
cold-stored  kidneys  after  treatment  with  CO-RMs.  In  these  Chapters,  the 
beneficial  vascular  effects  mediated  by  CO-RMs  were  lost  in  the  presence  of 
ODQ,  a guanylate cyclase inhibitor;  indicating that CO released from CORM-A1 
induced  its  vasodilatory  effect  via  the  cGMP  pathway.  Nowadays,  it  is  well 
known that  CO  induced  vasorelaxation through  a  mechanism that may  involve 
both  cGMP  pathway  and  Ca2+-activated  K+   channels  (Wang  et al.,  1997).  The 
increase  in  the  perfusate  flow  observed  with  CORM-A1  may  afford  some 
protection  from  hypoxic  renal  injury  and  ischaemia  by  restoring  oxygen 
sufficiency.  In  addition,  restoration  of blood flow to  ischaemic renal tissues can 
result in recovery of cells if they are reversibly injured.
Warm  ischaemic  injury  also  caused  a  significant  reduction  in  urine  flow  rate 
(UFR) and glomerular filtration rate (GFR), which can be due to the reduction in 
PFR  seen  with  Wl.  On  the  other  hand,  the  decrease  in  UFR  and  GFR  with 
CORM-A1  occurred  in  the  absence  of  any  fall  in  the  PFR.  This  may  be 
attributed  to  some  direct  effect  on  the  glomerular  membrane,  resulting  in 
reduced  permeability to fluid  and  to a  redistribution  of the  perfusate flow away 
from  the  glomerular  filtration  channels  which  leads  to  decrease  in  GFR  and 
increase in PFR.
In  IPRK  model,  severe  damage  to  the  active  transport  mechanisms  of  both 
glucose and sodium occurred after 1   hr Wl. After this ischaemic period, which is 
known  to  impair the  viability  and  function  of rabbit  kidneys  (Wusteman,  1977), 
there  were  no  significant  changes  with  CO  released  from  CORM-A1.  In 
addition,  the  activity  of  gamma-glutamyltransferase  (GGT)  was  severely 
increased  to  a  significant  extent  after  the  ischaemic  period.  Interestingly,
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treatment with  CORM-A1  increased  GGT values non-significantly as compared 
to  Wl  group.  Besides,  the  1   hr  Wl  was  sufficient  to  impair  the  ability  of  the 
kidney  to  retain  protein,  which  is  due  to  the  reduction  in  GFR.  However,  no 
further damage was observed with CORM-A1.
Protection  of mitochondrial function will  affect a variety of metabolic processes 
and  is  one  important  aspect  in  a  strategy for  recovering  ischaemic organs for 
transplantation  (Jassem  and  Heaton,  2004).  In this study,  1   hr of Wl  appeared 
to  cause  significant  mitochondrial  dysfunction.  The  results  clearly  show  a 
decreased  active-state  3  respiration  to  be the  main  cause of lower RCI  values 
after  ischaemia.  Nevertheless,  no  significant  changes  were  observed  with 
CORM-A1  indicating no role of CO in salvaging mitochondrial function after 1   hr 
of Wl.
The  results  of  this  study  appear  to  be  surprising:  Why  CO  released  from 
CORM-A1  improved  renal  and  mitochondrial functions after 24  hr cold  storage 
(Chapter 5) but without any observed changes after 1   hr Wl? The mechanism is 
not  clear.  However,  this  period  of  ischaemia  caused  significant  injury  as 
evidenced  by the  low  RCI  values and the  progressively impaired  active tubular 
reabsorption indicating an irreversible damage of mitochondria, which is beyond 
CO  protection.  On  the  other  hand,  the  kinetic  of  CO  release  from  CO-RMs 
under different conditions plays a crucial role in determining and maximizing the 
beneficial effects of these CO carriers.  In fact, CORM-A1  liberates CO in a slow 
fashion  and the rate of CO release is strictly dependent on pH  and temperature 
(Motterlini  et  al.,  2004).  For  instance,  the  half-life  of  CORM-A1  in  phosphate 
buffer at  37  °C  is  approximately 21  min  (Motterlini  et al.,  2004).  However,  the 
rate  of CO  release from  CORM-A1  is significantly decreased and  CO liberated
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more  gradually  during  the  24  h  CS  period  at  4  °C  (Chapter  5,  page  185). 
Therefore,  the  kinetic of CO release from  CORM-A1  in Celsior solution exerted 
a  stronger  pharmacological  activity  that  was  effective  to  provide  sufficient 
protection  after 24 hr CS at 4 °C  but unable to  improve renal function after 1   hr 
of Wl at 37 °C.  Another generally accepted concept is the solubility of the gas in 
the  solution,  as  the  solubility  of  CO  increases  when  the  temperature  of  the 
solution  decreases.  Therefore,  higher  doses  of  CO-RMs  might  be  needed 
during Wl to provide similar protective effects seen with lower doses of CO-RMs 
during cold storage.
In conclusion,  1   hr of Wl caused significant damage to the physiological function 
of kidneys measured by the ex vivo model of IPRK. The presence of CORM-A1 
was  only  beneficial  by  increasing  the  perfusion  flow  rate  at  reperfusion.  This 
finding  can  be  effective  in  providing  sustained  protection from  oxidative  stress 
caused by Wl during subsequent normothermic reperfusion.
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7  The Effect of Carbon Monoxide-Releasing Molecules (CO- 
RMs) on Cold Ischaemia-Reperfusion Injury in Renal 
Tubular Epithelial Cells
7.1  Introduction
Cold ischaemia  is considered the most important factor leading to delayed graft 
function,  which  is  a  major complication  after kidney  transplantation.  This  graft 
injury  during  transplantation  is  predominantly  caused  by  l-R  injury.  Therefore, 
cold ischaemia and subsequent reperfusion are crucial factors for graft outcome 
in  organ  transplantation.  Nevertheless,  preservation  solutions  are  one  of  the 
master  keys  to  improve  the  major  clinical  demands  in  organ  transplantation 
such  as  the  need  for  extended  ischaemia  times,  the  recruitment  of  marginal 
donors,  and  the  economic  aspects  (Janssen  et  al.,  2004).  In  addition, 
preservation  solutions  have  been  designed  to  prevent  ischaemic  injury  and 
hypothermia-induced  ionic  shifts  during  cold  preservation.  During  the  last 
decade, the University of Wisconsin solution (UW) was adopted as the standard 
preservation  solution  for  livers,  kidneys,  and  pancreases  (Muhlbacher  et  al., 
1999).  However,  the  promising  results  of  Celsior  solution  as  a  universal  cold 
storage  solution for intra-thoracic as well  as  intra-abdominal  organs support its 
use  in our study as  a novel  preservation solution for the  kidney  (Marcen et al., 
2005).  Interestingly,  no  data were  shown  comparing  UW and  Celsior solutions 
in renal epithelial tubular cells. Therefore, we used both solutions in this study.
In  order  to  counter  the  damaging  mechanisms  and  ameliorate  the  renal 
ischaemic injury,  the strategy of adding antioxidants to preservation solutions or 
pre-conditioning  the  organs  to  oxidative  stress  to  minimize  cold  preservation-
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induced organ damage was widely used.  Interesting novel approaches involving 
the  participation  of  HO-1  in  reducing  cold  storage  and  reperfusion  injury  have 
been reported  (Salahudeen et al.,  2000).  In this context,  CO donors (CO-RMs) 
were shown to protect against cold  l-R injury in rabbit isolated kidneys (Chapter 
5).  Hence,  it  is  also  worth  to  examine  the  effect  of  CO-RMs  during  cold 
preservation  using  in  vitro  model.  Nowadays,  the  development  of  modern  cell 
culture  technique  has  enabled  us  to  understand  the  mechanism  of  l-R  injury 
using in vitro models.  For instance,  LLC-PK1  is an established cell line derived 
from normal  porcine kidneys that has been widely used to study renal functions 
(Hull et al.,  1976).
7.2  Hypothesis
In  this  study,  we  tested  the  hypothesis  that  CO  released  from  CO-RMs  may 
protects against preservation injury using in vitro model of LLC-PKi cells.
7.3  Objective
•  To evaluate a possible cytotoxic effects of CORM-A1  and CORM-3 and their 
inactive forms on LLC-PKi cells.
•  To  examine  whether  adding  of  CO-RMs  to  the  preservation  solution  will 
attenuate the cold storage injury of renal tubular (LLC-PKi) cells.
•  To  investigate the  mechanism  by which  CO  may  affects  renal  tubular cells 
after cold preservation in the presence of CO-RMs.
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7.4  Materials and Methods
7.4.1  Cell Culture
LLC-PK1  cells,  an  analogue  of  proximal  tubular  epithelial  cells  of  pig  origin, 
were used as a model to examine the effect of CO-RMs on renal cells. Standard 
cell  culture  methods,  previously  reported  in  Chapter 2  in details (Heading 2.5), 
were employed.  For experimental studies, cells were grown to confluence in 24- 
well plates.  Only confluent cell monolayers were used for experiments.
7.4.2  Cytotoxicity Protocol
Cells were grown  in complete Dulbecco’s modified  Eagle’s medium (DMEM)  in 
24 well  plates.  Cells were kept in a cell culture incubator with 5% CO2 and 95% 
air  at  37  °C.  Confluent  monolayers  of  LLC-PK1  cells were  used  on  days  2-3 
after  seeding.  In  each  24-well  plate,  6  wells  were  used  as  control  (medium 
alone).  All  other wells were dispensed with an equal  number of cells  incubated 
for 24 hr with serial dilution of CO-RMs or iCO-RMs ranging from 10 to 1000 pM 
(6 well  per concentration).  The experiments were carried out in  1% fetal  bovine 
serum (FBS) medium for determination of lactate dehydrogenase (LDH).
7.4.3  Cold Storage Protocol
LLC-PKi  cells  were  grown  in  DMEM  to  a  confluent  monolayer  in  24  wells; 
DMEM  was  replaced  with  0.5  ml  of  pre-cooled  preservation  solution  after 
washing the cells twice with Hanks balanced solution. To induce cold ischaemic 
injury,  cells were subjected immediately for 2, 4, 8,  16, and 24 hr of cold storage 
at 4  °C  in  a  cooled  incubator  (Sanyo,  Model  MIR-153)  in  either of two  kidney 
preservation solutions,  UW or Celsior solutions.  Within the incubator, cells were 
placed  in  an  airtight  Plexiglas  chamber  (Billups-Rothenberg,  Del  Mar,  CA).
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Various concentrations of CO-RMs were added to either of the two-preservation 
solution  prior to  cold  storage.  In  another set of experiments  and following cold 
preservation,  cells were transferred to a cell  incubator for 2 hr rewarming at 37 
°C in 95% air 5% CO2 in the same solution.
7.4.4  Cell Viability Assays
A  colorimetric  assay  (Alamar  Blue)  kit  was  used  to  assess  cell  viability  as 
described  before  (Heading  2.5.2).  The  assay  is  based  on  the  detection  of 
metabolic activity of living cells using a redox indicator, which changes from an 
oxidized  (blue) form  to  a  reduced  (red) form.  The  intensity of the  red  colour is 
proportional to the metabolism of the cells, which is calculated as the difference 
in absorbance between 570-600 nm and expressed as a percentage of control.
7.4.5  LDH Release
Lactate  dehydrogenase  (LDH)  was  evaluated  using  the  Cytotoxicity  Detection 
Kits and  assay was  performed according to the  manufacturer’s instruction  (see 
Heading 2.5.3 for details).  At the  indicated times,  the  incubation  medium or the 
preservation solutions were removed and the release of LDH in the supernatant 
was  determined  spectrophotometrically  at  690  nm  wavelength.  Results  were 
presented as percentage of LDH release in the supernatants compared to LDH 
release from cells treated with 1% Triton X-100.
7.5  Statistical Analysis
Statistical  analysis  was  performed  using  one-way  ANOVA  combined  with 
Bonferroni  test or t-test  as  appropriate.  Data were  presented  as  mean  ±  SEM 
and differences were considered to be significant at P < 0.05.
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7.6  Results
7.6.1  Effect of CO-RMs  on  Proximal  Tubular Epithelial  Cell Viability and 
LDH Release
During  drug  development,  it  is  important  to  select  drugs  with  a  sufficient 
therapeutic safety window.  Here, we evaluated any possible cytotoxic effects of 
CORM-A1  and  CORM-3 and their inactive forms  on  LLC-PKi  cells.  Cells were 
exposed to each test compound for 24 hr before taking endpoint measurements 
to  evaluate  membrane  integrity  and  metabolic  activity.  The  dose  dependent 
effects  of CO-RMs  or  iCO-RMs  on  LLC-PKi  LDH  release  and  cell  viability are 
illustrated  in  Figure  7-1  and  Figure  7-2.  In  LLC-PKi  cell,  the  percent  of  LDH 
release for the control group was 9%. This was then increased to 12% with 250 
pM  CORM-A1,  to  15%  at  500  pM  and  to  20%  at  1000  pM  (Figure  7-1 A).  In 
addition,  CORM-A1  caused  a  significant  decrease  in  LLC-PKi  cell  viability  at 
concentrations  between  500  and  1000  pM  (Figure  7-1C)  vs.  control  (0  pM 
CORM-A1).  However,  there were  no  marked  changes in  LDH  release  and  cell 
viability with  10-100 pM CORM-A1  as compared to control.  In contrast,  iCORM- 
A1  induced  cytotoxicity  in  LLC-PKi  at  concentration  of  1000  pM  only  (Figure 
7-1B,  D,  P  <  0.05).  Interestingly,  both  CORM-3  and  iCORM-3  caused  a 
significant increase in LDH release at concentrations between 250 and 1000 pM 
(Figure 7-2A,  B)  and decline in  LLC-PKi  cell viability at concentrations of 1000 
pM (Figure 7-2C,  D) when compared to control cells (0 pM CORM-3).
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Figure  7-1:  Effect  of  CORM-A1  on  proximal  tubular  epithelial  cell  viability  and 
cytotoxicity
Cell  viability  (C  and  D)  and  lactate  dehydrogenase  (LDH)  release  (A  and  B)  were 
assessed  in  proximal  tubular  epithelial  cells  LLC-PKi  after  24  hr  incubation  with 
CORM-A1  or iCORM-A1  (10-1000 pM)  in cell  culture medium.  iCORM-A1, which does 
not  release  CO,  was  used  as  negative  control.  Viability  was  expressed  as  percent  of 
control;  percent  of  LDH  release  was  expressed  as  described  in  the  Materials  and 
Methods  Chapter.  Each  bar represents the  mean ±SEM  of 6 experiments.  *,  P < 0.05, 
**, P < 0.001  compared with control  (0 pM CORM-A1).
2467. EFFECT OF CO-RMs ON l-R INURY IN RENAL CELLS
CORM-3
CON  10  50  100  250  500  1000
[pM]
120
>»  100
<D
80
60
6  40
20
CORM-3
CON  10  50  100  250  500  1000
[pM]
iCORM-3
2  15
CON  10  50  100  250  500  1000
[pM]
120 
>»  100
re
a )
80
60
6  40 
20
iCORM-3
CON  10  50  100  250  500  1000
[pM]
Figure  7-2:  Effect  of  CORM-3  on  proximal  tubular  epithelial  cell  viability  and 
cytotoxicity
Cell  viability  (C  and  D)  and  lactate  dehydrogenase  (LDH)  release  (A  and  B)  were 
assessed  in  proximal  tubular  epithelial  cells  LLC-PK-i  after  24  hr  incubation  with 
CORM-3  or iCORM-3  (10-1000  pM)  in  cell  culture  medium.  iCORM-3,  which  does not 
release  CO,  was  used  as  negative  control.  Viability  was  expressed  as  percent  of 
control;  percent  of  LDH  release  was  expressed  as  described  in  the  Materials  and 
Methods  Chapter.  Each  bar represents the  mean ±SEM  of 6 experiments.  *,  P <  0.05, 
**, P < 0.001  compared with control  (0 pM CORM-3).
247tJCL 7. EFFECT OF CO-RMs ON l-R INURY IN RENAL CELLS
7.6.2  Time  Course  of  Cold-Storage  Induced  Injury  of  Proximal  Tubular 
Epithelial Cells
This  study  aimed  to  evaluate  cold-induced  injury  in  LLC-PKi  cells  in  various 
preservation  solutions.  Both  membrane  integrity  and  metabolic  activity,  as 
determined by the LDH release and Alamar Blue assay, were measured (Figure 
7-3A,  B).  Cells  were  incubated  at  4  °C  over  a  period  of 2  to  24  hr  in  culture 
medium (DMEM),  Celsior, and UW solutions and compared to cells incubated at 
37 °C  in  culture  medium  (control)  at each time  point.  Incubation  of LLC-PKi  in 
cell culture medium,  Celsior,  and UW solutions for 2 and 4 hr at 4 °C caused no 
changes  in  LDH  release and cell  metabolism  as compared with control  (Figure 
7-3A,  B).  However,  8  hr warm  incubation  resulted  in  4.9  %  LDH  release;  this 
increased  significantly to  18.4% and  13.4%  after 8 hr cold incubation in Celsior 
and DMEM,  respectively (Figure 7-3A).  In contrast, the increase in LDH release 
with  UW solution  was  only  9.1%  (P  <  0.05).  In  a  similar  manner,  cell  viability 
also  markedly  decreased  in  Celsior  and  DMEM  and  without  any  significant 
changes  in  UW  solution.  Additionally,  cultured  LLC-PI^  cells  showed  marked 
injury  after  16  hr of  cold  incubation  (73%,  55.3%,  and  64.8%  of  LDH  release 
and  44%,  81.3%,  and  55.3%  of  viable  cells  in  Celsior,  UW,  and  DMEM, 
respectively). This injury was further aggravated after 24 hr cold incubation and 
resulted  in  almost  maximum  release  of  LDH  (97.4%  in  Celsior,  86.4%  in  UW, 
and  93.6  in  DMEM)  and  severe  reduction  in  cell  viability  (10.2%  in  Celsior, 
36.2%  in  UW,  and  12.8%  in  DMEM).  Notably,  cold-induced  injury  between  8 
and 24 hr was different between the solutions used. Cell injury was higher in the 
Celsior solution, followed by DMEM and UW solution,  respectively.
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Figure 7-3:  Cold induced injury in proximal tubular epithelial (LLC-PKt) cells
LLC-PKi  cells  were  cold-stored  at  4  °C  in  cell  culture  medium  (DMEM),  Celsior  and 
University  of Wisconsin  (UW)  solution  over a  period  of 2  to  24  hr,  control  represents 
cells  incubated  in  DMEM  at  37  °C.  Cell  injury  was  measured  by  (A)  lactate 
dehydrogenase  (LDH)  release  and  (B)  viability  assay  using  a  colorimetric  assay  kit 
according to the manufacturer’s instructions (see the Materials and Methods).  Each bar 
represents the mean ±SEM of 8 experiments. * P < 0.05, **P < 0.001  vs. control.
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7.6.3  Effects of CO-RMs on Cold Storage-Induced Injury
Cellular injury was assessed by LDH release and Alamar Blue assay.  Because 
of  earlier  study  in  this  Chapter  indicating  the  cytotoxicity  of  CO-RMs  on  LLC- 
PKI,  a  concentration  range  of  10  to  100  pM  was  chosen  for  this  study.  In 
addition,  as 2  and 4 hr cold  incubation  produced  no significant injury,  while 24 
hr  caused  severe  injury.  Therefore,  in  all  subsequent  experiments,  cell  injury 
was assessed after 8 and  16 hr of cold incubation with or without CO-RMs (10- 
100  pM)  in  both  the  UW  and  Celsior  solutions.  Interestingly,  treatment  with 
either  CORM-A1  or  CORM-3  significantly  reduced  cold-induced  cell  injury  in 
either preservation solution. The results for 8 hr are presented in Figure 7-4 and 
Figure  7-5,  which  show  a  significant  reduction  of  cell  injury,  as  assessed  by 
LDH  release,  with  both  CO-RMs  as  compared to  0  pM  CO-RMs  (Figure 7-4A, 
B).  For instance,  8 hr cold incubation in Celsior resulted in 20.3%  LDH  release; 
this was significantly decreased with CORM-A1  to  10.3% at 50 pM and 6.4% at 
100  pM  (Figure  7-4A).  Similar  results were  observed  with  CORM-3  in  Celsior 
(Figure  7-4B).  However,  incubation  with  UW  solution  was  more  protective  to 
cells  as  noticed  before.  When  compared  with  0  pM  CORM-3  (9.6%),  LDH 
release  was  significantly  decreased  with  CORM-3  to  5.4%  at  100  pM  (Figure 
7-4D).  In contrast,  no significant changes were observed with CORM-A1  in  UW 
solution  (Figure  7-4C).  Notably,  no  differences  in  cell  viability  were  observed 
among  the  various  cold-preserved  groups  analyzed  as  compared  with  0  pM 
CO-RMs (Figure 7-5).
As  shown  in  Figure  7-6  and  Figure  7-7,  16  hr  CS  produced  more  damage  to 
LLC-PKi  cells.  Notably,  over  the  concentration  range  studied,  there  was  no 
significant  protection  with  CO-RMs  after  16  hr  of  cold  storage  in  Celsior  as
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assessed by LDH release (Figure 7-6A,  B) and cell viability assay (Figure 7-7A, 
B).  Nevertheless,  significant inhibition of the LDH release was obtained with 100 
|jM CO-RMs in UW solution as compared to 0 pM CO-RMs (Figure 7-6C,  D).  In 
addition,  CORM-3 caused a significant increase  in  LLC-PKi  cell viability in  UW 
solution  vs.  control  (0  pM  CORM-3).  In  the  presence  of CORM-3,  cell  viability 
increased from 61% for control to 82% at 10 pM, 89% at 50 pM and 98% at 100 
pM  (Figure  7-7D,  P <  0.05).  Interestingly,  no  obvious  changes were  observed 
with  100 pM iCO-RMs as compared to 0 pM CO-RMs.
2517. EFFECT OF CO-RMs ON l-R INURY IN RENAL CELLS
25
20
0)
(/)
ro
d)
15
0)
on 10
X
Q
_ l 5
n i r
z
O
o
E
re
5
an
o
o
s o
o
Celsior
an
O o
a n
O o
O '
O o
25
^  20 
0 ) < /)  A  C
rj  15  fl)
0 ) on  10
o 0
E
1
o c
o o
an
o o
UW
All
an
o o
o u >
an
O o
an
O o
o
o
B D
25
Sv  20 
0 )
re  15 
a >
O '  10
0
Celsior
25
^  20 
0 )
IS  15  0 )
0 )
a:  10
i
a  c
o
z *? *? •? » ? « ? z *? o Z z Z Z O s o an an an an an O an
E O O o o O E O k . o o o o o c re o
5 z a. z = L z a. z
a. z 3. 5 z
a.
o O o o o V O o O
o
Q C
o O
UW
l i l
an
o
o
an
o o
o :
o
o
Figure  7-4:  Protection  from  8  hr of cold-induced  injury  in  LLC-PKi  cells  by  CO- 
RMs using LDH release
LLC-PKt   cells were cold-stored at 4 °C in Celsior (A,  B) and UW (C,  D) solutions for 8 
hr  in  the  presence  of  0  to  100  pM  of  CORM-A1  (A,  C)  and  CORM-3  (B,  D),  warm 
control  represents  cells  incubated  in  regular medium  (DMEM)  at 37 °C for 8  hr.  Cell 
injury was  measured  by lactate dehydrogenase (LDH)  release (see the Materials and 
Methods).  iCO-RMs, which do not release CO, was used as negative control. Each bar 
represents the mean ±SEM of 6 experiments. *P < 0.05 vs. 0 pM CO-RMs.
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Figure 7-5:  Effect of CO-RMs on  proximal tubular epithelial cell viability after 8 hr 
of cold-induced injury
LLC-PKt   cells were cold-stored at 4 °C in Celsior (A,  B) and UW (C,  D) solutions for 8 
hr  in  the  presence  of  0  to  100  pM  of  CORM-A1  (A,  C)  and  CORM-3  (B,  D),  warm 
control  represents  cells  incubated  in  regular medium  (DMEM)  at 37 °C for 8  hr.  Cell 
injury was  measured  by viability assay using a colorimetric assay kit according to the 
manufacturer’s  instructions (see the Materials and  Methods).  iCO-RMs, which do not 
release CO,  was used as negative control.  Each bar represents the mean ±SEM of 6 
experiments.
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Figure  7-6:  Protection from  16  hr of cold-induced  injury  in  LLC-P^  cells  by CO- 
RMs using LDH release
LLC-PKi cells were cold-stored at 4 °C in Celsior (A,  B) and UW (C,  D) solutions for 16 
hr  in  the  presence  of  0  to  100  pM  of  CORM-A1  (A,  C)  and  CORM-3  (B,  D),  warm 
control  represents cells  incubated  in  regular medium  (DMEM)  at 37 °C for 16 hr.  Cell 
injury was  measured  by lactate dehydrogenase (LDH)  release (see the Materials and 
Methods). iCO-RMs, which do not release CO, was used as negative control. Each bar 
represents the mean ±SEM of 6 experiments. *P < 0.05 vs. 0 pM CO-RMs.
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Figure  7-7:  Effect  of CO-RMs  on  proximal tubular epithelial  cell  viability  after  16 
hr of cold-induced injury
LLC-PKi  cells were cold-stored at 4 °C in Celsior (A,  B) and  UW (C,  D) solutions for 16 
hr  in  the  presence  of  0  to  100  pM  of  CORM-A1  (A,  C)  and  CORM-3  (B,  D),  warm 
control  represents  cells  incubated  in  regular medium  (DMEM)  at 37  °C  for  16  hr.  Cell 
injury was  measured  by  viability  assay  using  a  colorimetric assay  kit according  to  the 
manufacturer’s  instructions  (see  the  Materials  and  Methods).  iCO-RMs,  which  do  not 
release  CO,  was  used  as  negative  control.  Each  bar represents  the  mean  ±SEM  of 6 
experiments. *P < 0.05 vs. 0  pM CO-RMs.
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7.6.4  Influence  of  Rewarming  Time  on  the Cold-Protective  Effect of CO- 
RMs
After  demonstrating  protective  effects  of  CO-RMs  after  8  and  16  hr  cold 
storage,  it seemed  important to observe if these cytoprotective effects could be 
sustained  during  rewarming  periods.  Therefore,  LLC-PKi  cells were  incubated 
with  CO-RMs  for  8  and  16  hr  cold  storage  (CS)  at  4  °C  in  the  preservation 
solutions followed  by 2  hr rewarming  in  the  same  solution  at 37 °C  in  95%  air 
5%  CO2.  Interestingly,  both  CORM-A1  and  CORM-3  decreased  cell  injury  as 
evaluated  by LDH  release in a concentration-dependent manner if compared to 
0  pM  CO-RMs  (Figure  7-8).  For  example,  Figure  7-8A  shows  that  in  the 
absence  of  CS,  LDH  release was  5%,  8  hr  CS  followed  by 2  hr rewarming  in 
Celsior increased LDH release significantly to 28.1%.  Incubation with CORM-A1 
reduced LDH  release to 17.5,  14.2 and  11.2 at 10,  50 and  100 pM,  respectively 
(P < 0.05).  Similarly,  8 hr CS/2 hr rewarming in UW solution caused a significant 
decrease  in  LDH  release  from  14.5%  at  0  pM  CORM-3  to  6.8%  at  100  pM 
CORM-3 (Figure 7-8B). Additionally,  16 hr CS/2 hr rewarming with CORM-A1  in 
UW  solution  reduced  LDH  release  from  79.4%  at  0  pM  to  74.4%,  48.8%  and
35.1  at  10,  50  and  100  pM,  respectively  (Figure  7-8C).  Whereas  cells  treated 
with  CORM-3  in  UW solution  showed  less  protection  than  CORM-A1,  as  LDH 
release  with  CORM-3  was  reduced  from  92.9%  at  0  pM  to  86.2%,  78%  and 
65%  at  10,  50  and  100  pM,  respectively (Figure 7-8D).  The  negative controls 
(iCO-RMs) did not cause significant differences in LDH release when compared 
to  0  pM  CO-RMs.  Interestingly,  CORM-3  caused  a  significant  increase  in  cell 
viability in  UW solution as compared to 0 pM  CORM-3 (P < 0.05,  Figure 7-9D), 
while no significant changes were observed with CORM-A1.
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Figure  7-8:  Effect  of  rewarming  on  CO-RMs-induced  protection from  cold  injury 
in LLC-PKi cells using LDH release
LLC-PKi  cells were  cold-stored  at 4 °C in Celsior (A)  and  UW (B,  C,  D)  solutions for 8 
or  16  hr  in  the  presence  of  0  to  100  pM  of  CORM-A1  (A,  C)  and  CORM-3  (B,  D) 
followed  by  rewarming  in  the  same  solution  for  2  hr,  warm  control  represents  cells 
incubated  in  regular  medium  (DMEM)  at  37  °C  for  10  or  18  hr.  Cell  injury  was 
measured  by  lactate  dehydrogenase  (LDH)  release  (see  the  Materials  and  Methods). 
iCO-RMs, which do not release CO, was used as negative control.  Each bar represents 
the mean ±SEM of 6 experiments. *P < 0.05 vs. 0 pM CO-RMs.
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Figure  7-9:  Effect  of  rewarming  on  CO-RMs-induced  protection  from  cold  injury 
in LLC-PKi cells using cell viability
LLC-PKi  cells were  cold-stored  at 4 °C  in  Celsior (A)  and  UW (B,  C,  D)  solutions for 8 
or  16  hr  in  the  presence  of  0  to  100  pM  of  CORM-A1  (A,  C)  and  CORM-3  (B,  D) 
followed  by  rewarming  in  the  same  solution  for  2  hr,  warm  control  represents  cells 
incubated  in  regular  medium  (DMEM)  at  37  °C  for  10  or  18  hr.  Cell  injury  was 
measured  by  viability  assay  using  a  colorimetric  assay  kit  according  to  the 
manufacturer’s  instructions  (see  the  Materials  and  Methods).  iCO-RMs,  which  do  not 
release  CO,  was  used  as  negative  control.  Each  bar  represents  the  mean  ±SEM  of 6 
experiments. *P < 0.05 vs. 0 pM CO-RMs.
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7.6.5  Effect  of  Potassium  Channel  Inhibitor  (Glibenclamide)  on  Cold- 
Protective Effect of CO-RMs in LLC-PKi Cells
To determine whether the observed protective effect with CO-RMs against cold- 
induced  injury  were  mediated  by  a  K+   channels  dependent  mechanism,  we 
measured  LDH  release  in  the  presence  of  glibenclamide,  K+   channel  blocker. 
Glibenclamide  was  added  to  the  UW  solution  (4  °C)  in  combination  with  CO- 
RMs for 16 hr cold storage (CS) and 2 hr rewarming.  As shown in Figure 7-10, 
16 hr CS/2  hr rewarming  in  UW solution reduced  LDH release from 78.3% at 0 
pM to 26.9% with  100  pM  CORM-A1  (Figure 7-10A)  and from 67.6% to 49.6% 
at  100  pM  CORM-3  (Figure 7-10B).  The combination  of glibenclamide  (50  pM) 
with  CORM-A1  or  CORM-3  does  not  prevent  the  decrease  in  LDH  release 
during the cold preservation and rewarming.
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Figure 7-10:  Effect of glibenclamide,  a  K+  channel  inhibitor,  on  CO-RMs-induced 
protection from cold injury in LLC-P^ cells
LLC-PKi  cells were  cold-stored  at 4 °C  in the  UW solution for  16  hr in the presence of 
100  pM of CORM-A1  (A) and CORM-3 (B) followed  by rewarming  in the same solution 
for 2 hr.  Glibenclamide (50 pM) was added to the UW solution  in combination with CO- 
RMs.  Warm  control  represents cells incubated  in regular medium  (DMEM) at 37 °C for 
18  hr.  Cell  injury  was  measured  by  lactate  dehydrogenase  (LDH)  release  (see  the 
Materials  and  Methods).  iCO-RMs,  which  do  not  release  CO,  was  used  as  negative 
control.  Each bar represents the mean ±SEM of 6 experiments.  *P < 0.05 vs. 0 pM CO- 
RMs (cold control).
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7.7  Discussion
In the  present study,  we  evaluated  any  possible cytotoxic effects  of CORM-A1 
and CORM-3 and their inactive forms to kidney (LLC-PKi) cells. The study also 
aimed  to  assess  the  effects  of  two  clinically  used  preservation  solutions,  i.e., 
UW and  Celsior solutions  on  cold  induced  injury of  LLC-PKi  cells.  In  addition, 
we  confirmed  the  central  role  of  CO-RMs  in  this  injury.  Furthermore,  we 
assessed  any  possible  role  of  potassium  channels  in  this  injury.  Both 
membrane  integrity  and  metabolic  activity,  as  determined  by the  LDH  release 
and Alamar Blue assay, were measured to evaluate cell injury.
During  drug discovery,  assessment of renal safety for a compound  is important 
for further development of a candidate drug.  LLC-PKi  is an established cell line 
derived  from  normal  porcine  kidneys that  has  been widely  used  to  study renal 
functions  (Hull  et  al.,  1976).  This  cell  line  has  been  used  to  study  the 
nephrotoxicity of a  number of compounds  and  demonstrated the  usefulness of 
kidney cell systems in studying chemical effects on renal functions (Ayala-Fierro 
and  Carter,  2000;  Li  et al.,  2003).  However,  it  is  believed that chemical  effects 
on  cells  of  human  origin  will  provide  optimal  predictive  information  for  human 
kidney function.  Nevertheless,  it is  uncertain whether findings  in  LLC-PKi  cells 
are different to those of human cells due to possible inter-species variations (Li 
et al.,  2003).  In this  study,  both  CORM-A1  and  CORM-3 caused significant cell 
damage between 250 and  1000 pM. Therefore,  the effects of CO-RMs on cold- 
induced  injury were examined  covering  a concentration  range of 10 to  100  pM 
as these concentrations was proven to be within the safety window.  In addition, 
these  concentrations  of  CO-RMs  used  on  normal  porcine  LLC-PK1  cells  are 
consistent  with  the  range  of  concentration  in  isolated  rat  mitochondria  and
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isolated  perfused  rabbit  kidney.  Several  possibilities  may  exist  to  explain  why 
CO  released  from  CO-RMs  was  found  to  be  cytotoxic  in  LLC-PKi  cells  at 
concentration  between  250  and  1000  pM.  Of  these,  CO  may  inhibit 
mitochondrial  respiration  and  oxidative  phosphorylation  by  direct  effect  on 
cytochrome  c oxidase,  it is  speculated  that measurements  of cytotoxicity were 
based  on  the  knowledge  that ATP  is  present  in  the  metabolically  active  LLC- 
PKi  cells  and  that  alteration  in  membrane  integrity,  mitochondrial function  and 
metabolic activity will  affect ATP  levels.  As  such,  a  reduction  in cellular ATP  is 
indicative of a cytotoxic effect (Li et al., 2003).
Kidney  preservation  can  be  improved  in  two  major  ways:  (1)  by  limiting  cold 
ischaemic  injury  during  Cold  storage  (CS),  and  (2)  by  protecting  organs  from 
the  aggression  of  the  initial  reperfusion.  Preservation  solutions  have  been 
designed  to  prevent  ischaemic  injury  during  cold  preservation.  In  this  context, 
cell  culture  models  could  be  an  important  source  to  evaluate  further  specific 
effects  of  preservation  solutions  to  different  cell  types  (Wilson  et  al.,  2004). 
However,  data analyzing Celsior and UW in a cell culture model of renal tubular 
epithelial cells (LLC-PKi) is still lacking. Therefore,  our study compared the LDH 
release and cell  viability in culture medium (DMEM),  Celsior,  and  UW solutions. 
Overall,  our cell culture model results reveal the order of effectiveness to protect 
LLC-PKi  cells  against  preservation  injury  as  follow:  UW  >  DMEM  >  Celsior. 
Since the clinical  introduction of Celsior in thoracic organ transplantation (Llosa 
et al.,  2000;  Xiong et al.,  1999),  several studies have examined this solution for 
the  preservation  of the  liver,  kidney,  pancreas  and  intestine of various species 
(Baldan  et  al.,  1997;  Boggi  et al.,  2005;  Cavallari et al.,  2003;  deRoover et al., 
2004).  Our  results  are  in  accordance  with  data  from  previous  study  which
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proved  the  superiority  of  UW  to  Celsior  in  the  protection  of  human  liver 
endothelial  cells  against  preservation  injury  as  measured  by  LDH  release, 
intracellular  ATP  level,  and  MTT  reduction  from  ischaemia  and  reperfusion 
(Janssen  et  al.,  2004).  However,  Celsior  has  also  been  used  for  kidney 
preservation  and  transplantation,  and  showed  an  equal  or superior efficacy to 
that of UW in experimental and clinical fields (Baldan et al.,  1997;  Faenza et al., 
2001;  Mohara et al.,  1999);(Montalti et al., 2005).
In the present study, we tested the possible cytoprotective effect of CO released 
from  CO-RMs during  CS on cold-induced renal  injury.  The results demonstrate 
that  CO-RMs  were  effective  to  ameliorate  renal  injury  in  LLC-PKi  cells  as 
evidence  by  reduction  of  LDH  release and  improved  cells  viability.  In  addition, 
inactive  compounds  (iCO-RMs),  which  do  not  liberate  CO,  failed  to  prevent 
renal  injury  suggesting  that  CO  is  directly  involved  in  protection  against  renal 
cell  injury.  Surprisingly,  no  reported  studies  on  the  effect  of  CO  on  LLC-PKi 
cells or the effect of CO on cold  storage in cell  culture model  have so far been 
published.  However,  several  studies  showing  the  ability  of CO  gas  and  HO-1- 
derived  CO  to  confer  significant  protection  against  renal  cold  ischaemia  and 
reperfusion  damage  in  various  in  vivo  models  have  been  published.  For 
instance,  kidney  grafts  preserved  in  UW  solution  at  4  °C  for  24  hr  and 
orthotopically  transplanted  into  syngeneic  rats  previously  treated  with  CO  gas 
displayed  an  increased  renal  cortical  blood  flow  and  was  accompanied  by 
enhanced serum creatinine clearance and improved animal survival (Neto et al., 
2004).  In  addition,  treatment  of  organ  donors  and  long-term  recipients  with 
methylene  chloride,  a  CO-generating  chemical,  ameliorated  renal  function  and 
reduced  histological  signs  of  deterioration  in  a  rat  model  of  kidney  allograft
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rejection  (Martins  et  al.,  2005).  Similarly,  induction  of  HO-1  preserved  kidney 
graft function and prevented post-reperfusion apoptosis after cold ischaemia, an 
effect that was  completely  reversed  by  inhibition of  HO  activity (Wagner et al., 
2003).  As  a  supportive  study  from  cell  culture  model,  salahudeen  and 
colleagues  demonstrated for the first time that  HO-1  over-expression  either by 
haemin  induction or by gene-transfer is associated with reduced proximal  renal 
tubular cell injury during cold storage (Salahudeen et al., 2001).
In  our  experiments,  the  reduction  of  LDH  release was  greater with  CORM-A1 
than  with  CORM-3.  In  addition,  we  had  better  inhibition  of  cold-induced  cell 
injury  by  LDH  release  with  UW  solution  than  with  Celsior.  These  findings 
indicate that the extent of protection by CO-RMs is dependent on the rate of CO 
release  in the  preservation  solution  and the  level  of cold  associated cell  injury, 
as  minimum  protection  have  been  conferred  with  minor  injury  as  well  as  with 
severe damage.  All  the same,  these results from the cell culture model  support 
the  protective  findings  of  CO-RMs  in  the  ex  vivo  model  of  IPRK  (Chapter  5). 
However,  in  vivo  studies  will  be  needed  to  verify  the  in  vitro  and  the  ex  vivo 
findings with whole kidneys in renal transplant models.  Nonetheless, these data 
was not sufficient in order comprehensively to evaluate the mechanism involved 
in CO protection against cold cellular injury.  Here, the observed protective effect 
with  CO-RMs  against  cold-induced  injury was  not  mediated  by  a  K+   channels 
dependent  mechanism.  However,  there  may  be  other  mechanisms  and 
explanations by which CO exerts its beneficial effects.  Of these,  Ca+  influx, free 
radical  formation,  cell  necrosis,  and  cell  proliferation  could  be  some  of  the 
pathways that CO may afford the cytoprotective effects.  So, further work will be 
needed to investigate these possible mechanisms of action.
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In  conclusion,  these data indicate that CO-RMs  is not directly toxic to LLC-PKi 
cells  between  10 and  100 pM.  Furthermore,  the study proves the superiority of 
UW  solution  to  Celsior  in  the  protection  of  LLC-PKi  cells  against  preservation 
injury  as  measured  by  LDH  release,  and  cell  viability.  In  addition,  the  results 
confirm for the first time that CO-RMs is associated with reduced LLC-PKi  cells 
injury during  CS  alone or followed  by rewarming  and  is directly correlated with 
CO  release from  CO-RMs.  Thus,  CO-RMs are effective therapeutic agents that 
can be used to ameliorate renal  injury that affect kidney function. These results 
strongly suggest that CO-RMs has a cytoprotective effect and may therefore be 
useful  for  kidney  preservation.  These  preliminary  findings  could  be  important 
and require confirmation in an auto-transplantation model.
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8  GENERAL DISCUSSION
8.1  Analysis of Methodology
8.1.1  Isolated Renal Mitochondria and Oxygen Consumption Studies
Isolated  mitochondria  are  of  great  significance  for  measurement  of 
mitochondrial  respiratory  rates  that  are widely  used  to  assess the functionality 
and  purity of mitochondria  by means  of specific substrates or by inhibitors that 
block portions  on  the respiratory chain (CHANCE  and WILLIAMS,  1956).  Their 
use  followed  the  improvements  in  centrifuge  technology  in  1940s,  and 
mitochondrial  experimental  work  accelerated  with  the  introduction  of  oxygen 
electrode technique by Chance and Williams in 1955 (CHANCE and WILLIAMS, 
1956).  A  great  deal  of  our  knowledge  of  electron  transport  in  mitochondria 
comes  from  oxygen  electron  recording  which  represents  a  powerful  tool  to 
characterize  the  respiratory  mitochondrial  function  in  mitochondria  isolated 
from tissues or cells  (Barrientos,  2002).  The experimental  model enables us to 
measure  substrate-stimulated  oxygen  consumption  as  an  indicator  of 
mitochondrial  function.  Furthermore,  it  helps  to  identify  the  site  of  action  and 
toxicity  of  certain  chemicals  and  drugs  on  the  respiratory  chain  (Wallace  and 
Starkov,  2000).  Isolated  mitochondria  are  a  useful  tool  to  investigate  specific 
mechanisms underlying mitochondrial dysfunction and contribute significantly to 
our  understanding  of  pathological  events  such  as  l-R  injury  (Jassem  et  al., 
2002).  It  is  also  useful  to  measure  mitochondrial  swelling,  mitochondrial 
permeability  transition  pore,  and  ATP  production.  In  addition  to  polarographic 
studies  of  oxygen  consumption,  spectrophotometric  analyses  of  the 
mitochondrial  respiratory chain enzymes are also a useful tool for mitochondrial
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function,  but these require additional equipment and time, which prevented their 
study in this Thesis.
The  described  method  (Chapter  2)  for  measuring  oxygen  utilization  is  rapid, 
convenient,  and  simple.  Even  so,  a  number of precautions  must  be observed. 
The rate of oxygen diffusion to the cathode of the monitoring electrode depends 
on  the  oxygen  concentration  in  the  main  incubation  chamber.  It  also  depends 
on  several  other  factors  that  must  be  controlled:  temperature,  membrane 
thickness  and  permeability,  and  stirring  speed.  There  is  no  intrinsic calibration 
of  an  oxygen  electrode  (Barrientos,  2002).  At  regular  intervals,  or  if  the 
instrument  is  disassembled,  it  must  be  recalibrated  with  a  reducing  agent 
(sodium  dithionite)  against  a  known  standard  (air),  as  the  maintenance  and 
calibration  of  the  polarograph  unit  is  also  essential  to  obtain  reproducible 
results.  Special  precaution  must  be  used  when  studying  the  influence  of 
inhibitors  dissolved  in  organic  solvents  which  often  give  artificial  responses. 
Therefore,  the  electrode  should  be  clean  and  free  of  oxidized  material.  In 
addition,  the  accuracy  and  reproducibility  of  polarographic  studies  in  isolated 
mitochondria  greatly  depend  on  the  quality  of  the  preparation.  Therefore, 
mitochondrial  samples  used  for  those  studies  must  be  isolated  immediately 
before assays.  Substrate oxidation should be followed in the presence (state 3) 
and absence of ADP (state 4).
8.1.2  Isolated Perfused Rabbit Kidney Model
Rabbits  proved to be a reliable model for renal  preservation studies,  as  rabbits 
are a robust,  healthy animal,  inexpensive, and rabbit kidney is a convenient size 
for  biochemical  study  (Fuller et  al.,  1977).  The  isolated  perfused  rabbit  kidney 
has  become  recognized  as  a  suitable  preparation  for  the  study  of
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haemodynamic,  biochemical  and  physiological  aspects  of the  kidney  (Kuzu  et 
al.,  1995; Watanabe et al.,  1987).  The advantages of the model are numerous; 
it  is  relatively  simple  technique,  which  allows  the  accurate  control  of  regional 
haemodynamic variables such as perfusion  pressure and flow intensity as well 
as the  elimination  of neurohumoral  and  blood  cell  influences  on renal function. 
It  resembles  the  in  vivo  situation  better  than  do  methods  of  tissue  slices 
procedures  and  therefore  can  be  considered  as  adequate  substitute  for 
transplantation  during the initial stages in the development of new preservation 
techniques  (Wusteman,  1977).  Furthermore,  it  has  been  shown  to  be 
discriminating  and  allows  the  measurements  of  several  renal  parameters  at 
once.  A  closed  circuit  mode  in  which  the  perfusate  solution  recirculates 
continuously through the kidney makes it cheaper than a single-pass perfusion. 
Therefore,  this  model  enables  reducing  the  time  and  expenses  involved  in 
transplantation  to  a  minimum.  In fact,  the  system  has  already  been  used to  in 
various  models  of  l-R  injury  in  various  organs  and  animals  (Adin  et  al.,  2004; 
Amersi et al., 2002;  Hauet et al.,  1997).
An appropriate composition of the artificial perfusate is of critical  importance for 
stable functioning isolated kidneys,  Krebs-bicarbonate buffer containing glucose 
as  substrate  and  macromolecule as  an  oncotic agent  is widely  used.  By using 
this model,  it has been shown that the GFR is close to the physiological normal, 
and although the reabsorption of water,  Na+,  and glucose is impaired and there 
is  significant  protein  leakage,  the  performance  is  reproducible  (Fuller  et  al., 
1977).  Interestingly,  the tubular reabsorption of sodium  is clearly the best index 
of ischaemic damage (Gregg et al.,  1986). Additionally, after ischaemic periods, 
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leakage of protein into the urine.  Since this function does not rely on any active 
process within the kidney, it is possible that protein retention could be used as a 
viability  assay  in  kidneys  that  are  being  preserved  for  human  transplantation 
purposes  by  hypothermic  perfusion.  However,  changes  in  renal  vascular 
resistance  are  difficult  to  assess  in  the  absence  of  preconstriction  as  the 
isolated  perfused  rat kidney model  is near maximally vasodilated under normal 
perfusion conditions (Maack,  1980).
In conclusion,  the isolated perfused kidney, which represents the renal vascular 
function  as  a  whole,  is  classically  used  in  the  field  of  vascular  research  to 
investigate  renal  vascular  reactivity  in  physiological  situations  as  well  as  in 
different  disease  states.  The  usefulness  of  this  preparation  has  been  widely 
demonstrated  in the study of different physiological and biochemical aspects of 
renal function (Fuller et al.,  1977).
8.1.3  Cell Culture
In  vitro  cell  culture  systems  have  proven  useful  for toxicity  prediction  of target 
organs on drugs (Davila et al.,  1998).  Renal tubular cells isolated from  humans 
and  animals  can  serve  as  useful  tools  for  assessing  the  biochemical  and 
physiological functions of the kidney (Li et al., 2003).  LLC-PKi  is an established 
cell line derived from normal porcine kidneys that has been widely used to study 
renal  functions  (Hull  et  al.,  1976).  Studies  indicate  that  LLC-PKi  cells  retain 
many  properties  of  native  proximal  tubular epithelial  cells  (Grundemann  et  al., 
1997)  and  have  been  used  to  study  the  nephrotoxicity  of  a  number  of  drugs 
(Nascimento  et  al.,  2005;  Okuda  et  al.,  2000;  van  der  Harst  et  al.,  2005). 
However,  it  is  believed  that  chemical  effects  on  cells  of  human  origin  will 
provide  optimal  predictive  information  for  human  kidney  function  (Li  et  al.,
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2003).  Only  sparse  reports  have  studied  chemical  effects  on  human  primary 
proximal  tubule  cells  (Hughes  et  al.,  1998;  Johnson  et  al.,  2000).  So  far,  the 
responsiveness  and  selectivity of primary  human  renal  proximal tubule cells to 
known nephrotoxins have not been studied.  It is also uncertain whether findings 
in  LLC-PK1  cells  are  different  to  those  of  human  cells  due  to  possible  inter­
species variations (Li et al., 2003).
This Thesis evaluates the performance of Alamar Blue assay and  LDH  release 
as an  index of in  vitro cytotoxicity.  However,  there are several  commonly used 
cytotoxicity  assays  that  are  currently  being  used  including  ATP  measurement 
(Untch et al.,  1994),  3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazoliumbromide 
(MTT)  (Mosmann,  1983),  neutral  red  (Babich  and  Borenfreund,  1991),  trypan 
blue  (Allison  and  Ridolpho,  1980),  and  glutathione  depletion  (Baker  et  al., 
1990).  Alamar  Blue  is  a  sensitive  oxidation-reduction  indicator that fluoresces 
and changes color upon  reduction by living cells. The reduction of Alamar Blue 
is  believed  to  be  mediated  by  mitochondrial  enzymes  (O'Brien  et  al.,  2000). 
Since this  assay relies on enzymatic transformation,  the redox reaction may  in 
some  circumstances  be  modulated  by  test  compounds  resulting  in 
misinterpretation of results and may produce false positives or negatives based 
on  the  mechanism  of  toxicity  of  the  test  compounds  (Hamid  et  al.,  2004). 
However,  these  disadvantages  are  common  among  in  vitro cell-based  assays; 
therefore,  careful  interpretation  of  results  is  warranted.  In  addition,  this  assay 
showed similar efficiency to MTT assay (Hamid et al., 2004).
In  our  laboratory,  we  have  employed  LDH  release  assay  to  gain  a  better 
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cell  injury such  as trypan blue exclusion  under similar conditions demonstrated 
no advantage compared to LDH release (Timm et al.,  1982).
8.1.4  Treatment with CO-RMs
The time of administration of CO-RMs  is an  important factor to accelerate their 
delivery and maximize their beneficial effects on  l-R injury in the kidney.  During 
kidney  harvesting from the donor,  cold  preservation,  and  transplantation,  there 
are  several  opportunities  for therapeutic  intervention  to  reduce  renal  damage, 
improve kidney viability, and graft survival (Table 8-1).  Notably, many studies of 
ischaemic  and  reperfusion  mechanisms  have  had  to  administer  therapeutic 
compounds  prior  to  ischaemia  during  the  harvest  procedure  prior  to  cold 
storage,  which  demonstrate  a  beneficial  effect  for  several  reasons.  Firstly, 
functional deficits in ischaemic kidneys occur from the combined effects of injury 
sustained during ischaemia and reperfusion.  Preventing reperfusion injury could 
reduce the  cumulative  damage  sustained  by the  kidney and  effectively extend 
the duration of tolerable warm  ischaemia.  Secondly,  suppression of reperfusion 
injury  is  difficult  since  treatments  cannot  be  administered  prior to  reperfusion 
due  to  the  absence  of  vascular  flow.  Thirdly,  treatments  applied  during 
reperfusion  may  be  less  effective  since  reperfusion-related  damage  may 
progress  rapidly  while  therapeutic  drugs  are  en  route  to  their  active  sites. 
Finally,  some  areas  of  the  microcirculation  may  remain  poorly  perfused  (no 
reflow),  sustaining continued hypoxic injury and  preventing drug penetration.  In 
this  study,  we  used  CO-RMs  during  the  reperfusion  period  after  24  hr  cold 
ischaemia  as  shown  in  Chapter 4.  As  well,  we  used  CO-RMs  administered  in 
the cold flush before the 24 hr cold l-R injury as shown in Chapter 5. The results 
indicate  better  protection  when  CO-RMs  were  used  prior  to  the  ischaemic
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p e rio d . T h e re fo re , w e  a p p lie d  C O -R M s  b e fo re  th e  is c h a e m ic  p e rio d  fo r e x  vivo 
s tu d ie s  (C h a p te rs  5  a n d  6 ) a n d  in vitro s tu d ie s  (C h a p te r 7 ). S u c h  a d m in is tra tio n  
a ls o  h a s  th e  a d v a n ta g e  o ff b e in g  e th ic a lly  ju s tifie d   in  th e  c u rre n t c o n te x t o f 
c lin ic a l  o rg a n   h a rv e s t,  w h e re a s   a d m in is tra tio n   o f  d ru g s   to   d o n o rs   b e fo re  
re m o v in g  th e  k id n e y  is  n o t c o n s id e re d  a c c e p ta b le  p ra c tic e . A n o th e r p o s s ib ility , 
w h ic h  c o u ld  n o t b e  s tu d ie d  in  th is  T h e s is  fo r la c k  o f tim e , is  th e  a d m in is tra tio n  o f 
C O -R M s  in  k id n e y s  c o ld -s to re d  b y  c o n tin u o u s  h y p o th e rm ic  p e rfu s io n . T h e re  is  a  
re s u rg e n c e  o f in te re s t in  h y p o th e rm ic  p e rfu s io n  in  re n a l p re s e rv a tio n  (B ra s ile  e t 
a l.,  2 0 0 3 ),  a lth o u g h   it is  n o t p o s s ib le  a t p re s e n t to  s p e c u la te  h o w  C O -R M s  
w o u ld  m o d u la te  re n a l fu n c tio n  in  th is  c o n d itio n .
CO donor [184]
1 Donor treatment
HO-1  inducer [321]
Using  modified flushing solution  during B iliru b in  +
2 [4]
donor harvesting Flushing solution
3 D u rin g  th e  c o ld  s to ra g e  p e rio d T rim e ta z id in e [130]
4 P rio r to  k id n e y  g ra ftin g  b e fo re  re p e rfu s io n M a n n ito l [167]
5 R e c ip ie n t tre a tm e n t b e fo re  tra n s p la n ta tio n C O  g a s [215,219]
C O  g a s [215,219]
6 R e c ip ie n t tre a tm e n t a fte r tra n s p la n ta tio n
C O  d o n o r [184]
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8.2  Thesis Discussion
Carbon  monoxide-releasing molecules (CO-RMs) are a novel class of bioactive 
agents  that  have  been  recently  identified  and  employed  to  substantiate  the 
important  biological  function  of CO  in  mammalian  systems  (Clark et al.,  2003; 
Motterlini  et  al.,  2002a;  Motterlini  et  al.,  2003).  We  have  proposed  that  their 
pharmacological properties could be exploited for the therapeutic delivery of CO 
in  the  treatments  of  a  variety  of  pathophysiological  states  that  affect  the 
cardiovascular system  (Clark et al.,  2003;  Foresti et al.,  2004b;  Motterlini et al., 
2004;  Sawle et al., 2005).
It  is  intriguing  to  note that the  intensity of bioactivity was different between the 
CO-RMs  utilized  under  the  same  condition.  There  was  some  variation  in  the 
efficiency  of  CO  liberated  from  CO-RMs  in  the  different  models  used  in  this 
Thesis.  This  is  rather  surprising  since  all  agents  were  equally  effective  to 
release  one  mole  of  CO  per  mole  of  the  compound.  The  reason  for  this 
apparent discrepancy  may lie in the different stability of CO-RMs in the various 
solutions  used,  their inherent chemical features,  and their ability to liberate CO 
with a specific rate.  Here,  we showed that both CORM-2 and CORM-3 are fast 
releaser of CO,  while CORM-A1  liberates CO very slowly.  This is in agreement 
with  previous  studies from  our  laboratories  (Clark et al.,  2003;  Motterlini  et al., 
2003;  Motterlini  et al.,  2004).  However,  we showed that at low temperatures (4 
°C),  the  rate  of  CO  release  from  CORM-3  and  CORM-A1  is  significantly 
decreased  and  CO  liberated  more  gradually from  both  compounds  during  the 
24  hr  CS  period.  This  indicates  that  the  kinetic  of  CO  release  from  CO-RMs 
under different conditions plays a crucial role in determining and maximizing the 
beneficial effects of these CO carriers.
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The  activation  of  HO-1,  and  consequently  the  production  of  CO,  has  been 
established  as  a  key  element  in  the  maintenance  of  kidney function  following 
injurious  events  or  in  conditions  affecting  the  renal  system  (Motterlini  et  al., 
2005).  The  mechanisms  responsible  for  the  protective  effects  in  renal  injury 
exerted  by  CO  are  not  well  understood.  However,  it  may  involve  multiple 
pathways  including  activation  of  soluble  guanylate  cyclase  (sGC),  potassium 
channels,  mitogen-activated protein kinase (MAPK), or mitochondria.
Firstly,  soluble guanylate cyclase (sGC) was one of the first pathways identified 
which  contributes  to  the  regulation  of  vascular  tone  (Sammut  et  al.,  1998a), 
neurotransmission  (Ingi  et  al.,  1996),  cell  proliferation  (Morita  et  al.,  1997), 
blockade of apoptosis (Liu et al., 2003),  inhibition of platelet aggregation (Brune 
and  Ullrich,  1987),  and  other  beneficial  actions  related  to  organ  ischaemia- 
reperfusion  (Nakao  et  al.,  2003a).  In  this  Thesis,  the  experimental  results 
demonstrate  the  beneficial  effects  of  CO  liberated  from  CO-RMs  against  cold 
renal injury at least in part by activation of sGC,  because ODQ (a sGC inhibitor) 
completely  reversed  the  vasodilatory  effect  conferred  by  CO.  These  data  are 
consistent  with  a  previous  report  by  Nakao  and  colleagues  showing  that  peri­
operative CO inhalation at a low concentration resulted in protection against l-R 
injury to intestinal grafts with prolonged cold preservation. The authors reported 
that the protective effects of CO  in this study were  mediated via sGC,  as ODQ 
completely reversed the beneficial effect conferred by CO (Nakao et al., 2003b). 
Similarly,  it  has  been  shown  by  our  group  that  CORM-3  and  CORM-A1 
produced  a concentration-dependent relaxation  in pre-contracted aortic vessels 
in  a  process  that  is  mediated  by  guanylate  cyclase  activation  (Foresti  et  al., 
2004b;  Motterlini  et  al.,  2004).  Additionally,  we  have  demonstrated  that  HO-1
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induction  in aortic tissue is correlated with an increased endogenous release of 
CO  that  suppresses  vascular contractility by activation  of sGC  (Sammut et al., 
1998a).  Furthermore,  it has  been demonstrated  that  CO  gas  causes  a cGMP- 
dependent  relaxation  of  both  rabbit  cavernosal  and  urethral  smooth  muscle 
(Naseem et al., 2000), and rabbit aortic rings (Hussain et al.,  1997).
Secondly,  potassium  channels  are  a  major  pathway  utilized  by  CO  to  exert 
biological  functions  and  data  in  the  literature  support their involvement  in  CO- 
induced vasorelaxation, which involves calcium-activated K+  channels (Wang et 
al.,  2001),  tetraethylammonium-sensitive  K+   channel  (Kaide  et  al.,  2001),  and 
the apical  70-pS  K+  channel  (Liu et al.,  1999).  Similarly,  our group have shown 
that  both  CORM-3  and  CORM-A1  produced  a  concentration-dependent 
relaxation in pre-contracted aortic vessels in a process that is mediated by ATP- 
dependent  K+   channels  (Foresti  et  al.,  2004b;  Motterlini  et  al.,  2004). 
Furthermore,  it  has  been  demonstrated  in  our  laboratory  that  the 
cardioprotective  effects  mediated  by  CORM-3  in  cardiac  cells  and  isolated 
hearts  were  totally  abolished  by  5-hydroxydecanoic  acid,  an  inhibitor  of 
mitochondrial  ATP-dependent  K+   channels  (Clark  et  al.,  2003).  Here,  ATP- 
dependent K+  channels did  not mediate the observed protective effect with CO- 
RMs against cold-induced injury in LLC-PK1  cells.  However,  the involvement of 
K+  channel pathway in CO-mediated protective effects in an  IPRK model cannot 
be excluded as this pathway was not investigated in this study.
Thirdly,  CO  appears  to  act  via  MAPK  pathways  which  contribute  to  the  anti- 
apoptotic  effects  (Brouard  et  al.,  2000;  Zhang  et  al.,  2003),  and  the  anti­
proliferative effects (Otterbein et al., 2003;  Song et al., 2002). Additional studies 
revealed  that  MAPK  pathways  are  also  likely  to  be  involved  in  affording
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protection  against  l-R injury of the lung (Zhang et al.,  2003),  heart (Fujimoto et 
al.,  2004),  liver (Amersi  et al.,  2002),  and as well as a protective role for CO  in 
vascular injury (Otterbein et al.,  2003).  However,  no  reports were  published on 
the  involvement  of this  pathway  in the kidney.  Therefore,  the protective role of 
CO, which may involve MAPK pathway, was not examined in this Thesis.
Fourth,  inhibition  of  inflammatory  mediators  may  play  a  major  role  in  the 
cytoprotective  effects  of CO.  These  include  inflammatory cytokines (IL-6,  TNF-
a),  stress-induced  molecules  (iNOS,  HO-1,  COX-2),  and  adhesion  molecule 
(ICAM-1)  as  well  as  nitrite  levels  in  the  urine  or serum.  For  instance,  CO  gas 
has been  shown  to protect against l-R injury in renal  (Nakao et al.,  2005;  Neto 
et  al.,  2004),  cardiac  (Fujimoto  et  al.,  2004;  Nakao  et  al.,  2005),  liver  (Draper 
and  Hadley,  1990)  and  small  intestinal  transplantation  (Nakao et al.,  2003b)  in 
part  by  decreasing  pro-inflammatory  mediators.  In  this  study,  we  showed  that 
CORM-3  reduced  nitrite  concentration  in  the  urine,  which  could  be  a  possible 
anti-inflammatory action of CO.  In support,  Nakao and co-workers showed that 
CO  reduced  serum  nitrate/nitrite  levels  in  a  model  of  small  intestinal 
transplantation (Nakao et al.,  2003a).  Furthermore,  our laboratory has provided 
more  recently  evidence  for  an  anti-inflammatory  action  of  CORM-3  which 
inhibits  the  increase  in  TNF-a  and  nitrite  levels  in  endotoxin-stimulated 
macrophages (Sawle et al., 2005).
Finally,  mitochondria  are  a  new  candidate  that  could  potentially  serve  as  a 
possible target by which CO confers protection following ischaemic injury.  They 
play  a  fundamental  role  in  l-R  injury  in  organ  transplantation  (Jassem  and 
Heaton,  2004) by controlling apoptotic events (Bernardi et al.,  2001;  Green and 
Reed,  1998)  and the generation of reactive oxygen species (ROS)  (Balaban et
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al.,  2005).  In  this  study,  we  showed  that  mitochondrial  respiration  was 
significantly  modulated  or  improved  with  CO-RMs.  Our  findings  are  in 
agreement  with  preliminary  studies  from  our  group  and  collaborators  which 
reveal  that  both  mitochondrial  respiratory chain  and free radical generation are 
targets  for  the  anti-proliferative  effect  of  CO-RMs  (Taille  et  al.,  2005). 
Furthermore,  we reported that CORM-3 protects against hypoxia-reoxygenation 
injury  in  cardiac  cells  via  activation  of  mitochondrial  ATP-dependent  K+  
channels  (Clark  et  al.,  2003).  Very  recently,  we  have  demonstrated  that  HO-1 
induction  can  modulate  mitochondrial  respiration  in  isolated  rat  kidneys 
(Sandouka et al., 2005).
Despite  the  different  rate  of CO  release,  the  results  confirm  the  ability  of CO- 
RMs  to  elicit  pharmacological  effects  that  are  typical  of  CO  gas  and  suggest 
that  CO  released  from  CO-RMs  confer  significant  protection  against  cold 
ischaemic  renal  injury.  This  is  in  agreement with the following  lines  of defence 
that  support  the  beneficial  role  of  CO  against  renal  l-R  injury.  Firstly,  low 
concentrations of CO  gas have been shown to play a significant protective role 
against cold  l-R injury associated with kidney transplantation (Neto et al., 2004). 
In  parallel,  dual-treatment with  CO  and  biliverdin  provides  enhanced  protection 
against transplant-associated  cold  l-R  injury of heart and  kidney grafts  (Nakao 
et  al.,  2005).  More  recently,  Neto  et.  al.  showed  that  inhaled  CO  at  a  low 
concentration  efficiently  ameliorates  chronic  fibro-inflammatory  changes 
associated  with  chronic  allograft  nephropathy  and  improves  long-term  renal 
allograft function  (Neto et al., 2005).  Secondly,  CO donors have been shown to 
provide protection in a similar way to CO gas.  For instance,  it has recently been 
shown  that  CO  released  from  CO-RMs  attenuates  renal  damage  in  warm
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ischaemia-induced  renal  failure  when  the  agents  were  given  prior  to  the 
ischaemic insult  (Vera et al.,  2005).  In addition Arregui and colleagues showed 
that CORM-1  plays an important role in the control of renal haemodynamics and 
function  in  vivo  (Arregui  et  al.,  2004).  Furthermore,  treatment  of  donors  and 
long-term  recipients with  methylene chloride,  a  CO  donor,  improved renal graft 
function  and  reduced  histological  signs  of  chronic  rejection  (Martins  et  al., 
2005).  Finally,  over-expression  of  HO-1  can  also  protect  against  renal  cold 
ischaemic injury both in vivo and in vitro (Katori et al., 2002b; Salahudeen et al., 
2001). This cytoprotection with the HO system may serve as a novel therapeutic 
strategy against l-R injury (Katori et al., 2002a).
For comparison,  considering the similarities between CO and NO,  NO has been 
shown  to  cause  vasorelaxation  in  reperfused  kidneys  after  cold  ischaemia 
(Hansen et al.,  1997).  The  NO  system  has been  implicated as playing a role in 
renal ischaemia and renal failure (Shoskes et al.,  1997) (Healy et al., 2000). For 
instance,  previous findings clearly indicate the beneficial effect of a spontaneous 
NO  releaser  FK409  on  the  impairment  of  renal  function  and  tissue  damages 
observed in postischaemic ARF in rats (Matsumura et al.,  1998).  In addition,  as 
shown  in animals or in humans,  inhibition of NO synthase results in a decrease 
in  renal  blood flow,  urinary  output,  urinary  sodium  excretion,  fractional  sodium 
excretion  and  glomerular filtration  rate  (Haynes  et  al.,  1997),  suggesting  that 
tonic  activity  of  the  NO  system.  Interestingly,  nitrate  excretion  is  elevated 
following  acute renal  ischaemia  (Goor et al.,  1996) and  NO  synthase blockade 
increases renal vascular resistances and decreases the glomerular ultrafiltration 
coefficient (Gabbai  and  Blantz,  1999).  It has also been  shown that  NO  plays a 
role  in  mitochondrial  biogenesis  in  a  cGMP-dependent  manner  (Nisoli  et  al.,
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2003).  Therefore,  considering  that  both  CO  and  NO  bind  reversibly  to 
cytochrome  c  oxidase  in  competition  with  O2  and  decrease  its  enzymatic 
activity,  the hypothesis that CO may also act as a physiological regulator of cell 
metabolism in a similar way to NO cannot be excluded at present.
8.3  Conclusion
Low  concentrations  of  CO  have  been  shown  to  be  protective  against  organ 
injury  in  a variety of models.  The main  hypothesis of the Thesis states that low 
concentrations of CO released from CO-RMs will  protect against l-R injury. The 
present Thesis was  designed  mainly to examine the  possible  beneficial  effects 
of CO  released  from  CO-RMs  against  renal  l-R  injury.  The  results  emphasize 
that  CO  liberated from  CO-RMs  modulates  mitochondrial  respiratory  activity  in 
isolated  renal  rat  mitochondria  suggesting  that  CO  may  cause  adverse  renal 
effects  by  decreasing  renal  oxygen  consumption  and  altered  mitochondrial 
function.  On the other hand, these results also suggest that CO,  like NO,  could 
be  a  physiological  regulator  of  cellular  metabolism  by  its  direct  action  on 
mitochondrial  oxidative  phosphorylation  and  may  be  of  particular  interest  in 
pathological  conditions  involving  metabolic  insults  such  as  l-R  injury  and  that 
CO  may  act  as  an  energy  preserver  rather than  energy  inhibitor.  In  an  IPRK 
model,  CO reduces tubular reabsorption and increases perfusate and urine flow 
rate and glomerular filtration rate of freshly isolated kidneys suggesting that CO 
may  afford  a  protection  from  hypoxic  renal  injury  by  restoring  energy  and 
oxygen  availability.  However,  in  the  same  model,  kidneys  flushed  with  a  cold 
preservation  solution  supplemented with  CO-RMs  and  stored  at 4 °C for 24  or 
48  hr  displayed  at  reperfusion  a  significant  protective  vasodilatory  effect, 
improved  renal  function  and  mitochondrial  respiration,  and  decreased  tubular
279GENERAL DISCUSSION
injury  markers  compared  to  control  kidneys  flushed  with  cold  solution  alone. 
The protective effects of CO in this model were mediated in part via the soluble 
guanylyl  cyclase  pathway.  In  contrast,  in  a  warm  l-R  model,  CO  was  only 
beneficial  by  increasing  the  perfusate  flow  rate  at  reperfusion.  In  addition,  CO 
protects  against  preservation  injury  using  the  in  vitro  model  of  LLC-PKi  cells. 
The  results  also  demonstrate  that  Celsior  and  UW  solutions  are  convenient 
carrier solutions with which to study CO-RMs in renal cold ischaemic injury. 
Altogether,  these  findings  suggest  that  CO  may  be  useful  for  renal  allograft 
preservation  and  could  be  used  therapeutically  in  preservation  solutions as an 
efficacious  strategy  to  prevent  the  injury  sustained  by  organs  during  cold 
storage prior to transplantation.  From the clinical point of view, the application of 
CO-RMs  directly  to  the  preservation  solution  at  the  time  of  organ  flushing  is 
particularly  attractive,  because  other  manipulations,  such  as  prior  induction  of 
HO-1  or  application  of  CO  gas,  would  be  difficult  to  achieve  due  to  practical, 
logistical  and  ethical  constraints.  The  data  presented  here  on the  ex  vivo  and 
the in vitro models suggest that treatment with CO-RMs may also improve renal 
function  after  hypothermic  preservation  and  subsequent  transplantation.  By 
doing  so,  CO  may  work  as  a  novel  agent  for  kidney  preservation  research.ij c l FUTURE STUDIES
PROPOSALS FOR FUTURE STUDIES
•  Further work  is  needed  to  study the  molecular targets  for  CO  action  when 
using  CO-RMs  during  cold  storage,  and  in  protection  against  ischaemic 
injury after cold preservation in in vivo transplantation models.
•  To  study  the  role  of reactive  oxygen  species  and  lipid  peroxidation  in  CO- 
RMs-mediated protective effects in IPRK model as well as in the cell culture 
model.
•  To  compare  the  observed  effects  of  CO-RMs  on  kidney  function  and  l-R 
injury with the effects of NO donors on the same models.
•  To study other mechanisms that may be involved in the protective effects of 
CO-RMs during cold  l-R injury such as K+  channels and MAPK pathways,  in 
addition to pro-inflammatory mediators.
•  To  measure  mitochondrial  respiratory  complexes  and  ATP  production  after 
treatment with CO-RMs.
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